Gene to GO BP test for over-representation
GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048519 | 0.000 | 3.033 | 200 | 383 | 2636 | negative regulation of biological process |
GO:0044767 | 0.000 | 2.991 | 216 | 402 | 2848 | single-organism developmental process |
GO:0050793 | 0.000 | 3.671 | 93 | 236 | 1230 | regulation of developmental process |
GO:0030154 | 0.000 | 3.046 | 164 | 331 | 2156 | cell differentiation |
GO:0048522 | 0.000 | 2.910 | 202 | 378 | 2660 | positive regulation of cellular process |
GO:0048523 | 0.000 | 2.944 | 184 | 355 | 2423 | negative regulation of cellular process |
GO:0048513 | 0.000 | 3.040 | 153 | 314 | 2015 | organ development |
GO:0048869 | 0.000 | 2.943 | 172 | 338 | 2270 | cellular developmental process |
GO:0048731 | 0.000 | 2.827 | 214 | 389 | 2821 | system development |
GO:0048856 | 0.000 | 2.758 | 244 | 422 | 3214 | anatomical structure development |
GO:0048518 | 0.000 | 2.762 | 221 | 394 | 2915 | positive regulation of biological process |
GO:0032502 | 0.000 | 2.706 | 272 | 451 | 3581 | developmental process |
GO:0042127 | 0.000 | 3.661 | 78 | 202 | 1023 | regulation of cell proliferation |
GO:2000026 | 0.000 | 3.692 | 73 | 192 | 958 | regulation of multicellular organismal development |
GO:0031325 | 0.000 | 3.052 | 125 | 268 | 1644 | positive regulation of cellular metabolic process |
GO:0010604 | 0.000 | 3.072 | 122 | 264 | 1606 | positive regulation of macromolecule metabolic process |
GO:0009893 | 0.000 | 2.994 | 131 | 276 | 1729 | positive regulation of metabolic process |
GO:0008283 | 0.000 | 3.203 | 102 | 234 | 1345 | cell proliferation |
GO:0045595 | 0.000 | 3.752 | 66 | 178 | 867 | regulation of cell differentiation |
GO:0007275 | 0.000 | 2.599 | 244 | 411 | 3213 | multicellular organismal development |
GO:0019222 | 0.000 | 2.548 | 283 | 453 | 3735 | regulation of metabolic process |
GO:0051239 | 0.000 | 2.989 | 118 | 253 | 1555 | regulation of multicellular organismal process |
GO:0080090 | 0.000 | 2.536 | 253 | 418 | 3340 | regulation of primary metabolic process |
GO:0009653 | 0.000 | 2.876 | 131 | 269 | 1724 | anatomical structure morphogenesis |
GO:0060255 | 0.000 | 2.537 | 244 | 407 | 3218 | regulation of macromolecule metabolic process |
GO:0009888 | 0.000 | 3.337 | 81 | 197 | 1064 | tissue development |
GO:0031323 | 0.000 | 2.501 | 256 | 418 | 3369 | regulation of cellular metabolic process |
GO:0010033 | 0.000 | 2.857 | 127 | 262 | 1677 | response to organic substance |
GO:0010557 | 0.000 | 3.339 | 78 | 192 | 1032 | positive regulation of macromolecule biosynthetic process |
GO:0009891 | 0.000 | 3.203 | 85 | 201 | 1123 | positive regulation of biosynthetic process |
GO:0032268 | 0.000 | 3.224 | 82 | 196 | 1085 | regulation of cellular protein metabolic process |
GO:0048646 | 0.000 | 2.983 | 103 | 225 | 1352 | anatomical structure formation involved in morphogenesis |
GO:0051246 | 0.000 | 3.065 | 94 | 213 | 1242 | regulation of protein metabolic process |
GO:0031328 | 0.000 | 3.171 | 84 | 197 | 1105 | positive regulation of cellular biosynthetic process |
GO:0023051 | 0.000 | 2.763 | 128 | 258 | 1686 | regulation of signaling |
GO:0010646 | 0.000 | 2.752 | 128 | 258 | 1691 | regulation of cell communication |
GO:0065009 | 0.000 | 2.827 | 116 | 241 | 1527 | regulation of molecular function |
GO:0009892 | 0.000 | 3.028 | 92 | 207 | 1212 | negative regulation of metabolic process |
GO:0048468 | 0.000 | 2.984 | 95 | 211 | 1253 | cell development |
GO:0009719 | 0.000 | 3.254 | 73 | 178 | 964 | response to endogenous stimulus |
GO:0010628 | 0.000 | 3.276 | 72 | 176 | 947 | positive regulation of gene expression |
GO:0042221 | 0.000 | 2.501 | 183 | 325 | 2411 | response to chemical stimulus |
GO:0009889 | 0.000 | 2.469 | 193 | 336 | 2538 | regulation of biosynthetic process |
GO:0012501 | 0.000 | 2.887 | 102 | 220 | 1349 | programmed cell death |
GO:0010941 | 0.000 | 3.099 | 82 | 190 | 1078 | regulation of cell death |
GO:0070887 | 0.000 | 2.770 | 116 | 238 | 1527 | cellular response to chemical stimulus |
GO:0008219 | 0.000 | 2.781 | 113 | 234 | 1492 | cell death |
GO:0010556 | 0.000 | 2.476 | 182 | 322 | 2399 | regulation of macromolecule biosynthetic process |
GO:0016265 | 0.000 | 2.776 | 113 | 234 | 1494 | death |
GO:2000112 | 0.000 | 2.487 | 176 | 315 | 2326 | regulation of cellular macromolecule biosynthetic process |
GO:0051094 | 0.000 | 3.851 | 46 | 133 | 612 | positive regulation of developmental process |
GO:0006915 | 0.000 | 2.858 | 101 | 217 | 1337 | apoptotic process |
GO:0019219 | 0.000 | 2.431 | 195 | 337 | 2574 | regulation of nucleobase-containing compound metabolic process |
GO:0031326 | 0.000 | 2.438 | 191 | 331 | 2511 | regulation of cellular biosynthetic process |
GO:0051173 | 0.000 | 3.089 | 80 | 185 | 1048 | positive regulation of nitrogen compound metabolic process |
GO:0045935 | 0.000 | 3.095 | 78 | 182 | 1027 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009966 | 0.000 | 2.742 | 112 | 230 | 1477 | regulation of signal transduction |
GO:0071310 | 0.000 | 2.917 | 91 | 201 | 1204 | cellular response to organic substance |
GO:0044707 | 0.000 | 2.299 | 332 | 485 | 4371 | single-multicellular organism process |
GO:0043067 | 0.000 | 3.048 | 80 | 184 | 1052 | regulation of programmed cell death |
GO:0010468 | 0.000 | 2.406 | 191 | 329 | 2514 | regulation of gene expression |
GO:0045597 | 0.000 | 4.378 | 34 | 108 | 443 | positive regulation of cell differentiation |
GO:0006366 | 0.000 | 2.863 | 93 | 202 | 1228 | transcription from RNA polymerase II promoter |
GO:0031399 | 0.000 | 3.202 | 67 | 164 | 889 | regulation of protein modification process |
GO:0050789 | 0.000 | 2.469 | 480 | 625 | 6331 | regulation of biological process |
GO:0010605 | 0.000 | 2.934 | 86 | 191 | 1130 | negative regulation of macromolecule metabolic process |
GO:0042981 | 0.000 | 3.010 | 79 | 181 | 1042 | regulation of apoptotic process |
GO:0051171 | 0.000 | 2.357 | 201 | 339 | 2648 | regulation of nitrogen compound metabolic process |
GO:0065007 | 0.000 | 2.547 | 510 | 650 | 6721 | biological regulation |
GO:0008284 | 0.000 | 3.837 | 43 | 124 | 568 | positive regulation of cell proliferation |
GO:0050794 | 0.000 | 2.396 | 456 | 602 | 6005 | regulation of cellular process |
GO:0051254 | 0.000 | 3.152 | 69 | 166 | 912 | positive regulation of RNA metabolic process |
GO:0031324 | 0.000 | 2.921 | 86 | 190 | 1127 | negative regulation of cellular metabolic process |
GO:0044093 | 0.000 | 3.092 | 73 | 171 | 957 | positive regulation of molecular function |
GO:0032501 | 0.000 | 2.255 | 342 | 492 | 4509 | multicellular organismal process |
GO:0045893 | 0.000 | 3.185 | 66 | 160 | 868 | positive regulation of transcription, DNA-dependent |
GO:0006357 | 0.000 | 2.960 | 81 | 182 | 1062 | regulation of transcription from RNA polymerase II promoter |
GO:0048583 | 0.000 | 2.478 | 146 | 270 | 1927 | regulation of response to stimulus |
GO:0010629 | 0.000 | 3.352 | 56 | 144 | 742 | negative regulation of gene expression |
GO:0023056 | 0.000 | 3.323 | 56 | 143 | 741 | positive regulation of signaling |
GO:0033993 | 0.000 | 3.965 | 37 | 111 | 491 | response to lipid |
GO:0001932 | 0.000 | 3.367 | 54 | 139 | 711 | regulation of protein phosphorylation |
GO:0042325 | 0.000 | 3.253 | 58 | 144 | 759 | regulation of phosphorylation |
GO:0010647 | 0.000 | 3.278 | 56 | 142 | 743 | positive regulation of cell communication |
GO:0051093 | 0.000 | 4.046 | 35 | 106 | 460 | negative regulation of developmental process |
GO:0051716 | 0.000 | 2.185 | 314 | 458 | 4142 | cellular response to stimulus |
GO:0048732 | 0.000 | 5.651 | 19 | 75 | 250 | gland development |
GO:0060548 | 0.000 | 3.688 | 42 | 117 | 549 | negative regulation of cell death |
GO:0071495 | 0.000 | 3.405 | 49 | 129 | 649 | cellular response to endogenous stimulus |
GO:0060429 | 0.000 | 3.819 | 38 | 109 | 495 | epithelium development |
GO:0045944 | 0.000 | 3.467 | 47 | 124 | 613 | positive regulation of transcription from RNA polymerase II promoter |
GO:0022008 | 0.000 | 2.917 | 72 | 164 | 954 | neurogenesis |
GO:0035556 | 0.000 | 2.508 | 118 | 227 | 1553 | intracellular signal transduction |
GO:0043069 | 0.000 | 3.683 | 40 | 113 | 529 | negative regulation of programmed cell death |
GO:0009887 | 0.000 | 3.298 | 52 | 132 | 682 | organ morphogenesis |
GO:0009967 | 0.000 | 3.252 | 53 | 134 | 701 | positive regulation of signal transduction |
GO:0045596 | 0.000 | 4.393 | 28 | 90 | 363 | negative regulation of cell differentiation |
GO:0007243 | 0.000 | 3.138 | 58 | 141 | 762 | intracellular protein kinase cascade |
GO:0007399 | 0.000 | 2.524 | 109 | 213 | 1435 | nervous system development |
GO:0006468 | 0.000 | 2.824 | 74 | 164 | 978 | protein phosphorylation |
GO:0043066 | 0.000 | 3.606 | 40 | 110 | 522 | negative regulation of apoptotic process |
GO:2001141 | 0.000 | 2.273 | 162 | 280 | 2141 | regulation of RNA biosynthetic process |
GO:0006355 | 0.000 | 2.273 | 161 | 278 | 2123 | regulation of transcription, DNA-dependent |
GO:0019220 | 0.000 | 2.730 | 79 | 170 | 1045 | regulation of phosphate metabolic process |
GO:0051252 | 0.000 | 2.242 | 166 | 283 | 2190 | regulation of RNA metabolic process |
GO:0048585 | 0.000 | 3.234 | 49 | 125 | 652 | negative regulation of response to stimulus |
GO:1901700 | 0.000 | 3.154 | 53 | 130 | 694 | response to oxygen-containing compound |
GO:0009890 | 0.000 | 2.931 | 64 | 147 | 841 | negative regulation of biosynthetic process |
GO:0000902 | 0.000 | 3.013 | 59 | 140 | 780 | cell morphogenesis |
GO:0032270 | 0.000 | 3.118 | 54 | 132 | 712 | positive regulation of cellular protein metabolic process |
GO:0050790 | 0.000 | 2.580 | 93 | 188 | 1223 | regulation of catalytic activity |
GO:0051247 | 0.000 | 3.007 | 59 | 139 | 775 | positive regulation of protein metabolic process |
GO:0010627 | 0.000 | 3.310 | 46 | 119 | 607 | regulation of intracellular protein kinase cascade |
GO:0010558 | 0.000 | 2.979 | 60 | 141 | 793 | negative regulation of macromolecule biosynthetic process |
GO:0031327 | 0.000 | 2.932 | 63 | 145 | 828 | negative regulation of cellular biosynthetic process |
GO:0051174 | 0.000 | 2.693 | 80 | 170 | 1056 | regulation of phosphorus metabolic process |
GO:0035295 | 0.000 | 4.128 | 28 | 88 | 371 | tube development |
GO:1901362 | 0.000 | 2.128 | 214 | 338 | 2823 | organic cyclic compound biosynthetic process |
GO:0016310 | 0.000 | 2.649 | 84 | 175 | 1105 | phosphorylation |
GO:0048699 | 0.000 | 2.837 | 68 | 152 | 895 | generation of neurons |
GO:0051172 | 0.000 | 2.977 | 59 | 139 | 781 | negative regulation of nitrogen compound metabolic process |
GO:0048584 | 0.000 | 2.733 | 76 | 163 | 996 | positive regulation of response to stimulus |
GO:0045859 | 0.000 | 3.472 | 40 | 109 | 532 | regulation of protein kinase activity |
GO:0051128 | 0.000 | 2.676 | 80 | 170 | 1061 | regulation of cellular component organization |
GO:0043549 | 0.000 | 3.382 | 42 | 112 | 559 | regulation of kinase activity |
GO:0019438 | 0.000 | 2.125 | 207 | 328 | 2722 | aromatic compound biosynthetic process |
GO:0032989 | 0.000 | 2.894 | 63 | 144 | 830 | cellular component morphogenesis |
GO:2000113 | 0.000 | 2.984 | 58 | 136 | 761 | negative regulation of cellular macromolecule biosynthetic process |
GO:0045934 | 0.000 | 2.970 | 58 | 137 | 770 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009605 | 0.000 | 2.638 | 82 | 172 | 1087 | response to external stimulus |
GO:0031401 | 0.000 | 3.181 | 49 | 122 | 643 | positive regulation of protein modification process |
GO:0007165 | 0.000 | 2.058 | 260 | 387 | 3424 | signal transduction |
GO:0034654 | 0.000 | 2.121 | 203 | 323 | 2674 | nucleobase-containing compound biosynthetic process |
GO:0006351 | 0.000 | 2.167 | 178 | 294 | 2349 | transcription, DNA-dependent |
GO:0006950 | 0.000 | 2.147 | 188 | 305 | 2472 | response to stress |
GO:0051338 | 0.000 | 3.316 | 43 | 113 | 573 | regulation of transferase activity |
GO:0050896 | 0.000 | 2.060 | 401 | 532 | 5287 | response to stimulus |
GO:0044271 | 0.000 | 2.102 | 211 | 332 | 2783 | cellular nitrogen compound biosynthetic process |
GO:0009725 | 0.000 | 3.265 | 45 | 115 | 591 | response to hormone stimulus |
GO:0009059 | 0.000 | 2.063 | 243 | 368 | 3206 | macromolecule biosynthetic process |
GO:0018130 | 0.000 | 2.104 | 207 | 327 | 2730 | heterocycle biosynthetic process |
GO:0009611 | 0.000 | 2.714 | 73 | 157 | 960 | response to wounding |
GO:0000904 | 0.000 | 3.220 | 46 | 116 | 603 | cell morphogenesis involved in differentiation |
GO:0032879 | 0.000 | 2.535 | 90 | 181 | 1187 | regulation of localization |
GO:0051253 | 0.000 | 3.039 | 53 | 127 | 696 | negative regulation of RNA metabolic process |
GO:1901576 | 0.000 | 2.022 | 298 | 426 | 3923 | organic substance biosynthetic process |
GO:0001568 | 0.000 | 3.594 | 35 | 98 | 462 | blood vessel development |
GO:0001944 | 0.000 | 3.509 | 37 | 101 | 486 | vasculature development |
GO:0045892 | 0.000 | 3.062 | 51 | 124 | 674 | negative regulation of transcription, DNA-dependent |
GO:0034645 | 0.000 | 2.053 | 235 | 357 | 3095 | cellular macromolecule biosynthetic process |
GO:0072358 | 0.000 | 3.011 | 53 | 127 | 701 | cardiovascular system development |
GO:0072359 | 0.000 | 3.011 | 53 | 127 | 701 | circulatory system development |
GO:0048729 | 0.000 | 3.791 | 31 | 90 | 405 | tissue morphogenesis |
GO:0007167 | 0.000 | 2.880 | 59 | 136 | 782 | enzyme linked receptor protein signaling pathway |
GO:0023052 | 0.000 | 2.007 | 291 | 417 | 3831 | signaling |
GO:0044700 | 0.000 | 2.007 | 291 | 417 | 3831 | single organism signaling |
GO:0001934 | 0.000 | 3.413 | 38 | 103 | 507 | positive regulation of protein phosphorylation |
GO:0008285 | 0.000 | 3.484 | 36 | 98 | 473 | negative regulation of cell proliferation |
GO:0010648 | 0.000 | 3.239 | 43 | 109 | 561 | negative regulation of cell communication |
GO:0006139 | 0.000 | 1.989 | 299 | 424 | 3936 | nucleobase-containing compound metabolic process |
GO:0040011 | 0.000 | 2.543 | 83 | 169 | 1096 | locomotion |
GO:0051726 | 0.000 | 3.085 | 48 | 117 | 629 | regulation of cell cycle |
GO:0016477 | 0.000 | 2.874 | 58 | 132 | 758 | cell migration |
GO:0002520 | 0.000 | 3.389 | 38 | 101 | 499 | immune system development |
GO:0042327 | 0.000 | 3.327 | 39 | 103 | 517 | positive regulation of phosphorylation |
GO:0009058 | 0.000 | 1.978 | 301 | 426 | 3973 | biosynthetic process |
GO:0023057 | 0.000 | 3.220 | 42 | 108 | 558 | negative regulation of signaling |
GO:0032774 | 0.000 | 2.090 | 183 | 295 | 2418 | RNA biosynthetic process |
GO:0014070 | 0.000 | 3.436 | 36 | 98 | 478 | response to organic cyclic compound |
GO:0022603 | 0.000 | 3.318 | 39 | 103 | 518 | regulation of anatomical structure morphogenesis |
GO:0007154 | 0.000 | 1.975 | 296 | 420 | 3903 | cell communication |
GO:0044249 | 0.000 | 1.972 | 292 | 415 | 3846 | cellular biosynthetic process |
GO:0002009 | 0.000 | 4.153 | 24 | 76 | 316 | morphogenesis of an epithelium |
GO:0048534 | 0.000 | 3.425 | 36 | 97 | 474 | hematopoietic or lymphoid organ development |
GO:0048870 | 0.000 | 2.761 | 61 | 136 | 808 | cell motility |
GO:0051674 | 0.000 | 2.761 | 61 | 136 | 808 | localization of cell |
GO:0065008 | 0.000 | 2.105 | 166 | 273 | 2193 | regulation of biological quality |
GO:0009968 | 0.000 | 3.221 | 40 | 103 | 530 | negative regulation of signal transduction |
GO:0006725 | 0.000 | 1.947 | 309 | 431 | 4071 | cellular aromatic compound metabolic process |
GO:0030182 | 0.000 | 2.725 | 62 | 137 | 823 | neuron differentiation |
GO:0046483 | 0.000 | 1.944 | 308 | 430 | 4061 | heterocycle metabolic process |
GO:0002376 | 0.000 | 2.244 | 119 | 213 | 1567 | immune system process |
GO:0044260 | 0.000 | 1.944 | 376 | 499 | 4962 | cellular macromolecule metabolic process |
GO:0034641 | 0.000 | 1.925 | 322 | 443 | 4247 | cellular nitrogen compound metabolic process |
GO:0043085 | 0.000 | 2.721 | 60 | 132 | 791 | positive regulation of catalytic activity |
GO:0010562 | 0.000 | 3.042 | 44 | 108 | 583 | positive regulation of phosphorus metabolic process |
GO:0045937 | 0.000 | 3.042 | 44 | 108 | 583 | positive regulation of phosphate metabolic process |
GO:1901360 | 0.000 | 1.919 | 323 | 443 | 4254 | organic cyclic compound metabolic process |
GO:0030097 | 0.000 | 3.401 | 34 | 91 | 445 | hemopoiesis |
GO:0090304 | 0.000 | 1.946 | 250 | 365 | 3291 | nucleic acid metabolic process |
GO:0048514 | 0.000 | 3.533 | 31 | 86 | 407 | blood vessel morphogenesis |
GO:0010467 | 0.000 | 1.942 | 249 | 364 | 3284 | gene expression |
GO:0000165 | 0.000 | 3.296 | 36 | 94 | 472 | MAPK cascade |
GO:0001525 | 0.000 | 3.841 | 25 | 76 | 335 | angiogenesis |
GO:1901698 | 0.000 | 3.031 | 43 | 106 | 573 | response to nitrogen compound |
GO:0006928 | 0.000 | 2.456 | 79 | 157 | 1037 | cellular component movement |
GO:0007049 | 0.000 | 2.381 | 87 | 168 | 1145 | cell cycle |
GO:0022612 | 0.000 | 7.872 | 8 | 39 | 102 | gland morphogenesis |
GO:0001655 | 0.000 | 4.414 | 19 | 63 | 248 | urogenital system development |
GO:0016043 | 0.000 | 1.916 | 255 | 368 | 3358 | cellular component organization |
GO:0009790 | 0.000 | 2.685 | 58 | 127 | 766 | embryo development |
GO:0022414 | 0.000 | 2.309 | 95 | 178 | 1251 | reproductive process |
GO:0006807 | 0.000 | 1.885 | 344 | 461 | 4528 | nitrogen compound metabolic process |
GO:0051090 | 0.000 | 4.127 | 21 | 67 | 278 | regulation of sequence-specific DNA binding transcription factor activity |
GO:0060284 | 0.000 | 3.362 | 32 | 87 | 428 | regulation of cell development |
GO:0044763 | 0.000 | 2.164 | 568 | 671 | 7490 | single-organism cellular process |
GO:0000122 | 0.000 | 3.331 | 33 | 87 | 431 | negative regulation of transcription from RNA polymerase II promoter |
GO:0043170 | 0.000 | 1.903 | 418 | 534 | 5511 | macromolecule metabolic process |
GO:0001763 | 0.000 | 5.389 | 13 | 50 | 169 | morphogenesis of a branching structure |
GO:0002682 | 0.000 | 2.664 | 57 | 124 | 751 | regulation of immune system process |
GO:0032880 | 0.000 | 3.722 | 25 | 72 | 324 | regulation of protein localization |
GO:0061138 | 0.000 | 5.437 | 12 | 48 | 161 | morphogenesis of a branching epithelium |
GO:0071840 | 0.000 | 1.872 | 261 | 371 | 3441 | cellular component organization or biogenesis |
GO:0000003 | 0.000 | 2.227 | 99 | 181 | 1310 | reproduction |
GO:0003006 | 0.000 | 3.573 | 26 | 75 | 349 | developmental process involved in reproduction |
GO:0007166 | 0.000 | 2.015 | 152 | 246 | 2002 | cell surface receptor signaling pathway |
GO:0016070 | 0.000 | 1.895 | 219 | 324 | 2892 | RNA metabolic process |
GO:0033674 | 0.000 | 3.400 | 29 | 79 | 383 | positive regulation of kinase activity |
GO:0050673 | 0.000 | 4.595 | 16 | 55 | 209 | epithelial cell proliferation |
GO:0070848 | 0.000 | 3.307 | 31 | 82 | 407 | response to growth factor stimulus |
GO:0045860 | 0.000 | 3.444 | 28 | 76 | 364 | positive regulation of protein kinase activity |
GO:0009628 | 0.000 | 2.657 | 52 | 114 | 687 | response to abiotic stimulus |
GO:0060485 | 0.000 | 5.767 | 10 | 43 | 138 | mesenchyme development |
GO:1901701 | 0.000 | 3.468 | 27 | 74 | 352 | cellular response to oxygen-containing compound |
GO:0051347 | 0.000 | 3.299 | 30 | 79 | 392 | positive regulation of transferase activity |
GO:0051270 | 0.000 | 3.180 | 32 | 83 | 425 | regulation of cellular component movement |
GO:0010740 | 0.000 | 3.170 | 32 | 83 | 426 | positive regulation of intracellular protein kinase cascade |
GO:0043408 | 0.000 | 3.221 | 31 | 81 | 410 | regulation of MAPK cascade |
GO:0010243 | 0.000 | 2.874 | 41 | 97 | 543 | response to organic nitrogen |
GO:0007417 | 0.000 | 2.770 | 45 | 103 | 596 | central nervous system development |
GO:0097305 | 0.000 | 4.445 | 16 | 53 | 206 | response to alcohol |
GO:0071363 | 0.000 | 3.210 | 30 | 78 | 395 | cellular response to growth factor stimulus |
GO:1901699 | 0.000 | 3.378 | 26 | 72 | 349 | cellular response to nitrogen compound |
GO:0048568 | 0.000 | 3.639 | 22 | 65 | 296 | embryonic organ development |
GO:0071396 | 0.000 | 4.474 | 15 | 51 | 197 | cellular response to lipid |
GO:0044237 | 0.000 | 1.871 | 496 | 598 | 6533 | cellular metabolic process |
GO:0040012 | 0.000 | 3.153 | 31 | 79 | 406 | regulation of locomotion |
GO:0051179 | 0.000 | 1.796 | 261 | 363 | 3436 | localization |
GO:0007169 | 0.000 | 2.757 | 43 | 97 | 561 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0008152 | 0.000 | 1.927 | 543 | 639 | 7153 | metabolic process |
GO:0051960 | 0.000 | 3.199 | 29 | 75 | 380 | regulation of nervous system development |
GO:0051240 | 0.000 | 2.970 | 34 | 84 | 454 | positive regulation of multicellular organismal process |
GO:0035239 | 0.000 | 3.866 | 19 | 58 | 251 | tube morphogenesis |
GO:0048545 | 0.000 | 3.974 | 18 | 56 | 237 | response to steroid hormone stimulus |
GO:0051272 | 0.000 | 4.099 | 17 | 54 | 223 | positive regulation of cellular component movement |
GO:0031175 | 0.000 | 2.678 | 45 | 100 | 593 | neuron projection development |
GO:2000145 | 0.000 | 3.178 | 29 | 75 | 382 | regulation of cell motility |
GO:0033043 | 0.000 | 3.021 | 33 | 81 | 431 | regulation of organelle organization |
GO:0010942 | 0.000 | 3.114 | 30 | 77 | 399 | positive regulation of cell death |
GO:0071704 | 0.000 | 1.870 | 517 | 615 | 6813 | organic substance metabolic process |
GO:0050678 | 0.000 | 4.578 | 14 | 47 | 178 | regulation of epithelial cell proliferation |
GO:0051130 | 0.000 | 2.986 | 33 | 81 | 435 | positive regulation of cellular component organization |
GO:0006793 | 0.000 | 1.893 | 158 | 245 | 2084 | phosphorus metabolic process |
GO:0030155 | 0.000 | 3.866 | 18 | 56 | 242 | regulation of cell adhesion |
GO:0002521 | 0.000 | 3.503 | 22 | 63 | 295 | leukocyte differentiation |
GO:0010608 | 0.000 | 3.456 | 23 | 64 | 303 | posttranscriptional regulation of gene expression |
GO:0007423 | 0.000 | 3.148 | 28 | 73 | 374 | sensory organ development |
GO:0048666 | 0.000 | 2.514 | 51 | 108 | 677 | neuron development |
GO:0022402 | 0.000 | 2.320 | 66 | 129 | 874 | cell cycle process |
GO:0001775 | 0.000 | 2.520 | 51 | 107 | 669 | cell activation |
GO:0043068 | 0.000 | 3.100 | 29 | 74 | 384 | positive regulation of programmed cell death |
GO:0060562 | 0.000 | 3.855 | 18 | 55 | 238 | epithelial tube morphogenesis |
GO:0044699 | 0.000 | 2.121 | 624 | 706 | 8231 | single-organism process |
GO:0048608 | 0.000 | 3.946 | 17 | 53 | 225 | reproductive structure development |
GO:0061458 | 0.000 | 3.946 | 17 | 53 | 225 | reproductive system development |
GO:0030334 | 0.000 | 3.150 | 28 | 71 | 363 | regulation of cell migration |
GO:0043065 | 0.000 | 3.084 | 29 | 73 | 380 | positive regulation of apoptotic process |
GO:0006796 | 0.000 | 1.876 | 155 | 240 | 2049 | phosphate-containing compound metabolic process |
GO:0044238 | 0.000 | 1.813 | 503 | 599 | 6624 | primary metabolic process |
GO:0030099 | 0.000 | 4.025 | 16 | 51 | 213 | myeloid cell differentiation |
GO:0050767 | 0.000 | 3.221 | 26 | 68 | 341 | regulation of neurogenesis |
GO:0051704 | 0.000 | 2.103 | 91 | 160 | 1194 | multi-organism process |
GO:0040007 | 0.000 | 2.494 | 50 | 105 | 661 | growth |
GO:0070201 | 0.000 | 3.492 | 21 | 60 | 281 | regulation of establishment of protein localization |
GO:0048762 | 0.000 | 5.619 | 9 | 36 | 117 | mesenchymal cell differentiation |
GO:0061061 | 0.000 | 2.986 | 30 | 75 | 401 | muscle structure development |
GO:0080134 | 0.000 | 2.486 | 50 | 104 | 656 | regulation of response to stress |
GO:2000147 | 0.000 | 3.927 | 16 | 51 | 217 | positive regulation of cell motility |
GO:0042063 | 0.000 | 4.924 | 11 | 40 | 143 | gliogenesis |
GO:0044267 | 0.000 | 1.786 | 195 | 284 | 2575 | cellular protein metabolic process |
GO:0006464 | 0.000 | 1.854 | 154 | 236 | 2027 | cellular protein modification process |
GO:0036211 | 0.000 | 1.854 | 154 | 236 | 2027 | protein modification process |
GO:0019538 | 0.000 | 1.743 | 235 | 328 | 3099 | protein metabolic process |
GO:0060541 | 0.000 | 4.729 | 11 | 41 | 151 | respiratory system development |
GO:0018108 | 0.000 | 4.305 | 14 | 45 | 178 | peptidyl-tyrosine phosphorylation |
GO:0032496 | 0.000 | 4.214 | 14 | 46 | 185 | response to lipopolysaccharide |
GO:0018193 | 0.000 | 2.588 | 43 | 93 | 564 | peptidyl-amino acid modification |
GO:0006935 | 0.000 | 2.645 | 40 | 89 | 529 | chemotaxis |
GO:0042330 | 0.000 | 2.645 | 40 | 89 | 529 | taxis |
GO:0042060 | 0.000 | 2.612 | 42 | 91 | 547 | wound healing |
GO:0014031 | 0.000 | 5.720 | 8 | 34 | 109 | mesenchymal cell development |
GO:0035270 | 0.000 | 5.352 | 9 | 36 | 121 | endocrine system development |
GO:0009607 | 0.000 | 2.697 | 38 | 85 | 496 | response to biotic stimulus |
GO:0043412 | 0.000 | 1.832 | 159 | 241 | 2094 | macromolecule modification |
GO:0018212 | 0.000 | 4.240 | 14 | 45 | 180 | peptidyl-tyrosine modification |
GO:0051170 | 0.000 | 4.045 | 15 | 47 | 195 | nuclear import |
GO:0040017 | 0.000 | 3.743 | 17 | 51 | 225 | positive regulation of locomotion |
GO:0048754 | 0.000 | 4.907 | 10 | 38 | 136 | branching morphogenesis of an epithelial tube |
GO:0007420 | 0.000 | 2.815 | 33 | 77 | 432 | brain development |
GO:0001501 | 0.000 | 3.125 | 25 | 65 | 333 | skeletal system development |
GO:0001503 | 0.000 | 3.561 | 19 | 54 | 248 | ossification |
GO:0030855 | 0.000 | 3.561 | 19 | 54 | 248 | epithelial cell differentiation |
GO:0051223 | 0.000 | 3.503 | 19 | 55 | 256 | regulation of protein transport |
GO:0030030 | 0.000 | 2.300 | 58 | 114 | 770 | cell projection organization |
GO:0071900 | 0.000 | 3.166 | 24 | 63 | 319 | regulation of protein serine/threonine kinase activity |
GO:0071417 | 0.000 | 3.133 | 25 | 64 | 327 | cellular response to organic nitrogen |
GO:0051707 | 0.000 | 2.694 | 36 | 82 | 478 | response to other organism |
GO:0030335 | 0.000 | 3.809 | 16 | 49 | 213 | positive regulation of cell migration |
GO:1900180 | 0.000 | 5.259 | 9 | 35 | 119 | regulation of protein localization to nucleus |
GO:0007568 | 0.000 | 4.265 | 13 | 43 | 171 | aging |
GO:0070997 | 0.000 | 4.443 | 12 | 41 | 158 | neuron death |
GO:0009991 | 0.000 | 3.451 | 20 | 55 | 259 | response to extracellular stimulus |
GO:0001649 | 0.000 | 5.197 | 9 | 35 | 120 | osteoblast differentiation |
GO:0051091 | 0.000 | 4.405 | 12 | 41 | 159 | positive regulation of sequence-specific DNA binding transcription factor activity |
GO:0033554 | 0.000 | 2.097 | 79 | 141 | 1042 | cellular response to stress |
GO:0030324 | 0.000 | 4.872 | 10 | 37 | 133 | lung development |
GO:0071407 | 0.000 | 4.614 | 11 | 39 | 146 | cellular response to organic cyclic compound |
GO:0048812 | 0.000 | 2.647 | 37 | 83 | 491 | neuron projection morphogenesis |
GO:0097285 | 0.000 | 3.528 | 19 | 53 | 245 | cell-type specific apoptotic process |
GO:0006996 | 0.000 | 1.863 | 133 | 208 | 1752 | organelle organization |
GO:0034504 | 0.000 | 3.686 | 17 | 50 | 223 | protein localization to nucleus |
GO:0002237 | 0.000 | 3.927 | 15 | 46 | 195 | response to molecule of bacterial origin |
GO:0072001 | 0.000 | 3.774 | 16 | 48 | 210 | renal system development |
GO:0048667 | 0.000 | 2.638 | 37 | 82 | 486 | cell morphogenesis involved in neuron differentiation |
GO:0033138 | 0.000 | 10.478 | 3 | 21 | 46 | positive regulation of peptidyl-serine phosphorylation |
GO:0030323 | 0.000 | 4.723 | 10 | 37 | 136 | respiratory tube development |
GO:0010721 | 0.000 | 5.734 | 8 | 31 | 99 | negative regulation of cell development |
GO:0043410 | 0.000 | 3.244 | 21 | 57 | 282 | positive regulation of MAPK cascade |
GO:0006606 | 0.000 | 3.889 | 15 | 45 | 192 | protein import into nucleus |
GO:0044744 | 0.000 | 3.889 | 15 | 45 | 192 | protein targeting to nucleus |
GO:0007409 | 0.000 | 2.689 | 34 | 77 | 448 | axonogenesis |
GO:0050730 | 0.000 | 4.628 | 10 | 37 | 138 | regulation of peptidyl-tyrosine phosphorylation |
GO:0032870 | 0.000 | 2.944 | 26 | 65 | 349 | cellular response to hormone stimulus |
GO:2000027 | 0.000 | 4.851 | 10 | 35 | 126 | regulation of organ morphogenesis |
GO:0051052 | 0.000 | 3.982 | 14 | 43 | 180 | regulation of DNA metabolic process |
GO:0048858 | 0.000 | 2.457 | 43 | 89 | 561 | cell projection morphogenesis |
GO:0000278 | 0.000 | 2.336 | 50 | 99 | 654 | mitotic cell cycle |
GO:0060341 | 0.000 | 2.411 | 45 | 92 | 590 | regulation of cellular localization |
GO:0048598 | 0.000 | 2.734 | 31 | 72 | 412 | embryonic morphogenesis |
GO:0010001 | 0.000 | 4.869 | 9 | 34 | 122 | glial cell differentiation |
GO:0051222 | 0.000 | 4.252 | 12 | 39 | 155 | positive regulation of protein transport |
GO:0042306 | 0.000 | 5.006 | 9 | 33 | 116 | regulation of protein import into nucleus |
GO:0033135 | 0.000 | 7.980 | 4 | 23 | 59 | regulation of peptidyl-serine phosphorylation |
GO:0048863 | 0.000 | 4.946 | 9 | 33 | 117 | stem cell differentiation |
GO:0006913 | 0.000 | 3.068 | 23 | 58 | 300 | nucleocytoplasmic transport |
GO:0051049 | 0.000 | 2.123 | 66 | 120 | 867 | regulation of transport |
GO:0033157 | 0.000 | 4.249 | 11 | 38 | 151 | regulation of intracellular protein transport |
GO:0070482 | 0.000 | 3.489 | 17 | 48 | 223 | response to oxygen levels |
GO:0010564 | 0.000 | 2.789 | 29 | 67 | 376 | regulation of cell cycle process |
GO:0032990 | 0.000 | 2.403 | 43 | 89 | 571 | cell part morphogenesis |
GO:0045787 | 0.000 | 5.383 | 8 | 30 | 100 | positive regulation of cell cycle |
GO:0031667 | 0.000 | 3.369 | 18 | 50 | 239 | response to nutrient levels |
GO:0051169 | 0.000 | 3.029 | 23 | 58 | 303 | nuclear transport |
GO:0007548 | 0.000 | 3.562 | 16 | 46 | 210 | sex differentiation |
GO:0071216 | 0.000 | 5.306 | 8 | 30 | 101 | cellular response to biotic stimulus |
GO:0030522 | 0.000 | 3.615 | 15 | 45 | 203 | intracellular receptor mediated signaling pathway |
GO:0045321 | 0.000 | 2.525 | 37 | 79 | 484 | leukocyte activation |
GO:0007507 | 0.000 | 2.856 | 26 | 63 | 346 | heart development |
GO:0043200 | 0.000 | 6.976 | 5 | 24 | 67 | response to amino acid stimulus |
GO:0030879 | 0.000 | 4.908 | 9 | 32 | 114 | mammary gland development |
GO:0051402 | 0.000 | 4.246 | 11 | 37 | 147 | neuron apoptotic process |
GO:0006809 | 0.000 | 9.226 | 4 | 20 | 47 | nitric oxide biosynthetic process |
GO:0090342 | 0.000 | 37.077 | 1 | 12 | 16 | regulation of cell aging |
GO:0050867 | 0.000 | 3.497 | 16 | 46 | 213 | positive regulation of cell activation |
GO:0050731 | 0.000 | 4.994 | 8 | 31 | 109 | positive regulation of peptidyl-tyrosine phosphorylation |
GO:0010638 | 0.000 | 3.681 | 14 | 43 | 191 | positive regulation of organelle organization |
GO:0046649 | 0.000 | 2.659 | 31 | 70 | 409 | lymphocyte activation |
GO:0035272 | 0.000 | 9.851 | 3 | 19 | 43 | exocrine system development |
GO:0044703 | 0.000 | 2.246 | 51 | 99 | 675 | multi-organism reproductive process |
GO:0048872 | 0.000 | 4.067 | 12 | 38 | 156 | homeostasis of number of cells |
GO:0016458 | 0.000 | 7.179 | 5 | 23 | 63 | gene silencing |
GO:0006954 | 0.000 | 2.606 | 32 | 72 | 428 | inflammatory response |
GO:0070661 | 0.000 | 3.861 | 13 | 40 | 171 | leukocyte proliferation |
GO:0048609 | 0.000 | 2.506 | 36 | 77 | 474 | multicellular organismal reproductive process |
GO:0051251 | 0.000 | 3.692 | 14 | 42 | 186 | positive regulation of lymphocyte activation |
GO:0034097 | 0.000 | 2.534 | 35 | 75 | 457 | response to cytokine stimulus |
GO:0045664 | 0.000 | 3.061 | 21 | 54 | 279 | regulation of neuron differentiation |
GO:0045165 | 0.000 | 3.667 | 14 | 42 | 187 | cell fate commitment |
GO:0001101 | 0.000 | 5.916 | 6 | 26 | 81 | response to acid |
GO:0046209 | 0.000 | 7.931 | 4 | 21 | 54 | nitric oxide metabolic process |
GO:0009617 | 0.000 | 3.084 | 21 | 53 | 272 | response to bacterium |
GO:0002696 | 0.000 | 3.507 | 15 | 44 | 203 | positive regulation of leukocyte activation |
GO:0051248 | 0.000 | 2.603 | 32 | 70 | 416 | negative regulation of protein metabolic process |
GO:0042592 | 0.000 | 1.961 | 81 | 137 | 1065 | homeostatic process |
GO:0045786 | 0.000 | 2.656 | 30 | 67 | 391 | negative regulation of cell cycle |
GO:0007259 | 0.000 | 5.317 | 7 | 28 | 94 | JAK-STAT cascade |
GO:0017038 | 0.000 | 3.374 | 17 | 46 | 219 | protein import |
GO:0071222 | 0.000 | 5.543 | 7 | 27 | 88 | cellular response to lipopolysaccharide |
GO:0032504 | 0.000 | 2.461 | 36 | 77 | 481 | multicellular organism reproduction |
GO:0042493 | 0.000 | 2.872 | 24 | 58 | 316 | response to drug |
GO:0050865 | 0.000 | 2.872 | 24 | 58 | 316 | regulation of cell activation |
GO:0055123 | 0.000 | 5.051 | 8 | 29 | 101 | digestive system development |
GO:0042110 | 0.000 | 2.929 | 23 | 56 | 300 | T cell activation |
GO:0048864 | 0.000 | 5.707 | 6 | 26 | 83 | stem cell development |
GO:0010720 | 0.000 | 4.119 | 11 | 35 | 142 | positive regulation of cell development |
GO:0071902 | 0.000 | 3.467 | 15 | 43 | 200 | positive regulation of protein serine/threonine kinase activity |
GO:0002684 | 0.000 | 2.438 | 36 | 76 | 478 | positive regulation of immune system process |
GO:1901214 | 0.000 | 4.081 | 11 | 35 | 143 | regulation of neuron death |
GO:0044087 | 0.000 | 2.869 | 23 | 56 | 305 | regulation of cellular component biogenesis |
GO:0046822 | 0.000 | 4.043 | 11 | 35 | 144 | regulation of nucleocytoplasmic transport |
GO:0014706 | 0.000 | 2.994 | 21 | 52 | 273 | striated muscle tissue development |
GO:0044702 | 0.000 | 2.324 | 41 | 83 | 545 | single organism reproductive process |
GO:0061448 | 0.000 | 3.674 | 13 | 39 | 173 | connective tissue development |
GO:0051129 | 0.000 | 2.915 | 22 | 54 | 290 | negative regulation of cellular component organization |
GO:0071219 | 0.000 | 5.200 | 7 | 27 | 92 | cellular response to molecule of bacterial origin |
GO:0090316 | 0.000 | 5.420 | 7 | 26 | 86 | positive regulation of intracellular protein transport |
GO:0022604 | 0.000 | 3.096 | 19 | 49 | 250 | regulation of cell morphogenesis |
GO:0002694 | 0.000 | 2.902 | 22 | 54 | 291 | regulation of leukocyte activation |
GO:0007411 | 0.000 | 2.808 | 24 | 57 | 316 | axon guidance |
GO:0060537 | 0.000 | 2.933 | 21 | 53 | 283 | muscle tissue development |
GO:0009987 | 0.000 | 2.712 | 734 | 778 | 9671 | cellular process |
GO:0018105 | 0.000 | 4.589 | 8 | 30 | 112 | peptidyl-serine phosphorylation |
GO:0045637 | 0.000 | 4.589 | 8 | 30 | 112 | regulation of myeloid cell differentiation |
GO:0043583 | 0.000 | 3.876 | 12 | 36 | 153 | ear development |
GO:0032269 | 0.000 | 2.662 | 27 | 62 | 360 | negative regulation of cellular protein metabolic process |
GO:0032101 | 0.000 | 2.709 | 26 | 60 | 343 | regulation of response to external stimulus |
GO:1901652 | 0.000 | 2.762 | 25 | 58 | 326 | response to peptide |
GO:0016055 | 0.000 | 3.108 | 19 | 48 | 244 | Wnt receptor signaling pathway |
GO:0080135 | 0.000 | 3.065 | 19 | 49 | 252 | regulation of cellular response to stress |
GO:0048839 | 0.000 | 4.148 | 10 | 33 | 133 | inner ear development |
GO:0033273 | 0.000 | 6.884 | 4 | 21 | 59 | response to vitamin |
GO:0048565 | 0.000 | 5.043 | 7 | 27 | 94 | digestive tract development |
GO:0018209 | 0.000 | 4.372 | 9 | 31 | 120 | peptidyl-serine modification |
GO:0007346 | 0.000 | 2.960 | 20 | 51 | 270 | regulation of mitotic cell cycle |
GO:0045137 | 0.000 | 3.507 | 14 | 40 | 184 | development of primary sexual characteristics |
GO:0051249 | 0.000 | 3.020 | 19 | 49 | 255 | regulation of lymphocyte activation |
GO:0042326 | 0.000 | 3.483 | 14 | 40 | 185 | negative regulation of phosphorylation |
GO:0097190 | 0.000 | 3.483 | 14 | 40 | 185 | apoptotic signaling pathway |
GO:1900117 | 0.000 | 3.483 | 14 | 40 | 185 | regulation of execution phase of apoptosis |
GO:0022403 | 0.000 | 2.118 | 53 | 98 | 700 | cell cycle phase |
GO:0030856 | 0.000 | 6.707 | 5 | 21 | 60 | regulation of epithelial cell differentiation |
GO:0050878 | 0.000 | 2.288 | 41 | 81 | 538 | regulation of body fluid levels |
GO:0002573 | 0.000 | 4.426 | 9 | 30 | 115 | myeloid leukocyte differentiation |
GO:0009894 | 0.000 | 2.466 | 32 | 69 | 428 | regulation of catabolic process |
GO:0032943 | 0.000 | 3.671 | 12 | 37 | 164 | mononuclear cell proliferation |
GO:0007178 | 0.000 | 3.117 | 18 | 46 | 233 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0001701 | 0.000 | 2.845 | 22 | 53 | 290 | in utero embryonic development |
GO:0001837 | 0.000 | 6.233 | 5 | 22 | 66 | epithelial to mesenchymal transition |
GO:0071230 | 0.000 | 11.616 | 2 | 15 | 31 | cellular response to amino acid stimulus |
GO:0010563 | 0.000 | 3.148 | 17 | 45 | 226 | negative regulation of phosphorus metabolic process |
GO:0045936 | 0.000 | 3.148 | 17 | 45 | 226 | negative regulation of phosphate metabolic process |
GO:0036293 | 0.000 | 3.236 | 16 | 43 | 211 | response to decreased oxygen levels |
GO:0044403 | 0.000 | 2.481 | 31 | 67 | 413 | symbiosis, encompassing mutualism through parasitism |
GO:0044419 | 0.000 | 2.481 | 31 | 67 | 413 | interspecies interaction between organisms |
GO:0030278 | 0.000 | 3.987 | 10 | 33 | 137 | regulation of ossification |
GO:0032386 | 0.000 | 3.083 | 18 | 46 | 235 | regulation of intracellular transport |
GO:0048589 | 0.000 | 3.083 | 18 | 46 | 235 | developmental growth |
GO:0010769 | 0.000 | 3.684 | 12 | 36 | 159 | regulation of cell morphogenesis involved in differentiation |
GO:0007050 | 0.000 | 2.691 | 25 | 57 | 327 | cell cycle arrest |
GO:0045667 | 0.000 | 5.205 | 6 | 25 | 85 | regulation of osteoblast differentiation |
GO:0030900 | 0.000 | 3.024 | 19 | 47 | 244 | forebrain development |
GO:0071496 | 0.000 | 3.585 | 13 | 37 | 167 | cellular response to external stimulus |
GO:0045785 | 0.000 | 4.431 | 8 | 29 | 111 | positive regulation of cell adhesion |
GO:0007569 | 0.000 | 6.378 | 5 | 21 | 62 | cell aging |
GO:0001654 | 0.000 | 3.008 | 19 | 47 | 245 | eye development |
GO:0051054 | 0.000 | 4.924 | 7 | 26 | 92 | positive regulation of DNA metabolic process |
GO:0007435 | 0.000 | 10.932 | 2 | 15 | 32 | salivary gland morphogenesis |
GO:0007517 | 0.000 | 2.785 | 22 | 53 | 295 | muscle organ development |
GO:0031960 | 0.000 | 4.552 | 8 | 28 | 105 | response to corticosteroid stimulus |
GO:0071559 | 0.000 | 3.415 | 14 | 39 | 183 | response to transforming growth factor beta stimulus |
GO:0051336 | 0.000 | 2.146 | 48 | 90 | 633 | regulation of hydrolase activity |
GO:0045428 | 0.000 | 9.447 | 3 | 16 | 37 | regulation of nitric oxide biosynthetic process |
GO:0046651 | 0.000 | 3.596 | 12 | 36 | 162 | lymphocyte proliferation |
GO:0007599 | 0.000 | 2.366 | 35 | 71 | 456 | hemostasis |
GO:0042692 | 0.000 | 2.925 | 19 | 48 | 256 | muscle cell differentiation |
GO:0001933 | 0.000 | 3.503 | 13 | 37 | 170 | negative regulation of protein phosphorylation |
GO:0001666 | 0.000 | 3.176 | 16 | 42 | 209 | response to hypoxia |
GO:0032868 | 0.000 | 3.123 | 16 | 43 | 217 | response to insulin stimulus |
GO:0006367 | 0.000 | 3.345 | 14 | 39 | 186 | transcription initiation from RNA polymerase II promoter |
GO:0048015 | 0.000 | 4.008 | 10 | 31 | 128 | phosphatidylinositol-mediated signaling |
GO:0048017 | 0.000 | 4.008 | 10 | 31 | 128 | inositol lipid-mediated signaling |
GO:0006952 | 0.000 | 1.922 | 70 | 118 | 922 | defense response |
GO:0040008 | 0.000 | 2.370 | 34 | 69 | 442 | regulation of growth |
GO:0051345 | 0.000 | 2.476 | 29 | 63 | 388 | positive regulation of hydrolase activity |
GO:0009792 | 0.000 | 2.321 | 36 | 72 | 470 | embryo development ending in birth or egg hatching |
GO:0007596 | 0.000 | 2.349 | 34 | 70 | 452 | blood coagulation |
GO:0043406 | 0.000 | 3.511 | 13 | 36 | 165 | positive regulation of MAP kinase activity |
GO:0016049 | 0.000 | 2.671 | 24 | 54 | 311 | cell growth |
GO:0006352 | 0.000 | 3.119 | 16 | 42 | 212 | DNA-dependent transcription, initiation |
GO:0006417 | 0.000 | 3.484 | 13 | 36 | 166 | regulation of translation |
GO:0050817 | 0.000 | 2.336 | 34 | 70 | 454 | coagulation |
GO:0051050 | 0.000 | 2.381 | 32 | 67 | 427 | positive regulation of transport |
GO:0009612 | 0.000 | 4.042 | 9 | 30 | 123 | response to mechanical stimulus |
GO:0050900 | 0.000 | 2.925 | 19 | 46 | 245 | leukocyte migration |
GO:0030098 | 0.000 | 3.154 | 16 | 41 | 205 | lymphocyte differentiation |
GO:0071560 | 0.000 | 3.323 | 14 | 38 | 182 | cellular response to transforming growth factor beta stimulus |
GO:0001816 | 0.000 | 2.486 | 28 | 61 | 374 | cytokine production |
GO:0051101 | 0.000 | 6.219 | 5 | 20 | 60 | regulation of DNA binding |
GO:0090183 | 0.000 | 7.812 | 3 | 17 | 44 | regulation of kidney development |
GO:0032388 | 0.000 | 4.126 | 9 | 29 | 117 | positive regulation of intracellular transport |
GO:0050768 | 0.000 | 5.213 | 6 | 23 | 78 | negative regulation of neurogenesis |
GO:0031047 | 0.000 | 10.828 | 2 | 14 | 30 | gene silencing by RNA |
GO:2000756 | 0.000 | 10.828 | 2 | 14 | 30 | regulation of peptidyl-lysine acetylation |
GO:0031099 | 0.000 | 4.729 | 7 | 25 | 91 | regeneration |
GO:0008544 | 0.000 | 3.064 | 16 | 42 | 215 | epidermis development |
GO:0044092 | 0.000 | 2.155 | 43 | 82 | 572 | negative regulation of molecular function |
GO:0070663 | 0.000 | 3.848 | 10 | 31 | 132 | regulation of leukocyte proliferation |
GO:0070665 | 0.000 | 4.908 | 6 | 24 | 85 | positive regulation of leukocyte proliferation |
GO:0019827 | 0.000 | 5.120 | 6 | 23 | 79 | stem cell maintenance |
GO:0043405 | 0.000 | 3.000 | 17 | 43 | 224 | regulation of MAP kinase activity |
GO:0051216 | 0.000 | 3.633 | 11 | 33 | 147 | cartilage development |
GO:0031663 | 0.000 | 9.289 | 3 | 15 | 35 | lipopolysaccharide-mediated signaling pathway |
GO:0051098 | 0.000 | 3.463 | 12 | 35 | 162 | regulation of binding |
GO:0030850 | 0.000 | 7.533 | 3 | 17 | 45 | prostate gland development |
GO:0048708 | 0.000 | 8.264 | 3 | 16 | 40 | astrocyte differentiation |
GO:0042307 | 0.000 | 6.381 | 4 | 19 | 56 | positive regulation of protein import into nucleus |
GO:0051384 | 0.000 | 4.449 | 8 | 26 | 99 | response to glucocorticoid stimulus |
GO:0043523 | 0.000 | 3.772 | 10 | 31 | 134 | regulation of neuron apoptotic process |
GO:0043009 | 0.000 | 2.280 | 35 | 70 | 463 | chordate embryonic development |
GO:0001657 | 0.000 | 4.751 | 7 | 24 | 87 | ureteric bud development |
GO:0042509 | 0.000 | 7.272 | 3 | 17 | 46 | regulation of tyrosine phosphorylation of STAT protein |
GO:0007431 | 0.000 | 8.846 | 3 | 15 | 36 | salivary gland development |
GO:0071229 | 0.000 | 8.846 | 3 | 15 | 36 | cellular response to acid |
GO:0032844 | 0.000 | 2.858 | 19 | 45 | 244 | regulation of homeostatic process |
GO:0001890 | 0.000 | 3.945 | 9 | 29 | 121 | placenta development |
GO:0019216 | 0.000 | 3.189 | 14 | 38 | 188 | regulation of lipid metabolic process |
GO:0045429 | 0.000 | 11.479 | 2 | 13 | 27 | positive regulation of nitric oxide biosynthetic process |
GO:0006955 | 0.000 | 1.880 | 69 | 115 | 913 | immune response |
GO:0031056 | 0.000 | 5.784 | 5 | 20 | 63 | regulation of histone modification |
GO:0051325 | 0.000 | 2.468 | 27 | 58 | 357 | interphase |
GO:0016568 | 0.000 | 2.446 | 28 | 59 | 366 | chromatin modification |
GO:0007179 | 0.000 | 3.442 | 12 | 34 | 158 | transforming growth factor beta receptor signaling pathway |
GO:0051649 | 0.000 | 1.684 | 117 | 173 | 1543 | establishment of localization in cell |
GO:0006917 | 0.000 | 3.279 | 13 | 36 | 174 | induction of apoptosis |
GO:0050671 | 0.000 | 4.858 | 6 | 23 | 82 | positive regulation of lymphocyte proliferation |
GO:0010810 | 0.000 | 4.457 | 7 | 25 | 95 | regulation of cell-substrate adhesion |
GO:0008406 | 0.000 | 3.415 | 12 | 34 | 159 | gonad development |
GO:0009895 | 0.000 | 5.073 | 6 | 22 | 76 | negative regulation of catabolic process |
GO:0071478 | 0.000 | 5.333 | 5 | 21 | 70 | cellular response to radiation |
GO:0046661 | 0.000 | 4.115 | 8 | 27 | 109 | male sex differentiation |
GO:0012502 | 0.000 | 3.255 | 13 | 36 | 175 | induction of programmed cell death |
GO:0030217 | 0.000 | 3.550 | 11 | 32 | 145 | T cell differentiation |
GO:0032946 | 0.000 | 4.777 | 6 | 23 | 83 | positive regulation of mononuclear cell proliferation |
GO:0033036 | 0.000 | 1.680 | 115 | 170 | 1517 | macromolecule localization |
GO:0006325 | 0.000 | 2.304 | 32 | 65 | 425 | chromatin organization |
GO:0043434 | 0.000 | 2.547 | 24 | 53 | 317 | response to peptide hormone stimulus |
GO:0035065 | 0.000 | 10.712 | 2 | 13 | 28 | regulation of histone acetylation |
GO:0051301 | 0.000 | 2.387 | 29 | 60 | 380 | cell division |
GO:0051329 | 0.000 | 2.448 | 27 | 57 | 353 | interphase of mitotic cell cycle |
GO:0071214 | 0.000 | 3.519 | 11 | 32 | 146 | cellular response to abiotic stimulus |
GO:0043491 | 0.000 | 4.332 | 7 | 25 | 97 | protein kinase B signaling cascade |
GO:0032869 | 0.000 | 3.143 | 14 | 37 | 185 | cellular response to insulin stimulus |
GO:0090398 | 0.000 | 12.349 | 2 | 12 | 24 | cellular senescence |
GO:0060070 | 0.000 | 3.488 | 11 | 32 | 147 | canonical Wnt receptor signaling pathway |
GO:2000177 | 0.000 | 7.344 | 3 | 16 | 43 | regulation of neural precursor cell proliferation |
GO:0050776 | 0.000 | 2.210 | 36 | 70 | 475 | regulation of immune response |
GO:0010464 | 0.000 | 8.075 | 3 | 15 | 38 | regulation of mesenchymal cell proliferation |
GO:0030198 | 0.000 | 3.185 | 14 | 36 | 178 | extracellular matrix organization |
GO:0033044 | 0.000 | 4.466 | 7 | 24 | 91 | regulation of chromosome organization |
GO:0014065 | 0.000 | 5.122 | 5 | 21 | 72 | phosphatidylinositol 3-kinase cascade |
GO:0046425 | 0.000 | 5.405 | 5 | 20 | 66 | regulation of JAK-STAT cascade |
GO:0016569 | 0.000 | 2.825 | 18 | 43 | 235 | covalent chromatin modification |
GO:0045926 | 0.000 | 3.231 | 13 | 35 | 171 | negative regulation of growth |
GO:0070371 | 0.000 | 3.846 | 9 | 28 | 119 | ERK1 and ERK2 cascade |
GO:0043062 | 0.000 | 3.163 | 14 | 36 | 179 | extracellular structure organization |
GO:0043900 | 0.000 | 3.101 | 14 | 37 | 187 | regulation of multi-organism process |
GO:0051146 | 0.000 | 3.101 | 14 | 37 | 187 | striated muscle cell differentiation |
GO:0046903 | 0.000 | 1.983 | 52 | 91 | 683 | secretion |
GO:0050870 | 0.000 | 3.427 | 11 | 32 | 149 | positive regulation of T cell activation |
GO:0007010 | 0.000 | 1.995 | 50 | 89 | 664 | cytoskeleton organization |
GO:0001822 | 0.000 | 3.207 | 13 | 35 | 172 | kidney development |
GO:0050670 | 0.000 | 3.701 | 10 | 29 | 127 | regulation of lymphocyte proliferation |
GO:0048562 | 0.000 | 3.080 | 14 | 37 | 188 | embryonic organ morphogenesis |
GO:0051641 | 0.000 | 1.627 | 131 | 187 | 1724 | cellular localization |
GO:0009314 | 0.000 | 2.652 | 21 | 47 | 271 | response to radiation |
GO:0034101 | 0.000 | 4.548 | 7 | 23 | 86 | erythrocyte homeostasis |
GO:0002053 | 0.000 | 8.659 | 3 | 14 | 34 | positive regulation of mesenchymal cell proliferation |
GO:0050863 | 0.000 | 3.005 | 15 | 38 | 197 | regulation of T cell activation |
GO:0007584 | 0.000 | 3.663 | 10 | 29 | 128 | response to nutrient |
GO:0032944 | 0.000 | 3.663 | 10 | 29 | 128 | regulation of mononuclear cell proliferation |
GO:0048705 | 0.000 | 3.310 | 12 | 33 | 158 | skeletal system morphogenesis |
GO:0035195 | 0.000 | 17.606 | 1 | 10 | 17 | gene silencing by miRNA |
GO:0071375 | 0.000 | 2.734 | 19 | 44 | 247 | cellular response to peptide hormone stimulus |
GO:1901653 | 0.000 | 2.734 | 19 | 44 | 247 | cellular response to peptide |
GO:2000241 | 0.000 | 3.097 | 14 | 36 | 182 | regulation of reproductive process |
GO:0031589 | 0.000 | 2.986 | 15 | 38 | 198 | cell-substrate adhesion |
GO:0051241 | 0.000 | 2.486 | 24 | 52 | 317 | negative regulation of multicellular organismal process |
GO:0001817 | 0.000 | 2.437 | 25 | 54 | 335 | regulation of cytokine production |
GO:0010463 | 0.000 | 6.836 | 3 | 16 | 45 | mesenchymal cell proliferation |
GO:0048634 | 0.000 | 4.273 | 7 | 24 | 94 | regulation of muscle organ development |
GO:0046546 | 0.000 | 4.103 | 8 | 25 | 101 | development of primary male sexual characteristics |
GO:0050679 | 0.000 | 4.103 | 8 | 25 | 101 | positive regulation of epithelial cell proliferation |
GO:0032940 | 0.000 | 2.029 | 46 | 82 | 601 | secretion by cell |
GO:0051493 | 0.000 | 2.785 | 18 | 42 | 232 | regulation of cytoskeleton organization |
GO:0042176 | 0.000 | 3.508 | 10 | 30 | 137 | regulation of protein catabolic process |
GO:0048871 | 0.000 | 3.508 | 10 | 30 | 137 | multicellular organismal homeostasis |
GO:0006259 | 0.000 | 1.951 | 53 | 91 | 692 | DNA metabolic process |
GO:0010717 | 0.000 | 8.246 | 3 | 14 | 35 | regulation of epithelial to mesenchymal transition |
GO:0060425 | 0.000 | 8.246 | 3 | 14 | 35 | lung morphogenesis |
GO:0045834 | 0.000 | 4.407 | 7 | 23 | 88 | positive regulation of lipid metabolic process |
GO:0007260 | 0.000 | 6.199 | 4 | 17 | 51 | tyrosine phosphorylation of STAT protein |
GO:0032147 | 0.000 | 2.903 | 16 | 39 | 208 | activation of protein kinase activity |
GO:0060973 | 0.000 | 85.999 | 1 | 7 | 8 | cell migration involved in heart development |
GO:0060977 | 0.000 | 85.999 | 1 | 7 | 8 | coronary vasculature morphogenesis |
GO:2000772 | 0.000 | 85.999 | 1 | 7 | 8 | regulation of cellular senescence |
GO:0002697 | 0.000 | 2.979 | 15 | 37 | 193 | regulation of immune effector process |
GO:0010212 | 0.000 | 4.340 | 7 | 23 | 89 | response to ionizing radiation |
GO:0046660 | 0.000 | 4.154 | 7 | 24 | 96 | female sex differentiation |
GO:0061180 | 0.000 | 5.243 | 5 | 19 | 64 | mammary gland epithelium development |
GO:0035196 | 0.000 | 32.796 | 1 | 8 | 11 | production of miRNAs involved in gene silencing by miRNA |
GO:0060976 | 0.000 | 32.796 | 1 | 8 | 11 | coronary vasculature development |
GO:0033598 | 0.000 | 12.335 | 2 | 11 | 22 | mammary gland epithelial cell proliferation |
GO:0006469 | 0.000 | 3.606 | 9 | 28 | 125 | negative regulation of protein kinase activity |
GO:0000060 | 0.000 | 7.870 | 3 | 14 | 36 | protein import into nucleus, translocation |
GO:0072215 | 0.000 | 15.404 | 1 | 10 | 18 | regulation of metanephros development |
GO:0050680 | 0.000 | 4.663 | 6 | 21 | 77 | negative regulation of epithelial cell proliferation |
GO:0043010 | 0.000 | 2.834 | 16 | 39 | 212 | camera-type eye development |
GO:0030168 | 0.000 | 2.876 | 15 | 38 | 204 | platelet activation |
GO:0042476 | 0.000 | 4.211 | 7 | 23 | 91 | odontogenesis |
GO:0008286 | 0.000 | 3.288 | 11 | 31 | 149 | insulin receptor signaling pathway |
GO:0006260 | 0.000 | 2.730 | 17 | 41 | 230 | DNA replication |
GO:0043388 | 0.000 | 9.876 | 2 | 12 | 27 | positive regulation of DNA binding |
GO:0061351 | 0.000 | 4.580 | 6 | 21 | 78 | neural precursor cell proliferation |
GO:0044706 | 0.000 | 3.007 | 14 | 35 | 181 | multi-multicellular organism process |
GO:0030111 | 0.000 | 3.350 | 11 | 30 | 142 | regulation of Wnt receptor signaling pathway |
GO:0051348 | 0.000 | 3.350 | 11 | 30 | 142 | negative regulation of transferase activity |
GO:0016570 | 0.000 | 2.715 | 18 | 41 | 231 | histone modification |
GO:0033673 | 0.000 | 3.419 | 10 | 29 | 135 | negative regulation of kinase activity |
GO:0097194 | 0.000 | 2.986 | 14 | 35 | 182 | execution phase of apoptosis |
GO:0002440 | 0.000 | 3.986 | 8 | 24 | 99 | production of molecular mediator of immune response |
GO:0008104 | 0.000 | 1.668 | 99 | 147 | 1305 | protein localization |
GO:0051701 | 0.000 | 2.264 | 29 | 58 | 383 | interaction with host |
GO:0010741 | 0.000 | 3.497 | 10 | 28 | 128 | negative regulation of intracellular protein kinase cascade |
GO:0014066 | 0.000 | 5.695 | 4 | 17 | 54 | regulation of phosphatidylinositol 3-kinase cascade |
GO:2000811 | 0.000 | 18.465 | 1 | 9 | 15 | negative regulation of anoikis |
GO:0007389 | 0.000 | 2.354 | 26 | 53 | 338 | pattern specification process |
GO:2000116 | 0.000 | 3.154 | 12 | 32 | 159 | regulation of cysteine-type endopeptidase activity |
GO:0042098 | 0.000 | 3.685 | 9 | 26 | 114 | T cell proliferation |
GO:0045665 | 0.000 | 6.630 | 3 | 15 | 43 | negative regulation of neuron differentiation |
GO:0050864 | 0.000 | 4.688 | 6 | 20 | 73 | regulation of B cell activation |
GO:0016202 | 0.000 | 4.090 | 7 | 23 | 93 | regulation of striated muscle tissue development |
GO:1901861 | 0.000 | 4.090 | 7 | 23 | 93 | regulation of muscle tissue development |
GO:0043276 | 0.000 | 13.691 | 1 | 10 | 19 | anoikis |
GO:0043281 | 0.000 | 3.205 | 12 | 31 | 152 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0022415 | 0.000 | 2.076 | 38 | 70 | 500 | viral reproductive process |
GO:0030218 | 0.000 | 4.424 | 6 | 21 | 80 | erythrocyte differentiation |
GO:0097306 | 0.000 | 6.005 | 4 | 16 | 49 | cellular response to alcohol |
GO:0043627 | 0.000 | 3.643 | 9 | 26 | 115 | response to estrogen stimulus |
GO:0045444 | 0.000 | 3.643 | 9 | 26 | 115 | fat cell differentiation |
GO:0045639 | 0.000 | 5.545 | 4 | 17 | 55 | positive regulation of myeloid cell differentiation |
GO:0048145 | 0.000 | 5.545 | 4 | 17 | 55 | regulation of fibroblast proliferation |
GO:0031344 | 0.000 | 2.704 | 17 | 40 | 226 | regulation of cell projection organization |
GO:0050769 | 0.000 | 3.754 | 8 | 25 | 108 | positive regulation of neurogenesis |
GO:0000080 | 0.000 | 6.400 | 3 | 15 | 44 | G1 phase of mitotic cell cycle |
GO:0014068 | 0.000 | 6.400 | 3 | 15 | 44 | positive regulation of phosphatidylinositol 3-kinase cascade |
GO:0031050 | 0.000 | 24.594 | 1 | 8 | 12 | dsRNA fragmentation |
GO:0070918 | 0.000 | 24.594 | 1 | 8 | 12 | production of small RNA involved in gene silencing by RNA |
GO:0009411 | 0.000 | 4.146 | 7 | 22 | 88 | response to UV |
GO:0030518 | 0.000 | 3.976 | 7 | 23 | 95 | intracellular steroid hormone receptor signaling pathway |
GO:1901215 | 0.000 | 3.976 | 7 | 23 | 95 | negative regulation of neuron death |
GO:0032602 | 0.000 | 5.827 | 4 | 16 | 50 | chemokine production |
GO:0090344 | 0.000 | 42.995 | 1 | 7 | 9 | negative regulation of cell aging |
GO:0001889 | 0.000 | 4.516 | 6 | 20 | 75 | liver development |
GO:0021983 | 0.000 | 6.924 | 3 | 14 | 39 | pituitary gland development |
GO:0044765 | 0.000 | 1.512 | 173 | 230 | 2280 | single-organism transport |
GO:0048146 | 0.000 | 7.647 | 3 | 13 | 34 | positive regulation of fibroblast proliferation |
GO:0030858 | 0.000 | 8.712 | 2 | 12 | 29 | positive regulation of epithelial cell differentiation |
GO:0048730 | 0.000 | 8.712 | 2 | 12 | 29 | epidermis morphogenesis |
GO:0007155 | 0.000 | 1.822 | 60 | 98 | 791 | cell adhesion |
GO:0007565 | 0.000 | 3.177 | 11 | 30 | 148 | female pregnancy |
GO:0051318 | 0.000 | 6.186 | 3 | 15 | 45 | G1 phase |
GO:0060688 | 0.000 | 6.186 | 3 | 15 | 45 | regulation of morphogenesis of a branching structure |
GO:0022610 | 0.000 | 1.816 | 60 | 98 | 793 | biological adhesion |
GO:0048144 | 0.000 | 5.266 | 4 | 17 | 57 | fibroblast proliferation |
GO:0070372 | 0.000 | 3.735 | 8 | 24 | 104 | regulation of ERK1 and ERK2 cascade |
GO:0031400 | 0.000 | 2.465 | 21 | 45 | 275 | negative regulation of protein modification process |
GO:0042303 | 0.000 | 4.623 | 5 | 19 | 70 | molting cycle |
GO:0042633 | 0.000 | 4.623 | 5 | 19 | 70 | hair cycle |
GO:0046824 | 0.000 | 4.623 | 5 | 19 | 70 | positive regulation of nucleocytoplasmic transport |
GO:0045685 | 0.000 | 6.657 | 3 | 14 | 40 | regulation of glial cell differentiation |
GO:0061008 | 0.000 | 4.357 | 6 | 20 | 77 | hepaticobiliary system development |
GO:0001570 | 0.000 | 4.852 | 5 | 18 | 64 | vasculogenesis |
GO:0031347 | 0.000 | 2.209 | 29 | 56 | 377 | regulation of defense response |
GO:0007492 | 0.000 | 5.986 | 3 | 15 | 46 | endoderm development |
GO:0048663 | 0.000 | 5.986 | 3 | 15 | 46 | neuron fate commitment |
GO:0042102 | 0.000 | 5.137 | 4 | 17 | 58 | positive regulation of T cell proliferation |
GO:0040029 | 0.000 | 3.815 | 7 | 23 | 98 | regulation of gene expression, epigenetic |
GO:0051276 | 0.000 | 1.956 | 43 | 76 | 572 | chromosome organization |
GO:0060512 | 0.000 | 8.228 | 2 | 12 | 30 | prostate gland morphogenesis |
GO:0007173 | 0.000 | 3.177 | 11 | 29 | 143 | epidermal growth factor receptor signaling pathway |
GO:0031668 | 0.000 | 3.539 | 9 | 25 | 113 | cellular response to extracellular stimulus |
GO:0002064 | 0.000 | 4.281 | 6 | 20 | 78 | epithelial cell development |
GO:0032768 | 0.000 | 6.409 | 3 | 14 | 41 | regulation of monooxygenase activity |
GO:0042531 | 0.000 | 6.409 | 3 | 14 | 41 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0060039 | 0.000 | 19.673 | 1 | 8 | 13 | pericardium development |
GO:0031329 | 0.000 | 2.202 | 28 | 55 | 371 | regulation of cellular catabolic process |
GO:0051234 | 0.000 | 1.463 | 211 | 270 | 2783 | establishment of localization |
GO:0090066 | 0.000 | 2.503 | 19 | 42 | 253 | regulation of anatomical structure size |
GO:2001233 | 0.000 | 4.448 | 5 | 19 | 72 | regulation of apoptotic signaling pathway |
GO:0038127 | 0.000 | 3.121 | 11 | 29 | 145 | ERBB signaling pathway |
GO:0061082 | 0.000 | 13.846 | 1 | 9 | 17 | myeloid leukocyte cytokine production |
GO:2000209 | 0.000 | 13.846 | 1 | 9 | 17 | regulation of anoikis |
GO:2000736 | 0.000 | 13.846 | 1 | 9 | 17 | regulation of stem cell differentiation |
GO:0072006 | 0.000 | 4.208 | 6 | 20 | 79 | nephron development |
GO:0031016 | 0.000 | 4.649 | 5 | 18 | 66 | pancreas development |
GO:0060558 | 0.000 | 73.621 | 1 | 6 | 7 | regulation of calcidiol 1-monooxygenase activity |
GO:0060693 | 0.000 | 73.621 | 1 | 6 | 7 | regulation of branching involved in salivary gland morphogenesis |
GO:2000679 | 0.000 | 73.621 | 1 | 6 | 7 | positive regulation of transcription regulatory region DNA binding |
GO:0043254 | 0.000 | 2.900 | 13 | 32 | 170 | regulation of protein complex assembly |
GO:0030308 | 0.000 | 3.340 | 9 | 26 | 123 | negative regulation of cell growth |
GO:0001656 | 0.000 | 4.365 | 6 | 19 | 73 | metanephros development |
GO:0071156 | 0.000 | 2.537 | 18 | 40 | 238 | regulation of cell cycle arrest |
GO:0001558 | 0.000 | 2.500 | 19 | 41 | 247 | regulation of cell growth |
GO:0050871 | 0.000 | 5.622 | 4 | 15 | 48 | positive regulation of B cell activation |
GO:0042698 | 0.000 | 4.138 | 6 | 20 | 80 | ovulation cycle |
GO:0044344 | 0.000 | 3.147 | 11 | 28 | 139 | cellular response to fibroblast growth factor stimulus |
GO:0016441 | 0.000 | 10.265 | 2 | 10 | 22 | posttranscriptional gene silencing |
GO:0035194 | 0.000 | 10.265 | 2 | 10 | 22 | posttranscriptional gene silencing by RNA |
GO:0002252 | 0.000 | 2.127 | 30 | 57 | 396 | immune effector process |
GO:0001892 | 0.000 | 4.285 | 6 | 19 | 74 | embryonic placenta development |
GO:0022602 | 0.000 | 4.285 | 6 | 19 | 74 | ovulation cycle process |
GO:0071774 | 0.000 | 3.118 | 11 | 28 | 140 | response to fibroblast growth factor stimulus |
GO:0006810 | 0.000 | 1.453 | 208 | 265 | 2739 | transport |
GO:0006275 | 0.000 | 3.893 | 7 | 21 | 88 | regulation of DNA replication |
GO:0008584 | 0.000 | 3.893 | 7 | 21 | 88 | male gonad development |
GO:0021543 | 0.000 | 3.893 | 7 | 21 | 88 | pallium development |
GO:0043331 | 0.000 | 7.403 | 2 | 12 | 32 | response to dsRNA |
GO:0014013 | 0.000 | 5.078 | 4 | 16 | 55 | regulation of gliogenesis |
GO:0048610 | 0.000 | 2.061 | 33 | 61 | 436 | cellular process involved in reproduction |
GO:0042113 | 0.000 | 3.016 | 11 | 29 | 149 | B cell activation |
GO:0001818 | 0.000 | 3.347 | 9 | 25 | 118 | negative regulation of cytokine production |
GO:0006978 | 0.000 | 16.393 | 1 | 8 | 14 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
GO:0042772 | 0.000 | 16.393 | 1 | 8 | 14 | DNA damage response, signal transduction resulting in transcription |
GO:0048771 | 0.000 | 3.432 | 8 | 24 | 111 | tissue remodeling |
GO:0002700 | 0.000 | 4.679 | 5 | 17 | 62 | regulation of production of molecular mediator of immune response |
GO:0001952 | 0.000 | 4.950 | 4 | 16 | 56 | regulation of cell-matrix adhesion |
GO:0031054 | 0.000 | Inf | 0 | 5 | 5 | pre-miRNA processing |
GO:0061309 | 0.000 | Inf | 0 | 5 | 5 | cardiac neural crest cell development involved in outflow tract morphogenesis |
GO:0046427 | 0.000 | 5.300 | 4 | 15 | 50 | positive regulation of JAK-STAT cascade |
GO:0007160 | 0.000 | 3.116 | 10 | 27 | 135 | cell-matrix adhesion |
GO:0021537 | 0.000 | 3.116 | 10 | 27 | 135 | telencephalon development |
GO:0042129 | 0.000 | 3.779 | 7 | 21 | 90 | regulation of T cell proliferation |
GO:0010332 | 0.000 | 7.050 | 3 | 12 | 33 | response to gamma radiation |
GO:0035162 | 0.000 | 9.474 | 2 | 10 | 23 | embryonic hemopoiesis |
GO:0001819 | 0.000 | 2.777 | 13 | 32 | 176 | positive regulation of cytokine production |
GO:0051403 | 0.000 | 2.675 | 15 | 34 | 193 | stress-activated MAPK cascade |
GO:0060740 | 0.000 | 7.976 | 2 | 11 | 28 | prostate gland epithelium morphogenesis |
GO:0000082 | 0.000 | 2.758 | 13 | 32 | 177 | G1/S transition of mitotic cell cycle |
GO:0046890 | 0.000 | 3.878 | 6 | 20 | 84 | regulation of lipid biosynthetic process |
GO:0050727 | 0.000 | 2.805 | 13 | 31 | 169 | regulation of inflammatory response |
GO:0045740 | 0.000 | 5.580 | 3 | 14 | 45 | positive regulation of DNA replication |
GO:0060538 | 0.000 | 2.858 | 12 | 30 | 161 | skeletal muscle organ development |
GO:0019048 | 0.000 | 2.165 | 26 | 51 | 348 | virus-host interaction |
GO:0033599 | 0.000 | 21.493 | 1 | 7 | 11 | regulation of mammary gland epithelial cell proliferation |
GO:0007265 | 0.000 | 2.561 | 16 | 36 | 212 | Ras protein signal transduction |
GO:0060828 | 0.000 | 3.549 | 8 | 22 | 99 | regulation of canonical Wnt receptor signaling pathway |
GO:0031098 | 0.000 | 2.641 | 15 | 34 | 195 | stress-activated protein kinase signaling cascade |
GO:0033280 | 0.000 | 11.075 | 1 | 9 | 19 | response to vitamin D |
GO:0031058 | 0.000 | 6.729 | 3 | 12 | 34 | positive regulation of histone modification |
GO:0097193 | 0.000 | 3.403 | 8 | 23 | 107 | intrinsic apoptotic signaling pathway |
GO:0035066 | 0.000 | 14.050 | 1 | 8 | 15 | positive regulation of histone acetylation |
GO:0009615 | 0.000 | 2.467 | 18 | 38 | 231 | response to virus |
GO:0034613 | 0.000 | 1.731 | 61 | 96 | 807 | cellular protein localization |
GO:0010770 | 0.000 | 7.532 | 2 | 11 | 29 | positive regulation of cell morphogenesis involved in differentiation |
GO:0022407 | 0.000 | 4.385 | 5 | 17 | 65 | regulation of cell-cell adhesion |
GO:0001836 | 0.000 | 5.405 | 3 | 14 | 46 | release of cytochrome c from mitochondria |
GO:0002367 | 0.000 | 5.405 | 3 | 14 | 46 | cytokine production involved in immune response |
GO:0019915 | 0.000 | 5.405 | 3 | 14 | 46 | lipid storage |
GO:0031018 | 0.000 | 5.405 | 3 | 14 | 46 | endocrine pancreas development |
GO:0032642 | 0.000 | 5.405 | 3 | 14 | 46 | regulation of chemokine production |
GO:0007276 | 0.000 | 2.157 | 26 | 50 | 342 | gamete generation |
GO:0000079 | 0.000 | 4.130 | 5 | 18 | 72 | regulation of cyclin-dependent protein kinase activity |
GO:0044764 | 0.000 | 1.833 | 47 | 78 | 620 | multi-organism cellular process |
GO:0060348 | 0.000 | 3.759 | 7 | 20 | 86 | bone development |
GO:0016482 | 0.000 | 1.840 | 46 | 77 | 610 | cytoplasmic transport |
GO:0033365 | 0.000 | 2.003 | 33 | 60 | 439 | protein localization to organelle |
GO:0070727 | 0.000 | 1.721 | 62 | 96 | 811 | cellular macromolecule localization |
GO:0001942 | 0.000 | 4.295 | 5 | 17 | 66 | hair follicle development |
GO:0022404 | 0.000 | 4.295 | 5 | 17 | 66 | molting cycle process |
GO:0022405 | 0.000 | 4.295 | 5 | 17 | 66 | hair cycle process |
GO:0048709 | 0.000 | 4.880 | 4 | 15 | 53 | oligodendrocyte differentiation |
GO:0022607 | 0.000 | 1.579 | 96 | 137 | 1264 | cellular component assembly |
GO:0007162 | 0.000 | 3.861 | 6 | 19 | 80 | negative regulation of cell adhesion |
GO:0035051 | 0.000 | 3.861 | 6 | 19 | 80 | cardiocyte differentiation |
GO:0060443 | 0.000 | 5.241 | 4 | 14 | 47 | mammary gland morphogenesis |
GO:0030219 | 0.000 | 10.067 | 2 | 9 | 20 | megakaryocyte differentiation |
GO:0048701 | 0.000 | 7.135 | 2 | 11 | 30 | embryonic cranial skeleton morphogenesis |
GO:2000179 | 0.000 | 7.135 | 2 | 11 | 30 | positive regulation of neural precursor cell proliferation |
GO:0008637 | 0.000 | 4.498 | 5 | 16 | 60 | apoptotic mitochondrial changes |
GO:0043433 | 0.000 | 3.522 | 7 | 21 | 95 | negative regulation of sequence-specific DNA binding transcription factor activity |
GO:0051896 | 0.000 | 3.798 | 6 | 19 | 81 | regulation of protein kinase B signaling cascade |
GO:0034109 | 0.000 | 6.167 | 3 | 12 | 36 | homotypic cell-cell adhesion |
GO:0016032 | 0.000 | 1.811 | 47 | 77 | 618 | viral reproduction |
GO:0033630 | 0.000 | 12.292 | 1 | 8 | 16 | positive regulation of cell adhesion mediated by integrin |
GO:0042522 | 0.000 | 12.292 | 1 | 8 | 16 | regulation of tyrosine phosphorylation of Stat5 protein |
GO:0071359 | 0.000 | 12.292 | 1 | 8 | 16 | cellular response to dsRNA |
GO:2000758 | 0.000 | 12.292 | 1 | 8 | 16 | positive regulation of peptidyl-lysine acetylation |
GO:0014032 | 0.000 | 5.086 | 4 | 14 | 48 | neural crest cell development |
GO:0045136 | 0.000 | 17.193 | 1 | 7 | 12 | development of secondary sexual characteristics |
GO:0072111 | 0.000 | 17.193 | 1 | 7 | 12 | cell proliferation involved in kidney development |
GO:2001252 | 0.000 | 5.533 | 3 | 13 | 42 | positive regulation of chromosome organization |
GO:0007498 | 0.000 | 3.595 | 7 | 20 | 89 | mesoderm development |
GO:0043524 | 0.000 | 3.595 | 7 | 20 | 89 | negative regulation of neuron apoptotic process |
GO:0050792 | 0.000 | 3.331 | 8 | 22 | 104 | regulation of viral reproduction |
GO:0006887 | 0.000 | 2.412 | 17 | 37 | 229 | exocytosis |
GO:0006886 | 0.000 | 1.816 | 46 | 75 | 600 | intracellular protein transport |
GO:0071479 | 0.000 | 6.778 | 2 | 11 | 31 | cellular response to ionizing radiation |
GO:0060351 | 0.000 | 9.227 | 2 | 9 | 21 | cartilage development involved in endochondral bone morphogenesis |
GO:0042475 | 0.000 | 4.302 | 5 | 16 | 62 | odontogenesis of dentin-containing tooth |
GO:0010035 | 0.000 | 2.201 | 22 | 44 | 295 | response to inorganic substance |
GO:0046637 | 0.000 | 5.920 | 3 | 12 | 37 | regulation of alpha-beta T cell differentiation |
GO:0019932 | 0.000 | 2.915 | 10 | 26 | 137 | second-messenger-mediated signaling |
GO:0050714 | 0.000 | 3.843 | 6 | 18 | 76 | positive regulation of protein secretion |
GO:0003007 | 0.000 | 2.717 | 12 | 29 | 162 | heart morphogenesis |
GO:0048011 | 0.000 | 2.484 | 16 | 34 | 205 | nerve growth factor receptor signaling pathway |
GO:0046545 | 0.000 | 3.493 | 7 | 20 | 91 | development of primary female sexual characteristics |
GO:0007369 | 0.000 | 3.139 | 9 | 23 | 114 | gastrulation |
GO:0072203 | 0.000 | 24.535 | 1 | 6 | 9 | cell proliferation involved in metanephros development |
GO:0001894 | 0.000 | 3.340 | 8 | 21 | 99 | tissue homeostasis |
GO:0006109 | 0.000 | 3.340 | 8 | 21 | 99 | regulation of carbohydrate metabolic process |
GO:0034644 | 0.000 | 6.454 | 2 | 11 | 32 | cellular response to UV |
GO:0042345 | 0.000 | 6.454 | 2 | 11 | 32 | regulation of NF-kappaB import into nucleus |
GO:0042348 | 0.000 | 6.454 | 2 | 11 | 32 | NF-kappaB import into nucleus |
GO:0043392 | 0.000 | 6.454 | 2 | 11 | 32 | negative regulation of DNA binding |
GO:0021700 | 0.000 | 2.746 | 12 | 28 | 155 | developmental maturation |
GO:0046777 | 0.000 | 2.746 | 12 | 28 | 155 | protein autophosphorylation |
GO:0031345 | 0.000 | 3.969 | 5 | 17 | 70 | negative regulation of cell projection organization |
GO:0019953 | 0.000 | 1.987 | 31 | 55 | 404 | sexual reproduction |
GO:0010771 | 0.000 | 10.925 | 1 | 8 | 17 | negative regulation of cell morphogenesis involved in differentiation |
GO:0036296 | 0.000 | 10.925 | 1 | 8 | 17 | response to increased oxygen levels |
GO:0055093 | 0.000 | 10.925 | 1 | 8 | 17 | response to hyperoxia |
GO:2000677 | 0.000 | 10.925 | 1 | 8 | 17 | regulation of transcription regulatory region DNA binding |
GO:0006605 | 0.000 | 1.973 | 31 | 56 | 414 | protein targeting |
GO:0061308 | 0.000 | 61.275 | 0 | 5 | 6 | cardiac neural crest cell development involved in heart development |
GO:0090343 | 0.000 | 61.275 | 0 | 5 | 6 | positive regulation of cell aging |
GO:0048661 | 0.000 | 5.691 | 3 | 12 | 38 | positive regulation of smooth muscle cell proliferation |
GO:0007519 | 0.000 | 2.724 | 12 | 28 | 156 | skeletal muscle tissue development |
GO:0031646 | 0.000 | 4.413 | 4 | 15 | 57 | positive regulation of neurological system process |
GO:0009913 | 0.000 | 3.567 | 6 | 19 | 85 | epidermal cell differentiation |
GO:0045471 | 0.000 | 3.567 | 6 | 19 | 85 | response to ethanol |
GO:0042516 | 0.000 | 7.242 | 2 | 10 | 27 | regulation of tyrosine phosphorylation of Stat3 protein |
GO:0003002 | 0.000 | 2.282 | 19 | 39 | 253 | regionalization |
GO:0045687 | 0.000 | 8.516 | 2 | 9 | 22 | positive regulation of glial cell differentiation |
GO:0060445 | 0.000 | 8.516 | 2 | 9 | 22 | branching involved in salivary gland morphogenesis |
GO:0006925 | 0.000 | 14.326 | 1 | 7 | 13 | inflammatory cell apoptotic process |
GO:0045342 | 0.000 | 14.326 | 1 | 7 | 13 | MHC class II biosynthetic process |
GO:0002699 | 0.000 | 3.396 | 7 | 20 | 93 | positive regulation of immune effector process |
GO:0051147 | 0.000 | 3.396 | 7 | 20 | 93 | regulation of muscle cell differentiation |
GO:0045682 | 0.000 | 6.160 | 3 | 11 | 33 | regulation of epidermis development |
GO:0030512 | 0.000 | 4.310 | 4 | 15 | 58 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0090101 | 0.000 | 3.653 | 6 | 18 | 79 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0052547 | 0.000 | 2.344 | 17 | 36 | 228 | regulation of peptidase activity |
GO:0048878 | 0.000 | 1.689 | 58 | 89 | 761 | chemical homeostasis |
GO:0048806 | 0.000 | 5.480 | 3 | 12 | 39 | genitalia development |
GO:0061005 | 0.000 | 5.480 | 3 | 12 | 39 | cell differentiation involved in kidney development |
GO:0021761 | 0.000 | 4.037 | 5 | 16 | 65 | limbic system development |
GO:0031669 | 0.000 | 3.350 | 7 | 20 | 94 | cellular response to nutrient levels |
GO:0060326 | 0.000 | 2.788 | 11 | 26 | 142 | cell chemotaxis |
GO:0033002 | 0.000 | 3.215 | 8 | 21 | 102 | muscle cell proliferation |
GO:1901342 | 0.000 | 2.661 | 12 | 28 | 159 | regulation of vasculature development |
GO:0050708 | 0.000 | 3.102 | 8 | 22 | 110 | regulation of protein secretion |
GO:0051971 | 0.000 | 4.549 | 4 | 14 | 52 | positive regulation of transmission of nerve impulse |
GO:0030520 | 0.000 | 6.839 | 2 | 10 | 28 | intracellular estrogen receptor signaling pathway |
GO:0045668 | 0.000 | 6.839 | 2 | 10 | 28 | negative regulation of osteoblast differentiation |
GO:0052548 | 0.000 | 2.350 | 17 | 35 | 221 | regulation of endopeptidase activity |
GO:0042506 | 0.000 | 9.832 | 1 | 8 | 18 | tyrosine phosphorylation of Stat5 protein |
GO:0042990 | 0.000 | 4.212 | 4 | 15 | 59 | regulation of transcription factor import into nucleus |
GO:0051897 | 0.000 | 4.212 | 4 | 15 | 59 | positive regulation of protein kinase B signaling cascade |
GO:0043086 | 0.000 | 1.905 | 34 | 58 | 442 | negative regulation of catalytic activity |
GO:0045058 | 0.000 | 7.907 | 2 | 9 | 23 | T cell selection |
GO:0009636 | 0.000 | 2.974 | 9 | 23 | 119 | response to toxin |
GO:0031100 | 0.000 | 5.284 | 3 | 12 | 40 | organ regeneration |
GO:0007267 | 0.000 | 1.607 | 71 | 105 | 942 | cell-cell signaling |
GO:0032103 | 0.000 | 2.740 | 11 | 26 | 144 | positive regulation of response to external stimulus |
GO:0006338 | 0.000 | 3.537 | 6 | 18 | 81 | chromatin remodeling |
GO:0014033 | 0.000 | 4.432 | 4 | 14 | 53 | neural crest cell differentiation |
GO:0043255 | 0.000 | 4.432 | 4 | 14 | 53 | regulation of carbohydrate biosynthetic process |
GO:0006974 | 0.000 | 1.826 | 39 | 65 | 515 | response to DNA damage stimulus |
GO:0030036 | 0.000 | 2.012 | 27 | 49 | 355 | actin cytoskeleton organization |
GO:0009896 | 0.000 | 2.943 | 9 | 23 | 120 | positive regulation of catabolic process |
GO:0021536 | 0.000 | 4.118 | 5 | 15 | 60 | diencephalon development |
GO:0042991 | 0.000 | 4.118 | 5 | 15 | 60 | transcription factor import into nucleus |
GO:0044259 | 0.000 | 4.118 | 5 | 15 | 60 | multicellular organismal macromolecule metabolic process |
GO:0070555 | 0.000 | 4.118 | 5 | 15 | 60 | response to interleukin-1 |
GO:0008354 | 0.000 | 12.278 | 1 | 7 | 14 | germ cell migration |
GO:0032495 | 0.000 | 18.400 | 1 | 6 | 10 | response to muramyl dipeptide |
GO:0035886 | 0.000 | 18.400 | 1 | 6 | 10 | vascular smooth muscle cell differentiation |
GO:0035914 | 0.000 | 4.717 | 4 | 13 | 47 | skeletal muscle cell differentiation |
GO:0045087 | 0.000 | 1.874 | 35 | 59 | 456 | innate immune response |
GO:0002244 | 0.000 | 6.478 | 2 | 10 | 29 | hematopoietic progenitor cell differentiation |
GO:0010977 | 0.000 | 6.478 | 2 | 10 | 29 | negative regulation of neuron projection development |
GO:0022409 | 0.000 | 6.478 | 2 | 10 | 29 | positive regulation of cell-cell adhesion |
GO:0060396 | 0.000 | 6.478 | 2 | 10 | 29 | growth hormone receptor signaling pathway |
GO:0032872 | 0.000 | 2.774 | 10 | 25 | 137 | regulation of stress-activated MAPK cascade |
GO:0016192 | 0.000 | 1.676 | 56 | 86 | 739 | vesicle-mediated transport |
GO:0060729 | 0.000 | Inf | 0 | 4 | 4 | intestinal epithelial structure maintenance |
GO:0060982 | 0.000 | Inf | 0 | 4 | 4 | coronary artery morphogenesis |
GO:2000737 | 0.000 | Inf | 0 | 4 | 4 | negative regulation of stem cell differentiation |
GO:2000774 | 0.000 | Inf | 0 | 4 | 4 | positive regulation of cellular senescence |
GO:0002443 | 0.000 | 2.491 | 14 | 30 | 180 | leukocyte mediated immunity |
GO:0072210 | 0.000 | 5.646 | 3 | 11 | 35 | metanephric nephron development |
GO:0032963 | 0.000 | 4.321 | 4 | 14 | 54 | collagen metabolic process |
GO:0045619 | 0.000 | 3.314 | 7 | 19 | 90 | regulation of lymphocyte differentiation |
GO:0070302 | 0.000 | 2.749 | 10 | 25 | 138 | regulation of stress-activated protein kinase signaling cascade |
GO:2000602 | 0.000 | 2.749 | 10 | 25 | 138 | regulation of interphase of mitotic cell cycle |
GO:0001704 | 0.000 | 3.803 | 5 | 16 | 68 | formation of primary germ layer |
GO:0051100 | 0.000 | 3.803 | 5 | 16 | 68 | negative regulation of binding |
GO:0090090 | 0.000 | 4.028 | 5 | 15 | 61 | negative regulation of canonical Wnt receptor signaling pathway |
GO:0060397 | 0.000 | 7.379 | 2 | 9 | 24 | JAK-STAT cascade involved in growth hormone signaling pathway |
GO:0002544 | 0.000 | 8.937 | 1 | 8 | 19 | chronic inflammatory response |
GO:0048635 | 0.000 | 8.937 | 1 | 8 | 19 | negative regulation of muscle organ development |
GO:0045765 | 0.000 | 2.671 | 11 | 26 | 147 | regulation of angiogenesis |
GO:0032835 | 0.000 | 4.582 | 4 | 13 | 48 | glomerulus development |
GO:0046907 | 0.000 | 1.567 | 77 | 111 | 1019 | intracellular transport |
GO:0008585 | 0.000 | 3.563 | 6 | 17 | 76 | female gonad development |
GO:0043409 | 0.000 | 3.268 | 7 | 19 | 91 | negative regulation of MAPK cascade |
GO:0000279 | 0.000 | 1.896 | 32 | 55 | 420 | M phase |
GO:0045598 | 0.000 | 4.215 | 4 | 14 | 55 | regulation of fat cell differentiation |
GO:0048641 | 0.000 | 4.215 | 4 | 14 | 55 | regulation of skeletal muscle tissue development |
GO:0051781 | 0.000 | 4.215 | 4 | 14 | 55 | positive regulation of cell division |
GO:0045184 | 0.000 | 1.553 | 81 | 115 | 1065 | establishment of protein localization |
GO:0071702 | 0.000 | 1.458 | 123 | 163 | 1617 | organic substance transport |
GO:1901654 | 0.000 | 3.731 | 5 | 16 | 69 | response to ketone |
GO:0060135 | 0.000 | 4.930 | 3 | 12 | 42 | maternal process involved in female pregnancy |
GO:0042503 | 0.000 | 6.154 | 2 | 10 | 30 | tyrosine phosphorylation of Stat3 protein |
GO:0071378 | 0.000 | 6.154 | 2 | 10 | 30 | cellular response to growth hormone stimulus |
GO:0002062 | 0.000 | 3.942 | 5 | 15 | 62 | chondrocyte differentiation |
GO:0046632 | 0.000 | 3.942 | 5 | 15 | 62 | alpha-beta T cell differentiation |
GO:0060560 | 0.000 | 3.027 | 8 | 21 | 107 | developmental growth involved in morphogenesis |
GO:0000320 | 0.000 | 30.634 | 1 | 5 | 7 | re-entry into mitotic cell cycle |
GO:0042368 | 0.000 | 30.634 | 1 | 5 | 7 | vitamin D biosynthetic process |
GO:0045348 | 0.000 | 30.634 | 1 | 5 | 7 | positive regulation of MHC class II biosynthetic process |
GO:0045618 | 0.000 | 30.634 | 1 | 5 | 7 | positive regulation of keratinocyte differentiation |
GO:0060462 | 0.000 | 30.634 | 1 | 5 | 7 | lung lobe development |
GO:0060463 | 0.000 | 30.634 | 1 | 5 | 7 | lung lobe morphogenesis |
GO:0060684 | 0.000 | 30.634 | 1 | 5 | 7 | epithelial-mesenchymal cell signaling |
GO:0061307 | 0.000 | 30.634 | 1 | 5 | 7 | cardiac neural crest cell differentiation involved in heart development |
GO:0097150 | 0.000 | 30.634 | 1 | 5 | 7 | neuronal stem cell maintenance |
GO:0048167 | 0.000 | 3.375 | 6 | 18 | 84 | regulation of synaptic plasticity |
GO:0071453 | 0.000 | 3.375 | 6 | 18 | 84 | cellular response to oxygen levels |
GO:0016575 | 0.000 | 5.419 | 3 | 11 | 36 | histone deacetylation |
GO:0001667 | 0.000 | 3.222 | 7 | 19 | 92 | ameboidal cell migration |
GO:0034612 | 0.000 | 3.504 | 6 | 17 | 77 | response to tumor necrosis factor |
GO:0090288 | 0.000 | 3.504 | 6 | 17 | 77 | negative regulation of cellular response to growth factor stimulus |
GO:0048546 | 0.000 | 4.454 | 4 | 13 | 49 | digestive tract morphogenesis |
GO:0050806 | 0.000 | 4.454 | 4 | 13 | 49 | positive regulation of synaptic transmission |
GO:0002320 | 0.000 | 10.742 | 1 | 7 | 15 | lymphoid progenitor cell differentiation |
GO:0003215 | 0.000 | 10.742 | 1 | 7 | 15 | cardiac right ventricle morphogenesis |
GO:0006359 | 0.000 | 10.742 | 1 | 7 | 15 | regulation of transcription from RNA polymerase III promoter |
GO:0010888 | 0.000 | 10.742 | 1 | 7 | 15 | negative regulation of lipid storage |
GO:0023019 | 0.000 | 10.742 | 1 | 7 | 15 | signal transduction involved in regulation of gene expression |
GO:0030857 | 0.000 | 10.742 | 1 | 7 | 15 | negative regulation of epithelial cell differentiation |
GO:0045684 | 0.000 | 10.742 | 1 | 7 | 15 | positive regulation of epidermis development |
GO:0060675 | 0.000 | 4.114 | 4 | 14 | 56 | ureteric bud morphogenesis |
GO:0016337 | 0.000 | 2.034 | 24 | 44 | 315 | cell-cell adhesion |
GO:0044085 | 0.000 | 1.482 | 105 | 142 | 1380 | cellular component biogenesis |
GO:0044710 | 0.000 | 1.379 | 191 | 237 | 2514 | single-organism metabolic process |
GO:0030888 | 0.000 | 4.771 | 3 | 12 | 43 | regulation of B cell proliferation |
GO:0045913 | 0.000 | 4.771 | 3 | 12 | 43 | positive regulation of carbohydrate metabolic process |
GO:0043280 | 0.000 | 3.179 | 7 | 19 | 93 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0010718 | 0.000 | 8.191 | 2 | 8 | 20 | positive regulation of epithelial to mesenchymal transition |
GO:0031069 | 0.000 | 8.191 | 2 | 8 | 20 | hair follicle morphogenesis |
GO:0070374 | 0.000 | 3.446 | 6 | 17 | 78 | positive regulation of ERK1 and ERK2 cascade |
GO:0010812 | 0.000 | 5.860 | 2 | 10 | 31 | negative regulation of cell-substrate adhesion |
GO:0010883 | 0.000 | 5.860 | 2 | 10 | 31 | regulation of lipid storage |
GO:0014015 | 0.000 | 5.860 | 2 | 10 | 31 | positive regulation of gliogenesis |
GO:0072332 | 0.000 | 5.860 | 2 | 10 | 31 | intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0060767 | 0.000 | 14.718 | 1 | 6 | 11 | epithelial cell proliferation involved in prostate gland development |
GO:0010038 | 0.000 | 2.318 | 15 | 32 | 204 | response to metal ion |
GO:0044236 | 0.000 | 3.595 | 5 | 16 | 71 | multicellular organismal metabolic process |
GO:0002698 | 0.000 | 4.333 | 4 | 13 | 50 | negative regulation of immune effector process |
GO:0031330 | 0.000 | 4.333 | 4 | 13 | 50 | negative regulation of cellular catabolic process |
GO:0030178 | 0.000 | 3.275 | 7 | 18 | 86 | negative regulation of Wnt receptor signaling pathway |
GO:0048511 | 0.000 | 2.524 | 12 | 27 | 160 | rhythmic process |
GO:0045666 | 0.000 | 4.018 | 4 | 14 | 57 | positive regulation of neuron differentiation |
GO:0043112 | 0.000 | 3.136 | 7 | 19 | 94 | receptor metabolic process |
GO:0002263 | 0.000 | 2.841 | 9 | 22 | 118 | cell activation involved in immune response |
GO:0002366 | 0.000 | 2.841 | 9 | 22 | 118 | leukocyte activation involved in immune response |
GO:0044057 | 0.000 | 1.881 | 31 | 53 | 407 | regulation of system process |
GO:0051051 | 0.000 | 2.159 | 19 | 37 | 251 | negative regulation of transport |
GO:0048469 | 0.000 | 3.021 | 8 | 20 | 102 | cell maturation |
GO:0032535 | 0.000 | 2.564 | 12 | 26 | 152 | regulation of cellular component size |
GO:0022412 | 0.000 | 2.684 | 10 | 24 | 135 | cellular process involved in reproduction in multicellular organism |
GO:0071383 | 0.000 | 4.621 | 3 | 12 | 44 | cellular response to steroid hormone stimulus |
GO:0051302 | 0.000 | 3.530 | 5 | 16 | 72 | regulation of cell division |
GO:0003197 | 0.000 | 6.510 | 2 | 9 | 26 | endocardial cushion development |
GO:0031102 | 0.000 | 6.510 | 2 | 9 | 26 | neuron projection regeneration |
GO:0032570 | 0.000 | 6.510 | 2 | 9 | 26 | response to progesterone stimulus |
GO:0030029 | 0.000 | 1.882 | 30 | 52 | 399 | actin filament-based process |
GO:0030902 | 0.000 | 2.984 | 8 | 20 | 103 | hindbrain development |
GO:0090092 | 0.000 | 2.659 | 10 | 24 | 136 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:2000377 | 0.000 | 4.219 | 4 | 13 | 51 | regulation of reactive oxygen species metabolic process |
GO:0002377 | 0.000 | 3.704 | 5 | 15 | 65 | immunoglobulin production |
GO:0008361 | 0.000 | 3.704 | 5 | 15 | 65 | regulation of cell size |
GO:0042177 | 0.000 | 5.017 | 3 | 11 | 38 | negative regulation of protein catabolic process |
GO:0043122 | 0.000 | 2.486 | 12 | 27 | 162 | regulation of I-kappaB kinase/NF-kappaB cascade |
GO:0072073 | 0.000 | 3.926 | 4 | 14 | 58 | kidney epithelium development |
GO:0000087 | 0.000 | 2.029 | 23 | 42 | 301 | M phase of mitotic cell cycle |
GO:0007264 | 0.000 | 1.876 | 30 | 52 | 400 | small GTPase mediated signal transduction |
GO:0002637 | 0.000 | 5.593 | 2 | 10 | 32 | regulation of immunoglobulin production |
GO:0071345 | 0.000 | 1.901 | 29 | 50 | 380 | cellular response to cytokine stimulus |
GO:0002576 | 0.000 | 3.336 | 6 | 17 | 80 | platelet degranulation |
GO:0046631 | 0.000 | 3.336 | 6 | 17 | 80 | alpha-beta T cell activation |
GO:0048736 | 0.000 | 2.783 | 9 | 22 | 120 | appendage development |
GO:0060173 | 0.000 | 2.783 | 9 | 22 | 120 | limb development |
GO:0016572 | 0.000 | 9.548 | 1 | 7 | 16 | histone phosphorylation |
GO:0045191 | 0.000 | 9.548 | 1 | 7 | 16 | regulation of isotype switching |
GO:0045616 | 0.000 | 9.548 | 1 | 7 | 16 | regulation of keratinocyte differentiation |
GO:0046605 | 0.000 | 9.548 | 1 | 7 | 16 | regulation of centrosome cycle |
GO:0045604 | 0.000 | 7.561 | 2 | 8 | 21 | regulation of epidermal cell differentiation |
GO:0060291 | 0.000 | 7.561 | 2 | 8 | 21 | long-term synaptic potentiation |
GO:0002526 | 0.000 | 3.054 | 7 | 19 | 96 | acute inflammatory response |
GO:2001056 | 0.000 | 3.054 | 7 | 19 | 96 | positive regulation of cysteine-type endopeptidase activity |
GO:0015031 | 0.000 | 1.534 | 78 | 110 | 1027 | protein transport |
GO:0045069 | 0.000 | 4.481 | 3 | 12 | 45 | regulation of viral genome replication |
GO:0045833 | 0.000 | 4.481 | 3 | 12 | 45 | negative regulation of lipid metabolic process |
GO:0048660 | 0.000 | 3.631 | 5 | 15 | 66 | regulation of smooth muscle cell proliferation |
GO:0017015 | 0.000 | 3.283 | 6 | 17 | 81 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0042100 | 0.000 | 4.110 | 4 | 13 | 52 | B cell proliferation |
GO:0071887 | 0.000 | 4.110 | 4 | 13 | 52 | leukocyte apoptotic process |
GO:0030162 | 0.000 | 2.612 | 10 | 24 | 138 | regulation of proteolysis |
GO:0032787 | 0.000 | 1.940 | 26 | 46 | 343 | monocarboxylic acid metabolic process |
GO:0035107 | 0.000 | 2.828 | 9 | 21 | 113 | appendage morphogenesis |
GO:0035108 | 0.000 | 2.828 | 9 | 21 | 113 | limb morphogenesis |
GO:0048706 | 0.000 | 3.014 | 7 | 19 | 97 | embryonic skeletal system development |
GO:0014902 | 0.000 | 4.837 | 3 | 11 | 39 | myotube differentiation |
GO:0033619 | 0.000 | 4.837 | 3 | 11 | 39 | membrane protein proteolysis |
GO:0009306 | 0.000 | 2.544 | 11 | 25 | 147 | protein secretion |
GO:0065003 | 0.000 | 1.581 | 64 | 93 | 841 | macromolecular complex assembly |
GO:0035116 | 0.000 | 6.147 | 2 | 9 | 27 | embryonic hindlimb morphogenesis |
GO:0035850 | 0.000 | 6.147 | 2 | 9 | 27 | epithelial cell differentiation involved in kidney development |
GO:0042993 | 0.000 | 6.147 | 2 | 9 | 27 | positive regulation of transcription factor import into nucleus |
GO:0051046 | 0.000 | 1.878 | 29 | 50 | 384 | regulation of secretion |
GO:0001755 | 0.000 | 5.350 | 3 | 10 | 33 | neural crest cell migration |
GO:0033628 | 0.000 | 5.350 | 3 | 10 | 33 | regulation of cell adhesion mediated by integrin |
GO:2001235 | 0.000 | 5.350 | 3 | 10 | 33 | positive regulation of apoptotic signaling pathway |
GO:0072331 | 0.000 | 2.727 | 9 | 22 | 122 | signal transduction by p53 class mediator |
GO:0045606 | 0.000 | 20.421 | 1 | 5 | 8 | positive regulation of epidermal cell differentiation |
GO:0043902 | 0.000 | 3.233 | 6 | 17 | 82 | positive regulation of multi-organism process |
GO:0002761 | 0.000 | 3.561 | 5 | 15 | 67 | regulation of myeloid leukocyte differentiation |
GO:0002701 | 0.000 | 12.264 | 1 | 6 | 12 | negative regulation of production of molecular mediator of immune response |
GO:0002719 | 0.000 | 12.264 | 1 | 6 | 12 | negative regulation of cytokine production involved in immune response |
GO:0010824 | 0.000 | 12.264 | 1 | 6 | 12 | regulation of centrosome duplication |
GO:0045073 | 0.000 | 12.264 | 1 | 6 | 12 | regulation of chemokine biosynthetic process |
GO:0045346 | 0.000 | 12.264 | 1 | 6 | 12 | regulation of MHC class II biosynthetic process |
GO:0051767 | 0.000 | 12.264 | 1 | 6 | 12 | nitric-oxide synthase biosynthetic process |
GO:0051769 | 0.000 | 12.264 | 1 | 6 | 12 | regulation of nitric-oxide synthase biosynthetic process |
GO:2000108 | 0.000 | 12.264 | 1 | 6 | 12 | positive regulation of leukocyte apoptotic process |
GO:0021766 | 0.000 | 4.349 | 3 | 12 | 46 | hippocampus development |
GO:0042471 | 0.000 | 3.092 | 7 | 18 | 90 | ear morphogenesis |
GO:0051092 | 0.000 | 3.092 | 7 | 18 | 90 | positive regulation of NF-kappaB transcription factor activity |
GO:0051341 | 0.000 | 3.755 | 5 | 14 | 60 | regulation of oxidoreductase activity |
GO:0046634 | 0.000 | 4.007 | 4 | 13 | 53 | regulation of alpha-beta T cell activation |
GO:0048738 | 0.000 | 2.699 | 9 | 22 | 123 | cardiac muscle tissue development |
GO:0010906 | 0.000 | 3.350 | 6 | 16 | 75 | regulation of glucose metabolic process |
GO:0042472 | 0.000 | 3.350 | 6 | 16 | 75 | inner ear morphogenesis |
GO:0003170 | 0.000 | 7.020 | 2 | 8 | 22 | heart valve development |
GO:0031670 | 0.000 | 7.020 | 2 | 8 | 22 | cellular response to nutrient |
GO:0002718 | 0.000 | 4.670 | 3 | 11 | 40 | regulation of cytokine production involved in immune response |
GO:0003143 | 0.000 | 4.670 | 3 | 11 | 40 | embryonic heart tube morphogenesis |
GO:0033627 | 0.000 | 4.670 | 3 | 11 | 40 | cell adhesion mediated by integrin |
GO:0045927 | 0.000 | 2.616 | 10 | 23 | 132 | positive regulation of growth |
GO:0002274 | 0.000 | 2.846 | 8 | 20 | 107 | myeloid leukocyte activation |
GO:0045732 | 0.000 | 3.494 | 5 | 15 | 68 | positive regulation of protein catabolic process |
GO:0010975 | 0.000 | 2.311 | 14 | 29 | 185 | regulation of neuron projection development |
GO:0001953 | 0.000 | 8.592 | 1 | 7 | 17 | negative regulation of cell-matrix adhesion |
GO:0036314 | 0.000 | 8.592 | 1 | 7 | 17 | response to sterol |
GO:0045648 | 0.000 | 8.592 | 1 | 7 | 17 | positive regulation of erythrocyte differentiation |
GO:0070723 | 0.000 | 8.592 | 1 | 7 | 17 | response to cholesterol |
GO:0008543 | 0.000 | 2.673 | 9 | 22 | 124 | fibroblast growth factor receptor signaling pathway |
GO:0006629 | 0.000 | 1.542 | 70 | 100 | 926 | lipid metabolic process |
GO:0050821 | 0.000 | 3.675 | 5 | 14 | 61 | protein stabilization |
GO:0060416 | 0.000 | 5.126 | 3 | 10 | 34 | response to growth hormone stimulus |
GO:0003338 | 0.000 | 5.823 | 2 | 9 | 28 | metanephros morphogenesis |
GO:0032722 | 0.000 | 5.823 | 2 | 9 | 28 | positive regulation of chemokine production |
GO:0051148 | 0.000 | 5.823 | 2 | 9 | 28 | negative regulation of muscle cell differentiation |
GO:0035265 | 0.000 | 3.293 | 6 | 16 | 76 | organ growth |
GO:2001020 | 0.000 | 3.293 | 6 | 16 | 76 | regulation of response to DNA damage stimulus |
GO:0007610 | 0.000 | 1.773 | 35 | 57 | 461 | behavior |
GO:0018205 | 0.000 | 2.592 | 10 | 23 | 133 | peptidyl-lysine modification |
GO:0007249 | 0.000 | 2.335 | 13 | 28 | 177 | I-kappaB kinase/NF-kappaB cascade |
GO:0010586 | 0.000 | 48.959 | 0 | 4 | 5 | miRNA metabolic process |
GO:0033600 | 0.000 | 48.959 | 0 | 4 | 5 | negative regulation of mammary gland epithelial cell proliferation |
GO:0035855 | 0.000 | 48.959 | 0 | 4 | 5 | megakaryocyte development |
GO:0042695 | 0.000 | 48.959 | 0 | 4 | 5 | thelarche |
GO:0048087 | 0.000 | 48.959 | 0 | 4 | 5 | positive regulation of developmental pigmentation |
GO:0060744 | 0.000 | 48.959 | 0 | 4 | 5 | mammary gland branching involved in thelarche |
GO:0010950 | 0.000 | 2.902 | 8 | 19 | 100 | positive regulation of endopeptidase activity |
GO:0019217 | 0.000 | 3.428 | 5 | 15 | 69 | regulation of fatty acid metabolic process |
GO:0048659 | 0.000 | 3.428 | 5 | 15 | 69 | smooth muscle cell proliferation |
GO:0051099 | 0.000 | 3.428 | 5 | 15 | 69 | positive regulation of binding |
GO:1901575 | 0.000 | 1.428 | 114 | 150 | 1505 | organic substance catabolic process |
GO:0001541 | 0.000 | 4.514 | 3 | 11 | 41 | ovarian follicle development |
GO:0033143 | 0.000 | 4.514 | 3 | 11 | 41 | regulation of intracellular steroid hormone receptor signaling pathway |
GO:0050810 | 0.000 | 4.514 | 3 | 11 | 41 | regulation of steroid biosynthetic process |
GO:0071482 | 0.000 | 4.514 | 3 | 11 | 41 | cellular response to light stimulus |
GO:0097191 | 0.000 | 4.514 | 3 | 11 | 41 | extrinsic apoptotic signaling pathway |
GO:0007368 | 0.000 | 3.598 | 5 | 14 | 62 | determination of left/right symmetry |
GO:0005996 | 0.000 | 2.118 | 18 | 34 | 234 | monosaccharide metabolic process |
GO:0006461 | 0.000 | 1.628 | 51 | 76 | 666 | protein complex assembly |
GO:0000280 | 0.000 | 1.982 | 22 | 40 | 292 | nuclear division |
GO:0007067 | 0.000 | 1.982 | 22 | 40 | 292 | mitosis |
GO:0030258 | 0.000 | 2.621 | 10 | 22 | 126 | lipid modification |
GO:0045862 | 0.000 | 3.815 | 4 | 13 | 55 | positive regulation of proteolysis |
GO:0071260 | 0.000 | 3.815 | 4 | 13 | 55 | cellular response to mechanical stimulus |
GO:0001893 | 0.000 | 6.551 | 2 | 8 | 23 | maternal placenta development |
GO:0042517 | 0.000 | 6.551 | 2 | 8 | 23 | positive regulation of tyrosine phosphorylation of Stat3 protein |
GO:0050850 | 0.000 | 6.551 | 2 | 8 | 23 | positive regulation of calcium-mediated signaling |
GO:0072273 | 0.000 | 6.551 | 2 | 8 | 23 | metanephric nephron morphogenesis |
GO:0001974 | 0.000 | 4.921 | 3 | 10 | 35 | blood vessel remodeling |
GO:0046677 | 0.000 | 4.921 | 3 | 10 | 35 | response to antibiotic |
GO:0009855 | 0.000 | 3.366 | 5 | 15 | 70 | determination of bilateral symmetry |
GO:0045580 | 0.000 | 3.366 | 5 | 15 | 70 | regulation of T cell differentiation |
GO:0070271 | 0.000 | 1.622 | 51 | 76 | 668 | protein complex biogenesis |
GO:0019221 | 0.000 | 1.936 | 24 | 42 | 313 | cytokine-mediated signaling pathway |
GO:0045646 | 0.000 | 5.532 | 2 | 9 | 29 | regulation of erythrocyte differentiation |
GO:0051055 | 0.000 | 5.532 | 2 | 9 | 29 | negative regulation of lipid biosynthetic process |
GO:0006006 | 0.000 | 2.253 | 14 | 29 | 189 | glucose metabolic process |
GO:0002360 | 0.000 | 10.511 | 1 | 6 | 13 | T cell lineage commitment |
GO:0042033 | 0.000 | 10.511 | 1 | 6 | 13 | chemokine biosynthetic process |
GO:0072075 | 0.000 | 10.511 | 1 | 6 | 13 | metanephric mesenchyme development |
GO:0090287 | 0.000 | 2.595 | 10 | 22 | 127 | regulation of cellular response to growth factor stimulus |
GO:0000075 | 0.000 | 2.152 | 16 | 32 | 217 | cell cycle checkpoint |
GO:0036294 | 0.000 | 3.187 | 6 | 16 | 78 | cellular response to decreased oxygen levels |
GO:0071241 | 0.000 | 3.187 | 6 | 16 | 78 | cellular response to inorganic substance |
GO:0071456 | 0.000 | 3.187 | 6 | 16 | 78 | cellular response to hypoxia |
GO:0007281 | 0.000 | 2.831 | 8 | 19 | 102 | germ cell development |
GO:0009056 | 0.000 | 1.406 | 123 | 159 | 1619 | catabolic process |
GO:0060349 | 0.000 | 3.524 | 5 | 14 | 63 | bone morphogenesis |
GO:0001764 | 0.000 | 3.044 | 7 | 17 | 86 | neuron migration |
GO:0002703 | 0.000 | 3.044 | 7 | 17 | 86 | regulation of leukocyte mediated immunity |
GO:0010675 | 0.000 | 2.928 | 7 | 18 | 94 | regulation of cellular carbohydrate metabolic process |
GO:0010002 | 0.000 | 7.810 | 1 | 7 | 18 | cardioblast differentiation |
GO:0032770 | 0.000 | 7.810 | 1 | 7 | 18 | positive regulation of monooxygenase activity |
GO:0045686 | 0.000 | 7.810 | 1 | 7 | 18 | negative regulation of glial cell differentiation |
GO:0045843 | 0.000 | 7.810 | 1 | 7 | 18 | negative regulation of striated muscle tissue development |
GO:0060231 | 0.000 | 7.810 | 1 | 7 | 18 | mesenchymal to epithelial transition |
GO:1901862 | 0.000 | 7.810 | 1 | 7 | 18 | negative regulation of muscle tissue development |
GO:0048844 | 0.000 | 4.368 | 3 | 11 | 42 | artery morphogenesis |
GO:0032368 | 0.000 | 3.726 | 4 | 13 | 56 | regulation of lipid transport |
GO:0035821 | 0.000 | 3.726 | 4 | 13 | 56 | modification of morphology or physiology of other organism |
GO:0000186 | 0.000 | 3.995 | 4 | 12 | 49 | activation of MAPKK activity |
GO:0045638 | 0.000 | 3.995 | 4 | 12 | 49 | negative regulation of myeloid cell differentiation |
GO:0060491 | 0.000 | 3.995 | 4 | 12 | 49 | regulation of cell projection assembly |
GO:0060840 | 0.000 | 3.995 | 4 | 12 | 49 | artery development |
GO:0002683 | 0.000 | 2.404 | 12 | 25 | 154 | negative regulation of immune system process |
GO:0009799 | 0.000 | 3.305 | 5 | 15 | 71 | specification of symmetry |
GO:0031349 | 0.000 | 2.166 | 16 | 31 | 209 | positive regulation of defense response |
GO:0002676 | 0.000 | 15.314 | 1 | 5 | 9 | regulation of chronic inflammatory response |
GO:0021940 | 0.000 | 15.314 | 1 | 5 | 9 | positive regulation of cerebellar granule cell precursor proliferation |
GO:0033145 | 0.000 | 15.314 | 1 | 5 | 9 | positive regulation of intracellular steroid hormone receptor signaling pathway |
GO:0045080 | 0.000 | 15.314 | 1 | 5 | 9 | positive regulation of chemokine biosynthetic process |
GO:0046543 | 0.000 | 15.314 | 1 | 5 | 9 | development of secondary female sexual characteristics |
GO:0051770 | 0.000 | 15.314 | 1 | 5 | 9 | positive regulation of nitric-oxide synthase biosynthetic process |
GO:0070486 | 0.000 | 15.314 | 1 | 5 | 9 | leukocyte aggregation |
GO:0050920 | 0.000 | 2.889 | 7 | 18 | 95 | regulation of chemotaxis |
GO:0045216 | 0.000 | 2.439 | 11 | 24 | 146 | cell-cell junction organization |
GO:0001947 | 0.000 | 4.731 | 3 | 10 | 36 | heart looping |
GO:0070227 | 0.000 | 4.731 | 3 | 10 | 36 | lymphocyte apoptotic process |
GO:0009416 | 0.000 | 2.258 | 14 | 28 | 182 | response to light stimulus |
GO:0034130 | 0.000 | 3.453 | 5 | 14 | 64 | toll-like receptor 1 signaling pathway |
GO:0070507 | 0.000 | 3.453 | 5 | 14 | 64 | regulation of microtubule cytoskeleton organization |
GO:0000187 | 0.000 | 2.690 | 8 | 20 | 112 | activation of MAPK activity |
GO:0042770 | 0.000 | 2.690 | 8 | 20 | 112 | signal transduction in response to DNA damage |
GO:0019318 | 0.000 | 2.117 | 17 | 32 | 220 | hexose metabolic process |
GO:0046578 | 0.000 | 2.117 | 17 | 32 | 220 | regulation of Ras protein signal transduction |
GO:0045840 | 0.000 | 5.268 | 2 | 9 | 30 | positive regulation of mitosis |
GO:0051785 | 0.000 | 5.268 | 2 | 9 | 30 | positive regulation of nuclear division |
GO:0002088 | 0.000 | 3.641 | 4 | 13 | 57 | lens development in camera-type eye |
GO:0010952 | 0.000 | 2.764 | 8 | 19 | 104 | positive regulation of peptidase activity |
GO:0018394 | 0.000 | 2.764 | 8 | 19 | 104 | peptidyl-lysine acetylation |
GO:0034976 | 0.000 | 2.764 | 8 | 19 | 104 | response to endoplasmic reticulum stress |
GO:0002286 | 0.000 | 4.231 | 3 | 11 | 43 | T cell activation involved in immune response |
GO:0006476 | 0.000 | 4.231 | 3 | 11 | 43 | protein deacetylation |
GO:0051817 | 0.000 | 4.231 | 3 | 11 | 43 | modification of morphology or physiology of other organism involved in symbiotic interaction |
GO:0006959 | 0.000 | 2.852 | 7 | 18 | 96 | humoral immune response |
GO:0042035 | 0.000 | 3.086 | 6 | 16 | 80 | regulation of cytokine biosynthetic process |
GO:0010948 | 0.000 | 2.958 | 7 | 17 | 88 | negative regulation of cell cycle process |
GO:0033500 | 0.000 | 2.661 | 9 | 20 | 113 | carbohydrate homeostasis |
GO:0042593 | 0.000 | 2.661 | 9 | 20 | 113 | glucose homeostasis |
GO:0051145 | 0.000 | 4.555 | 3 | 10 | 37 | smooth muscle cell differentiation |
GO:0030878 | 0.000 | 7.159 | 1 | 7 | 19 | thyroid gland development |
GO:0042346 | 0.000 | 7.159 | 1 | 7 | 19 | positive regulation of NF-kappaB import into nucleus |
GO:0048713 | 0.000 | 7.159 | 1 | 7 | 19 | regulation of oligodendrocyte differentiation |
GO:0030326 | 0.000 | 2.816 | 7 | 18 | 97 | embryonic limb morphogenesis |
GO:0035113 | 0.000 | 2.816 | 7 | 18 | 97 | embryonic appendage morphogenesis |
GO:0019079 | 0.000 | 3.560 | 4 | 13 | 58 | viral genome replication |
GO:0001959 | 0.000 | 3.039 | 6 | 16 | 81 | regulation of cytokine-mediated signaling pathway |
GO:0006984 | 0.000 | 2.916 | 7 | 17 | 89 | ER-nucleus signaling pathway |
GO:0042523 | 0.000 | 9.196 | 1 | 6 | 14 | positive regulation of tyrosine phosphorylation of Stat5 protein |
GO:0060216 | 0.000 | 9.196 | 1 | 6 | 14 | definitive hemopoiesis |
GO:0071285 | 0.000 | 9.196 | 1 | 6 | 14 | cellular response to lithium ion |
GO:0072074 | 0.000 | 9.196 | 1 | 6 | 14 | kidney mesenchyme development |
GO:0009952 | 0.000 | 2.249 | 13 | 27 | 176 | anterior/posterior pattern specification |
GO:0035050 | 0.000 | 3.789 | 4 | 12 | 51 | embryonic heart tube development |
GO:0045669 | 0.000 | 3.789 | 4 | 12 | 51 | positive regulation of osteoblast differentiation |
GO:0035601 | 0.000 | 4.102 | 3 | 11 | 44 | protein deacylation |
GO:0043588 | 0.000 | 4.102 | 3 | 11 | 44 | skin development |
GO:0071822 | 0.000 | 1.519 | 66 | 93 | 869 | protein complex subunit organization |
GO:0030199 | 0.000 | 5.028 | 2 | 9 | 31 | collagen fibril organization |
GO:0046320 | 0.000 | 5.028 | 2 | 9 | 31 | regulation of fatty acid oxidation |
GO:0051353 | 0.000 | 5.028 | 2 | 9 | 31 | positive regulation of oxidoreductase activity |
GO:0061326 | 0.000 | 5.028 | 2 | 9 | 31 | renal tubule development |
GO:0072080 | 0.000 | 5.028 | 2 | 9 | 31 | nephron tubule development |
GO:0014014 | 0.000 | 5.779 | 2 | 8 | 25 | negative regulation of gliogenesis |
GO:2001236 | 0.000 | 5.779 | 2 | 8 | 25 | regulation of extrinsic apoptotic signaling pathway |
GO:0043542 | 0.000 | 2.780 | 7 | 18 | 98 | endothelial cell migration |
GO:0048285 | 0.000 | 1.888 | 24 | 41 | 312 | organelle fission |
GO:0071248 | 0.000 | 3.136 | 6 | 15 | 74 | cellular response to metal ion |
GO:0048592 | 0.000 | 2.604 | 9 | 20 | 115 | eye morphogenesis |
GO:0090068 | 0.000 | 2.360 | 11 | 24 | 150 | positive regulation of cell cycle process |
GO:0031331 | 0.000 | 2.876 | 7 | 17 | 90 | positive regulation of cellular catabolic process |
GO:0042089 | 0.000 | 2.876 | 7 | 17 | 90 | cytokine biosynthetic process |
GO:0031334 | 0.000 | 2.992 | 6 | 16 | 82 | positive regulation of protein complex assembly |
GO:0044248 | 0.000 | 1.413 | 105 | 138 | 1390 | cellular catabolic process |
GO:0033077 | 0.000 | 3.482 | 4 | 13 | 59 | T cell differentiation in thymus |
GO:0032102 | 0.000 | 2.669 | 8 | 19 | 107 | negative regulation of response to external stimulus |
GO:0051969 | 0.000 | 2.219 | 14 | 27 | 178 | regulation of transmission of nerve impulse |
GO:0007159 | 0.000 | 4.392 | 3 | 10 | 38 | leukocyte cell-cell adhesion |
GO:0007405 | 0.000 | 4.392 | 3 | 10 | 38 | neuroblast proliferation |
GO:0061371 | 0.000 | 4.392 | 3 | 10 | 38 | determination of heart left/right asymmetry |
GO:0001658 | 0.000 | 3.694 | 4 | 12 | 52 | branching involved in ureteric bud morphogenesis |
GO:0032956 | 0.000 | 2.296 | 12 | 25 | 160 | regulation of actin cytoskeleton organization |
GO:0016573 | 0.000 | 2.746 | 8 | 18 | 99 | histone acetylation |
GO:0030216 | 0.000 | 3.257 | 5 | 14 | 67 | keratinocyte differentiation |
GO:0032355 | 0.000 | 3.257 | 5 | 14 | 67 | response to estradiol stimulus |
GO:0030595 | 0.000 | 2.577 | 9 | 20 | 116 | leukocyte chemotaxis |
GO:0032886 | 0.000 | 3.084 | 6 | 15 | 75 | regulation of microtubule-based process |
GO:0019722 | 0.000 | 2.947 | 6 | 16 | 83 | calcium-mediated signaling |
GO:0003253 | 0.000 | Inf | 0 | 3 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0035441 | 0.000 | Inf | 0 | 3 | 3 | cell migration involved in vasculogenesis |
GO:0035986 | 0.000 | Inf | 0 | 3 | 3 | senescence-associated heterochromatin focus assembly |
GO:0038086 | 0.000 | Inf | 0 | 3 | 3 | VEGF-activated platelet-derived growth factor receptor signaling pathway |
GO:0038091 | 0.000 | Inf | 0 | 3 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0051152 | 0.000 | Inf | 0 | 3 | 3 | positive regulation of smooth muscle cell differentiation |
GO:0060020 | 0.000 | Inf | 0 | 3 | 3 | Bergmann glial cell differentiation |
GO:0060559 | 0.000 | Inf | 0 | 3 | 3 | positive regulation of calcidiol 1-monooxygenase activity |
GO:2000773 | 0.000 | Inf | 0 | 3 | 3 | negative regulation of cellular senescence |
GO:0031017 | 0.000 | 24.477 | 0 | 4 | 6 | exocrine pancreas development |
GO:0043589 | 0.000 | 24.477 | 0 | 4 | 6 | skin morphogenesis |
GO:0045945 | 0.000 | 24.477 | 0 | 4 | 6 | positive regulation of transcription from RNA polymerase III promoter |
GO:0060556 | 0.000 | 24.477 | 0 | 4 | 6 | regulation of vitamin D biosynthetic process |
GO:0070933 | 0.000 | 24.477 | 0 | 4 | 6 | histone H4 deacetylation |
GO:0097084 | 0.000 | 24.477 | 0 | 4 | 6 | vascular smooth muscle cell development |
GO:0010876 | 0.000 | 2.131 | 15 | 29 | 198 | lipid localization |
GO:0010935 | 0.000 | 12.250 | 1 | 5 | 10 | regulation of macrophage cytokine production |
GO:0021936 | 0.000 | 12.250 | 1 | 5 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0060768 | 0.000 | 12.250 | 1 | 5 | 10 | regulation of epithelial cell proliferation involved in prostate gland development |
GO:0071305 | 0.000 | 12.250 | 1 | 5 | 10 | cellular response to vitamin D |
GO:0072182 | 0.000 | 12.250 | 1 | 5 | 10 | regulation of nephron tubule epithelial cell differentiation |
GO:2000178 | 0.000 | 12.250 | 1 | 5 | 10 | negative regulation of neural precursor cell proliferation |
GO:0034446 | 0.000 | 4.809 | 2 | 9 | 32 | substrate adhesion-dependent cell spreading |
GO:0050848 | 0.000 | 4.809 | 2 | 9 | 32 | regulation of calcium-mediated signaling |
GO:0003179 | 0.000 | 6.607 | 2 | 7 | 20 | heart valve morphogenesis |
GO:0010165 | 0.000 | 6.607 | 2 | 7 | 20 | response to X-ray |
GO:0051385 | 0.000 | 6.607 | 2 | 7 | 20 | response to mineralocorticoid stimulus |
GO:0052312 | 0.000 | 6.607 | 2 | 7 | 20 | modulation of transcription in other organism involved in symbiotic interaction |
GO:2000826 | 0.000 | 6.607 | 2 | 7 | 20 | regulation of heart morphogenesis |
GO:0045621 | 0.000 | 3.408 | 5 | 13 | 60 | positive regulation of lymphocyte differentiation |
GO:0009057 | 0.000 | 1.551 | 55 | 80 | 731 | macromolecule catabolic process |
GO:2000243 | 0.000 | 2.712 | 8 | 18 | 100 | positive regulation of reproductive process |
GO:0043933 | 0.000 | 1.456 | 81 | 110 | 1071 | macromolecular complex subunit organization |
GO:0014823 | 0.000 | 5.458 | 2 | 8 | 26 | response to activity |
GO:0032885 | 0.000 | 5.458 | 2 | 8 | 26 | regulation of polysaccharide biosynthetic process |
GO:0032964 | 0.000 | 5.458 | 2 | 8 | 26 | collagen biosynthetic process |
GO:0051893 | 0.000 | 5.458 | 2 | 8 | 26 | regulation of focal adhesion assembly |
GO:0090109 | 0.000 | 5.458 | 2 | 8 | 26 | regulation of cell-substrate junction assembly |
GO:0034134 | 0.000 | 3.196 | 5 | 14 | 68 | toll-like receptor 2 signaling pathway |
GO:0055001 | 0.000 | 2.410 | 10 | 22 | 135 | muscle cell development |
GO:0002285 | 0.000 | 3.033 | 6 | 15 | 76 | lymphocyte activation involved in immune response |
GO:0006919 | 0.000 | 3.033 | 6 | 15 | 76 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0071901 | 0.000 | 3.033 | 6 | 15 | 76 | negative regulation of protein serine/threonine kinase activity |
GO:0071347 | 0.001 | 4.240 | 3 | 10 | 39 | cellular response to interleukin-1 |
GO:0050778 | 0.001 | 1.853 | 24 | 41 | 317 | positive regulation of immune response |
GO:0010821 | 0.001 | 3.867 | 3 | 11 | 46 | regulation of mitochondrion organization |
GO:0043149 | 0.001 | 3.867 | 3 | 11 | 46 | stress fiber assembly |
GO:0021984 | 0.001 | 8.174 | 1 | 6 | 15 | adenohypophysis development |
GO:0030540 | 0.001 | 8.174 | 1 | 6 | 15 | female genitalia development |
GO:0033028 | 0.001 | 8.174 | 1 | 6 | 15 | myeloid cell apoptotic process |
GO:0033158 | 0.001 | 8.174 | 1 | 6 | 15 | regulation of protein import into nucleus, translocation |
GO:0045736 | 0.001 | 8.174 | 1 | 6 | 15 | negative regulation of cyclin-dependent protein kinase activity |
GO:0050755 | 0.001 | 8.174 | 1 | 6 | 15 | chemokine metabolic process |
GO:2001238 | 0.001 | 8.174 | 1 | 6 | 15 | positive regulation of extrinsic apoptotic signaling pathway |
GO:0030163 | 0.001 | 1.717 | 33 | 52 | 431 | protein catabolic process |
GO:0018393 | 0.001 | 2.679 | 8 | 18 | 101 | internal peptidyl-lysine acetylation |
GO:0060249 | 0.001 | 2.208 | 13 | 26 | 172 | anatomical structure homeostasis |
GO:0031644 | 0.001 | 2.132 | 14 | 28 | 191 | regulation of neurological system process |
GO:0042107 | 0.001 | 2.762 | 7 | 17 | 93 | cytokine metabolic process |
GO:0072593 | 0.001 | 2.580 | 8 | 19 | 110 | reactive oxygen species metabolic process |
GO:0030183 | 0.001 | 3.137 | 5 | 14 | 69 | B cell differentiation |
GO:0097202 | 0.001 | 2.984 | 6 | 15 | 77 | activation of cysteine-type endopeptidase activity |
GO:0003382 | 0.001 | 4.608 | 3 | 9 | 33 | epithelial cell morphogenesis |
GO:0022617 | 0.001 | 4.608 | 3 | 9 | 33 | extracellular matrix disassembly |
GO:0002250 | 0.001 | 2.193 | 13 | 26 | 173 | adaptive immune response |
GO:0034330 | 0.001 | 2.193 | 13 | 26 | 173 | cell junction organization |
GO:0006473 | 0.001 | 2.498 | 9 | 20 | 119 | protein acetylation |
GO:0021953 | 0.001 | 2.647 | 8 | 18 | 102 | central nervous system neuron differentiation |
GO:0030330 | 0.001 | 2.647 | 8 | 18 | 102 | DNA damage response, signal transduction by p53 class mediator |
GO:0003008 | 0.001 | 1.392 | 108 | 139 | 1417 | system process |
GO:0045727 | 0.001 | 3.759 | 4 | 11 | 47 | positive regulation of translation |
GO:0046635 | 0.001 | 4.098 | 3 | 10 | 40 | positive regulation of alpha-beta T cell activation |
GO:0072009 | 0.001 | 4.098 | 3 | 10 | 40 | nephron epithelium development |
GO:2000106 | 0.001 | 4.098 | 3 | 10 | 40 | regulation of leukocyte apoptotic process |
GO:0030225 | 0.001 | 6.135 | 2 | 7 | 21 | macrophage differentiation |
GO:0048710 | 0.001 | 6.135 | 2 | 7 | 21 | regulation of astrocyte differentiation |
GO:0030521 | 0.001 | 3.268 | 5 | 13 | 62 | androgen receptor signaling pathway |
GO:0006342 | 0.001 | 5.170 | 2 | 8 | 27 | chromatin silencing |
GO:0031572 | 0.001 | 5.170 | 2 | 8 | 27 | G2/M transition DNA damage checkpoint |
GO:0045599 | 0.001 | 5.170 | 2 | 8 | 27 | negative regulation of fat cell differentiation |
GO:0006631 | 0.001 | 1.972 | 18 | 33 | 241 | fatty acid metabolic process |
GO:0060759 | 0.001 | 2.820 | 7 | 16 | 86 | regulation of response to cytokine stimulus |
GO:0007015 | 0.001 | 2.105 | 15 | 28 | 193 | actin filament organization |
GO:0019395 | 0.001 | 2.936 | 6 | 15 | 78 | fatty acid oxidation |
GO:0048524 | 0.001 | 2.936 | 6 | 15 | 78 | positive regulation of viral reproduction |
GO:0043543 | 0.001 | 2.405 | 10 | 21 | 129 | protein acylation |
GO:0043534 | 0.001 | 3.435 | 4 | 12 | 55 | blood vessel endothelial cell migration |
GO:0007566 | 0.001 | 4.423 | 3 | 9 | 34 | embryo implantation |
GO:0031576 | 0.001 | 4.423 | 3 | 9 | 34 | G2/M transition checkpoint |
GO:0035137 | 0.001 | 4.423 | 3 | 9 | 34 | hindlimb morphogenesis |
GO:0060603 | 0.001 | 4.423 | 3 | 9 | 34 | mammary gland duct morphogenesis |
GO:1900076 | 0.001 | 4.423 | 3 | 9 | 34 | regulation of cellular response to insulin stimulus |
GO:1901888 | 0.001 | 4.423 | 3 | 9 | 34 | regulation of cell junction assembly |
GO:0001776 | 0.001 | 3.657 | 4 | 11 | 48 | leukocyte homeostasis |
GO:0002755 | 0.001 | 3.027 | 5 | 14 | 71 | MyD88-dependent toll-like receptor signaling pathway |
GO:0060350 | 0.001 | 3.966 | 3 | 10 | 41 | endochondral bone morphogenesis |
GO:0002052 | 0.001 | 7.355 | 1 | 6 | 16 | positive regulation of neuroblast proliferation |
GO:0033146 | 0.001 | 7.355 | 1 | 6 | 16 | regulation of intracellular estrogen receptor signaling pathway |
GO:0046697 | 0.001 | 7.355 | 1 | 6 | 16 | decidualization |
GO:0051043 | 0.001 | 7.355 | 1 | 6 | 16 | regulation of membrane protein ectodomain proteolysis |
GO:0072089 | 0.001 | 7.355 | 1 | 6 | 16 | stem cell proliferation |
GO:0007440 | 0.001 | 10.207 | 1 | 5 | 11 | foregut morphogenesis |
GO:0008347 | 0.001 | 10.207 | 1 | 5 | 11 | glial cell migration |
GO:0010719 | 0.001 | 10.207 | 1 | 5 | 11 | negative regulation of epithelial to mesenchymal transition |
GO:0010934 | 0.001 | 10.207 | 1 | 5 | 11 | macrophage cytokine production |
GO:0021781 | 0.001 | 10.207 | 1 | 5 | 11 | glial cell fate commitment |
GO:0030730 | 0.001 | 10.207 | 1 | 5 | 11 | sequestering of triglyceride |
GO:0042362 | 0.001 | 10.207 | 1 | 5 | 11 | fat-soluble vitamin biosynthetic process |
GO:0043217 | 0.001 | 10.207 | 1 | 5 | 11 | myelin maintenance |
GO:0043518 | 0.001 | 10.207 | 1 | 5 | 11 | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0043922 | 0.001 | 10.207 | 1 | 5 | 11 | negative regulation by host of viral transcription |
GO:0045830 | 0.001 | 10.207 | 1 | 5 | 11 | positive regulation of isotype switching |
GO:0060068 | 0.001 | 10.207 | 1 | 5 | 11 | vagina development |
GO:0060736 | 0.001 | 10.207 | 1 | 5 | 11 | prostate gland growth |
GO:1901797 | 0.001 | 10.207 | 1 | 5 | 11 | negative regulation of signal transduction by p53 class mediator |
GO:0031346 | 0.001 | 2.424 | 9 | 20 | 122 | positive regulation of cell projection organization |
GO:0007254 | 0.001 | 2.259 | 11 | 23 | 149 | JNK cascade |
GO:0051153 | 0.001 | 3.357 | 4 | 12 | 56 | regulation of striated muscle cell differentiation |
GO:0010907 | 0.001 | 4.911 | 2 | 8 | 28 | positive regulation of glucose metabolic process |
GO:0030890 | 0.001 | 4.911 | 2 | 8 | 28 | positive regulation of B cell proliferation |
GO:0042092 | 0.001 | 4.911 | 2 | 8 | 28 | type 2 immune response |
GO:0046638 | 0.001 | 4.911 | 2 | 8 | 28 | positive regulation of alpha-beta T cell differentiation |
GO:0008015 | 0.001 | 1.799 | 25 | 41 | 325 | blood circulation |
GO:0051056 | 0.001 | 1.856 | 22 | 37 | 285 | regulation of small GTPase mediated signal transduction |
GO:0010573 | 0.001 | 5.725 | 2 | 7 | 22 | vascular endothelial growth factor production |
GO:0010574 | 0.001 | 5.725 | 2 | 7 | 22 | regulation of vascular endothelial growth factor production |
GO:0051592 | 0.001 | 2.845 | 6 | 15 | 80 | response to calcium ion |
GO:0007219 | 0.001 | 2.471 | 9 | 19 | 114 | Notch signaling pathway |
GO:0048704 | 0.001 | 2.974 | 5 | 14 | 72 | embryonic skeletal system morphogenesis |
GO:0003013 | 0.001 | 1.792 | 25 | 41 | 326 | circulatory system process |
GO:0010811 | 0.001 | 3.561 | 4 | 11 | 49 | positive regulation of cell-substrate adhesion |
GO:0030593 | 0.001 | 3.561 | 4 | 11 | 49 | neutrophil chemotaxis |
GO:0003018 | 0.001 | 2.400 | 9 | 20 | 123 | vascular process in circulatory system |
GO:0050795 | 0.001 | 2.400 | 9 | 20 | 123 | regulation of behavior |
GO:0019725 | 0.001 | 1.547 | 49 | 71 | 648 | cellular homeostasis |
GO:0016447 | 0.001 | 4.253 | 3 | 9 | 35 | somatic recombination of immunoglobulin gene segments |
GO:0050994 | 0.001 | 4.253 | 3 | 9 | 35 | regulation of lipid catabolic process |
GO:0061035 | 0.001 | 3.842 | 3 | 10 | 42 | regulation of cartilage development |
GO:0006346 | 0.001 | 16.316 | 1 | 4 | 7 | methylation-dependent chromatin silencing |
GO:0009629 | 0.001 | 16.316 | 1 | 4 | 7 | response to gravity |
GO:0030656 | 0.001 | 16.316 | 1 | 4 | 7 | regulation of vitamin metabolic process |
GO:0031507 | 0.001 | 16.316 | 1 | 4 | 7 | heterochromatin assembly |
GO:0032627 | 0.001 | 16.316 | 1 | 4 | 7 | interleukin-23 production |
GO:0032667 | 0.001 | 16.316 | 1 | 4 | 7 | regulation of interleukin-23 production |
GO:0035413 | 0.001 | 16.316 | 1 | 4 | 7 | positive regulation of catenin import into nucleus |
GO:0046666 | 0.001 | 16.316 | 1 | 4 | 7 | retinal cell programmed cell death |
GO:0051450 | 0.001 | 16.316 | 1 | 4 | 7 | myoblast proliferation |
GO:0060670 | 0.001 | 16.316 | 1 | 4 | 7 | branching involved in labyrinthine layer morphogenesis |
GO:0070230 | 0.001 | 16.316 | 1 | 4 | 7 | positive regulation of lymphocyte apoptotic process |
GO:0070561 | 0.001 | 16.316 | 1 | 4 | 7 | vitamin D receptor signaling pathway |
GO:0072239 | 0.001 | 16.316 | 1 | 4 | 7 | metanephric glomerulus vasculature development |
GO:1901419 | 0.001 | 16.316 | 1 | 4 | 7 | regulation of response to alcohol |
GO:0046620 | 0.001 | 3.282 | 4 | 12 | 57 | regulation of organ growth |
GO:0051053 | 0.001 | 3.282 | 4 | 12 | 57 | negative regulation of DNA metabolic process |
GO:0021915 | 0.001 | 2.445 | 9 | 19 | 115 | neural tube development |
GO:0002449 | 0.001 | 2.268 | 11 | 22 | 142 | lymphocyte mediated immunity |
GO:0007611 | 0.001 | 2.268 | 11 | 22 | 142 | learning or memory |
GO:0034440 | 0.001 | 2.802 | 6 | 15 | 81 | lipid oxidation |
GO:0051047 | 0.001 | 2.066 | 14 | 27 | 189 | positive regulation of secretion |
GO:0031214 | 0.001 | 2.590 | 7 | 17 | 98 | biomineral tissue development |
GO:0031647 | 0.001 | 2.590 | 7 | 17 | 98 | regulation of protein stability |
GO:0006475 | 0.001 | 2.497 | 8 | 18 | 107 | internal protein amino acid acetylation |
GO:0044283 | 0.001 | 1.713 | 29 | 46 | 381 | small molecule biosynthetic process |
GO:0043901 | 0.001 | 3.469 | 4 | 11 | 50 | negative regulation of multi-organism process |
GO:0045582 | 0.001 | 3.469 | 4 | 11 | 50 | positive regulation of T cell differentiation |
GO:0050890 | 0.001 | 2.206 | 12 | 23 | 152 | cognition |
GO:0001569 | 0.001 | 4.677 | 2 | 8 | 29 | patterning of blood vessels |
GO:0032881 | 0.001 | 4.677 | 2 | 8 | 29 | regulation of polysaccharide metabolic process |
GO:0072028 | 0.001 | 4.677 | 2 | 8 | 29 | nephron morphogenesis |
GO:0055082 | 0.001 | 1.565 | 44 | 65 | 586 | cellular chemical homeostasis |
GO:0002065 | 0.001 | 6.686 | 1 | 6 | 17 | columnar/cuboidal epithelial cell differentiation |
GO:0030539 | 0.001 | 6.686 | 1 | 6 | 17 | male genitalia development |
GO:0032620 | 0.001 | 6.686 | 1 | 6 | 17 | interleukin-17 production |
GO:0032660 | 0.001 | 6.686 | 1 | 6 | 17 | regulation of interleukin-17 production |
GO:0033631 | 0.001 | 6.686 | 1 | 6 | 17 | cell-cell adhesion mediated by integrin |
GO:0042359 | 0.001 | 6.686 | 1 | 6 | 17 | vitamin D metabolic process |
GO:0045061 | 0.001 | 6.686 | 1 | 6 | 17 | thymic T cell selection |
GO:0060487 | 0.001 | 6.686 | 1 | 6 | 17 | lung epithelial cell differentiation |
GO:0070849 | 0.001 | 6.686 | 1 | 6 | 17 | response to epidermal growth factor stimulus |
GO:0002040 | 0.001 | 3.725 | 3 | 10 | 43 | sprouting angiogenesis |
GO:0008630 | 0.001 | 3.725 | 3 | 10 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0007044 | 0.001 | 3.210 | 4 | 12 | 58 | cell-substrate junction assembly |
GO:0032846 | 0.001 | 3.210 | 4 | 12 | 58 | positive regulation of homeostatic process |
GO:0021885 | 0.001 | 4.095 | 3 | 9 | 36 | forebrain cell migration |
GO:0045930 | 0.001 | 4.095 | 3 | 9 | 36 | negative regulation of mitotic cell cycle |
GO:0044711 | 0.001 | 1.695 | 30 | 47 | 393 | single-organism biosynthetic process |
GO:0002042 | 0.001 | 5.367 | 2 | 7 | 23 | cell migration involved in sprouting angiogenesis |
GO:0010226 | 0.001 | 5.367 | 2 | 7 | 23 | response to lithium ion |
GO:0010623 | 0.001 | 5.367 | 2 | 7 | 23 | developmental programmed cell death |
GO:0051057 | 0.001 | 5.367 | 2 | 7 | 23 | positive regulation of small GTPase mediated signal transduction |
GO:0051298 | 0.001 | 5.367 | 2 | 7 | 23 | centrosome duplication |
GO:0060330 | 0.001 | 5.367 | 2 | 7 | 23 | regulation of response to interferon-gamma |
GO:0060334 | 0.001 | 5.367 | 2 | 7 | 23 | regulation of interferon-gamma-mediated signaling pathway |
GO:1900077 | 0.001 | 5.367 | 2 | 7 | 23 | negative regulation of cellular response to insulin stimulus |
GO:0008063 | 0.001 | 2.875 | 6 | 14 | 74 | Toll signaling pathway |
GO:0009791 | 0.001 | 2.875 | 6 | 14 | 74 | post-embryonic development |
GO:0050729 | 0.001 | 3.020 | 5 | 13 | 66 | positive regulation of inflammatory response |
GO:1900542 | 0.001 | 1.819 | 22 | 37 | 290 | regulation of purine nucleotide metabolic process |
GO:0051495 | 0.001 | 2.631 | 7 | 16 | 91 | positive regulation of cytoskeleton organization |
GO:0031998 | 0.001 | 8.748 | 1 | 5 | 12 | regulation of fatty acid beta-oxidation |
GO:0038084 | 0.001 | 8.748 | 1 | 5 | 12 | vascular endothelial growth factor signaling pathway |
GO:0048070 | 0.001 | 8.748 | 1 | 5 | 12 | regulation of developmental pigmentation |
GO:0060525 | 0.001 | 8.748 | 1 | 5 | 12 | prostate glandular acinus development |
GO:0072160 | 0.001 | 8.748 | 1 | 5 | 12 | nephron tubule epithelial cell differentiation |
GO:2000696 | 0.001 | 8.748 | 1 | 5 | 12 | regulation of epithelial cell differentiation involved in kidney development |
GO:0003279 | 0.001 | 3.382 | 4 | 11 | 51 | cardiac septum development |
GO:0045766 | 0.001 | 2.719 | 6 | 15 | 83 | positive regulation of angiogenesis |
GO:0009953 | 0.001 | 2.827 | 6 | 14 | 75 | dorsal/ventral pattern formation |
GO:0019218 | 0.001 | 3.142 | 4 | 12 | 59 | regulation of steroid metabolic process |
GO:0032675 | 0.001 | 3.142 | 4 | 12 | 59 | regulation of interleukin-6 production |
GO:2000242 | 0.001 | 2.964 | 5 | 13 | 67 | negative regulation of reproductive process |
GO:0032233 | 0.001 | 4.464 | 2 | 8 | 30 | positive regulation of actin filament bundle assembly |
GO:0032755 | 0.001 | 4.464 | 2 | 8 | 30 | positive regulation of interleukin-6 production |
GO:0033261 | 0.001 | 4.464 | 2 | 8 | 30 | regulation of S phase |
GO:0045814 | 0.001 | 4.464 | 2 | 8 | 30 | negative regulation of gene expression, epigenetic |
GO:0090199 | 0.001 | 4.464 | 2 | 8 | 30 | regulation of release of cytochrome c from mitochondria |
GO:2000379 | 0.001 | 4.464 | 2 | 8 | 30 | positive regulation of reactive oxygen species metabolic process |
GO:0003206 | 0.001 | 2.596 | 7 | 16 | 92 | cardiac chamber morphogenesis |
GO:0002460 | 0.001 | 2.155 | 12 | 23 | 155 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0002381 | 0.001 | 3.948 | 3 | 9 | 37 | immunoglobulin production involved in immunoglobulin mediated immune response |
GO:0006953 | 0.001 | 3.948 | 3 | 9 | 37 | acute-phase response |
GO:0010676 | 0.001 | 3.948 | 3 | 9 | 37 | positive regulation of cellular carbohydrate metabolic process |
GO:0046889 | 0.001 | 3.948 | 3 | 9 | 37 | positive regulation of lipid biosynthetic process |
GO:0050771 | 0.001 | 3.948 | 3 | 9 | 37 | negative regulation of axonogenesis |
GO:0055006 | 0.001 | 3.948 | 3 | 9 | 37 | cardiac cell development |
GO:0006140 | 0.001 | 1.797 | 22 | 37 | 293 | regulation of nucleotide metabolic process |
GO:0008202 | 0.002 | 1.862 | 19 | 33 | 253 | steroid metabolic process |
GO:0031623 | 0.002 | 3.299 | 4 | 11 | 52 | receptor internalization |
GO:0042108 | 0.002 | 3.299 | 4 | 11 | 52 | positive regulation of cytokine biosynthetic process |
GO:0046879 | 0.002 | 2.003 | 15 | 27 | 194 | hormone secretion |
GO:0015893 | 0.002 | 5.051 | 2 | 7 | 24 | drug transport |
GO:0043516 | 0.002 | 5.051 | 2 | 7 | 24 | regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0043552 | 0.002 | 5.051 | 2 | 7 | 24 | positive regulation of phosphatidylinositol 3-kinase activity |
GO:0051851 | 0.002 | 5.051 | 2 | 7 | 24 | modification by host of symbiont morphology or physiology |
GO:0060444 | 0.002 | 5.051 | 2 | 7 | 24 | branching involved in mammary gland duct morphogenesis |
GO:1901796 | 0.002 | 5.051 | 2 | 7 | 24 | regulation of signal transduction by p53 class mediator |
GO:0001502 | 0.002 | 6.128 | 1 | 6 | 18 | cartilage condensation |
GO:0035909 | 0.002 | 6.128 | 1 | 6 | 18 | aorta morphogenesis |
GO:0046902 | 0.002 | 6.128 | 1 | 6 | 18 | regulation of mitochondrial membrane permeability |
GO:0050829 | 0.002 | 6.128 | 1 | 6 | 18 | defense response to Gram-negative bacterium |
GO:0060317 | 0.002 | 6.128 | 1 | 6 | 18 | cardiac epithelial to mesenchymal transition |
GO:0060479 | 0.002 | 6.128 | 1 | 6 | 18 | lung cell differentiation |
GO:0072012 | 0.002 | 6.128 | 1 | 6 | 18 | glomerulus vasculature development |
GO:2001021 | 0.002 | 6.128 | 1 | 6 | 18 | negative regulation of response to DNA damage stimulus |
GO:0030177 | 0.002 | 3.076 | 5 | 12 | 60 | positive regulation of Wnt receptor signaling pathway |
GO:0032635 | 0.002 | 3.076 | 5 | 12 | 60 | interleukin-6 production |
GO:0060021 | 0.002 | 3.076 | 5 | 12 | 60 | palate development |
GO:0003205 | 0.002 | 2.467 | 8 | 17 | 102 | cardiac chamber development |
GO:0003176 | 0.002 | 36.674 | 0 | 3 | 4 | aortic valve development |
GO:0003180 | 0.002 | 36.674 | 0 | 3 | 4 | aortic valve morphogenesis |
GO:0003219 | 0.002 | 36.674 | 0 | 3 | 4 | cardiac right ventricle formation |
GO:0010936 | 0.002 | 36.674 | 0 | 3 | 4 | negative regulation of macrophage cytokine production |
GO:0021798 | 0.002 | 36.674 | 0 | 3 | 4 | forebrain dorsal/ventral pattern formation |
GO:0021938 | 0.002 | 36.674 | 0 | 3 | 4 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation |
GO:0031053 | 0.002 | 36.674 | 0 | 3 | 4 | primary miRNA processing |
GO:0031284 | 0.002 | 36.674 | 0 | 3 | 4 | positive regulation of guanylate cyclase activity |
GO:0034116 | 0.002 | 36.674 | 0 | 3 | 4 | positive regulation of heterotypic cell-cell adhesion |
GO:0035234 | 0.002 | 36.674 | 0 | 3 | 4 | germ cell programmed cell death |
GO:0045023 | 0.002 | 36.674 | 0 | 3 | 4 | G0 to G1 transition |
GO:0060544 | 0.002 | 36.674 | 0 | 3 | 4 | regulation of necroptosis |
GO:0060665 | 0.002 | 36.674 | 0 | 3 | 4 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling |
GO:0060737 | 0.002 | 36.674 | 0 | 3 | 4 | prostate gland morphogenetic growth |
GO:0072262 | 0.002 | 36.674 | 0 | 3 | 4 | metanephric glomerular mesangial cell proliferation involved in metanephros development |
GO:1900125 | 0.002 | 36.674 | 0 | 3 | 4 | regulation of hyaluronan biosynthetic process |
GO:2000739 | 0.002 | 36.674 | 0 | 3 | 4 | regulation of mesenchymal stem cell differentiation |
GO:0006694 | 0.002 | 2.266 | 10 | 20 | 129 | steroid biosynthetic process |
GO:0032970 | 0.002 | 2.012 | 14 | 26 | 186 | regulation of actin filament-based process |
GO:0002204 | 0.002 | 4.269 | 2 | 8 | 31 | somatic recombination of immunoglobulin genes involved in immune response |
GO:0002208 | 0.002 | 4.269 | 2 | 8 | 31 | somatic diversification of immunoglobulins involved in immune response |
GO:0002287 | 0.002 | 4.269 | 2 | 8 | 31 | alpha-beta T cell activation involved in immune response |
GO:0002292 | 0.002 | 4.269 | 2 | 8 | 31 | T cell differentiation involved in immune response |
GO:0002293 | 0.002 | 4.269 | 2 | 8 | 31 | alpha-beta T cell differentiation involved in immune response |
GO:0002889 | 0.002 | 4.269 | 2 | 8 | 31 | regulation of immunoglobulin mediated immune response |
GO:0008593 | 0.002 | 4.269 | 2 | 8 | 31 | regulation of Notch signaling pathway |
GO:0043550 | 0.002 | 4.269 | 2 | 8 | 31 | regulation of lipid kinase activity |
GO:0045190 | 0.002 | 4.269 | 2 | 8 | 31 | isotype switching |
GO:0048538 | 0.002 | 4.269 | 2 | 8 | 31 | thymus development |
GO:0050999 | 0.002 | 4.269 | 2 | 8 | 31 | regulation of nitric-oxide synthase activity |
GO:0000018 | 0.002 | 3.811 | 3 | 9 | 38 | regulation of DNA recombination |
GO:0043525 | 0.002 | 3.811 | 3 | 9 | 38 | positive regulation of neuron apoptotic process |
GO:0048332 | 0.002 | 3.220 | 4 | 11 | 53 | mesoderm morphogenesis |
GO:0003264 | 0.002 | 12.236 | 1 | 4 | 8 | regulation of cardioblast proliferation |
GO:0003266 | 0.002 | 12.236 | 1 | 4 | 8 | regulation of secondary heart field cardioblast proliferation |
GO:0007262 | 0.002 | 12.236 | 1 | 4 | 8 | STAT protein import into nucleus |
GO:0030220 | 0.002 | 12.236 | 1 | 4 | 8 | platelet formation |
GO:0033148 | 0.002 | 12.236 | 1 | 4 | 8 | positive regulation of intracellular estrogen receptor signaling pathway |
GO:0033634 | 0.002 | 12.236 | 1 | 4 | 8 | positive regulation of cell-cell adhesion mediated by integrin |
GO:0036344 | 0.002 | 12.236 | 1 | 4 | 8 | platelet morphogenesis |
GO:0042977 | 0.002 | 12.236 | 1 | 4 | 8 | activation of JAK2 kinase activity |
GO:0048642 | 0.002 | 12.236 | 1 | 4 | 8 | negative regulation of skeletal muscle tissue development |
GO:0060218 | 0.002 | 12.236 | 1 | 4 | 8 | hematopoietic stem cell differentiation |
GO:0060712 | 0.002 | 12.236 | 1 | 4 | 8 | spongiotrophoblast layer development |
GO:0070828 | 0.002 | 12.236 | 1 | 4 | 8 | heterochromatin organization |
GO:1901722 | 0.002 | 12.236 | 1 | 4 | 8 | regulation of cell proliferation involved in kidney development |
GO:0001708 | 0.002 | 3.013 | 5 | 12 | 61 | cell fate specification |
GO:0031294 | 0.002 | 3.013 | 5 | 12 | 61 | lymphocyte costimulation |
GO:0032640 | 0.002 | 3.013 | 5 | 12 | 61 | tumor necrosis factor production |
GO:0032680 | 0.002 | 3.013 | 5 | 12 | 61 | regulation of tumor necrosis factor production |
GO:0050804 | 0.002 | 2.107 | 12 | 23 | 158 | regulation of synaptic transmission |
GO:0010669 | 0.002 | 7.654 | 1 | 5 | 13 | epithelial structure maintenance |
GO:0010939 | 0.002 | 7.654 | 1 | 5 | 13 | regulation of necrotic cell death |
GO:0030903 | 0.002 | 7.654 | 1 | 5 | 13 | notochord development |
GO:0042508 | 0.002 | 7.654 | 1 | 5 | 13 | tyrosine phosphorylation of Stat1 protein |
GO:0045064 | 0.002 | 7.654 | 1 | 5 | 13 | T-helper 2 cell differentiation |
GO:0045747 | 0.002 | 7.654 | 1 | 5 | 13 | positive regulation of Notch signaling pathway |
GO:0045911 | 0.002 | 7.654 | 1 | 5 | 13 | positive regulation of DNA recombination |
GO:0051150 | 0.002 | 7.654 | 1 | 5 | 13 | regulation of smooth muscle cell differentiation |
GO:0060602 | 0.002 | 7.654 | 1 | 5 | 13 | branch elongation of an epithelium |
GO:0071295 | 0.002 | 7.654 | 1 | 5 | 13 | cellular response to vitamin |
GO:0097066 | 0.002 | 7.654 | 1 | 5 | 13 | response to thyroid hormone stimulus |
GO:1901617 | 0.002 | 2.180 | 11 | 21 | 140 | organic hydroxy compound biosynthetic process |
GO:0030316 | 0.002 | 3.413 | 3 | 10 | 46 | osteoclast differentiation |
GO:0007088 | 0.002 | 2.694 | 6 | 14 | 78 | regulation of mitosis |
GO:0030968 | 0.002 | 2.694 | 6 | 14 | 78 | endoplasmic reticulum unfolded protein response |
GO:0034620 | 0.002 | 2.694 | 6 | 14 | 78 | cellular response to unfolded protein |
GO:0051783 | 0.002 | 2.694 | 6 | 14 | 78 | regulation of nuclear division |
GO:0022408 | 0.002 | 4.769 | 2 | 7 | 25 | negative regulation of cell-cell adhesion |
GO:0032720 | 0.002 | 4.769 | 2 | 7 | 25 | negative regulation of tumor necrosis factor production |
GO:0042771 | 0.002 | 4.769 | 2 | 7 | 25 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0043370 | 0.002 | 4.769 | 2 | 7 | 25 | regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0090218 | 0.002 | 4.769 | 2 | 7 | 25 | positive regulation of lipid kinase activity |
GO:0060993 | 0.002 | 3.684 | 3 | 9 | 39 | kidney morphogenesis |
GO:1901216 | 0.002 | 3.684 | 3 | 9 | 39 | positive regulation of neuron death |
GO:0032369 | 0.002 | 5.656 | 1 | 6 | 19 | negative regulation of lipid transport |
GO:0032689 | 0.002 | 5.656 | 1 | 6 | 19 | negative regulation of interferon-gamma production |
GO:0034105 | 0.002 | 5.656 | 1 | 6 | 19 | positive regulation of tissue remodeling |
GO:0043921 | 0.002 | 5.656 | 1 | 6 | 19 | modulation by host of viral transcription |
GO:0052472 | 0.002 | 5.656 | 1 | 6 | 19 | modulation by host of symbiont transcription |
GO:0060441 | 0.002 | 5.656 | 1 | 6 | 19 | epithelial tube branching involved in lung morphogenesis |
GO:0061437 | 0.002 | 5.656 | 1 | 6 | 19 | renal system vasculature development |
GO:0061440 | 0.002 | 5.656 | 1 | 6 | 19 | kidney vasculature development |
GO:0072132 | 0.002 | 5.656 | 1 | 6 | 19 | mesenchyme morphogenesis |
GO:0072207 | 0.002 | 5.656 | 1 | 6 | 19 | metanephric epithelium development |
GO:2000191 | 0.002 | 5.656 | 1 | 6 | 19 | regulation of fatty acid transport |
GO:2001014 | 0.002 | 5.656 | 1 | 6 | 19 | regulation of skeletal muscle cell differentiation |
GO:0002712 | 0.002 | 4.091 | 2 | 8 | 32 | regulation of B cell mediated immunity |
GO:0002763 | 0.002 | 4.091 | 2 | 8 | 32 | positive regulation of myeloid leukocyte differentiation |
GO:0006509 | 0.002 | 4.091 | 2 | 8 | 32 | membrane protein ectodomain proteolysis |
GO:0010817 | 0.002 | 1.709 | 25 | 40 | 331 | regulation of hormone levels |
GO:0034341 | 0.002 | 2.465 | 7 | 16 | 96 | response to interferon-gamma |
GO:0035150 | 0.002 | 2.382 | 8 | 17 | 105 | regulation of tube size |
GO:0050880 | 0.002 | 2.382 | 8 | 17 | 105 | regulation of blood vessel size |
GO:0032320 | 0.002 | 2.652 | 6 | 14 | 79 | positive regulation of Ras GTPase activity |
GO:0018107 | 0.002 | 3.321 | 4 | 10 | 47 | peptidyl-threonine phosphorylation |
GO:0043467 | 0.002 | 3.321 | 4 | 10 | 47 | regulation of generation of precursor metabolites and energy |
GO:0009914 | 0.002 | 1.932 | 15 | 27 | 200 | hormone transport |
GO:0071356 | 0.002 | 2.894 | 5 | 12 | 63 | cellular response to tumor necrosis factor |
GO:0003231 | 0.003 | 2.612 | 6 | 14 | 80 | cardiac ventricle development |
GO:0050663 | 0.003 | 2.612 | 6 | 14 | 80 | cytokine secretion |
GO:0016445 | 0.003 | 3.565 | 3 | 9 | 40 | somatic diversification of immunoglobulins |
GO:0060411 | 0.003 | 3.565 | 3 | 9 | 40 | cardiac septum morphogenesis |
GO:2001022 | 0.003 | 3.565 | 3 | 9 | 40 | positive regulation of response to DNA damage stimulus |
GO:0021795 | 0.003 | 4.518 | 2 | 7 | 26 | cerebral cortex cell migration |
GO:0043551 | 0.003 | 4.518 | 2 | 7 | 26 | regulation of phosphatidylinositol 3-kinase activity |
GO:0051496 | 0.003 | 4.518 | 2 | 7 | 26 | positive regulation of stress fiber assembly |
GO:0060325 | 0.003 | 4.518 | 2 | 7 | 26 | face morphogenesis |
GO:0070228 | 0.003 | 4.518 | 2 | 7 | 26 | regulation of lymphocyte apoptotic process |
GO:0061024 | 0.003 | 1.656 | 28 | 43 | 366 | membrane organization |
GO:0040013 | 0.003 | 2.166 | 10 | 20 | 134 | negative regulation of locomotion |
GO:0019724 | 0.003 | 2.497 | 7 | 15 | 89 | B cell mediated immunity |
GO:0003156 | 0.003 | 3.927 | 3 | 8 | 33 | regulation of organ formation |
GO:0014812 | 0.003 | 3.927 | 3 | 8 | 33 | muscle cell migration |
GO:0022029 | 0.003 | 3.927 | 3 | 8 | 33 | telencephalon cell migration |
GO:0043488 | 0.003 | 3.927 | 3 | 8 | 33 | regulation of mRNA stability |
GO:0048566 | 0.003 | 3.927 | 3 | 8 | 33 | embryonic digestive tract development |
GO:0033555 | 0.003 | 3.233 | 4 | 10 | 48 | multicellular organismal response to stress |
GO:0034333 | 0.003 | 3.233 | 4 | 10 | 48 | adherens junction assembly |
GO:0002902 | 0.003 | 6.803 | 1 | 5 | 14 | regulation of B cell apoptotic process |
GO:0021511 | 0.003 | 6.803 | 1 | 5 | 14 | spinal cord patterning |
GO:0032897 | 0.003 | 6.803 | 1 | 5 | 14 | negative regulation of viral transcription |
GO:0044126 | 0.003 | 6.803 | 1 | 5 | 14 | regulation of growth of symbiont in host |
GO:0044130 | 0.003 | 6.803 | 1 | 5 | 14 | negative regulation of growth of symbiont in host |
GO:0044144 | 0.003 | 6.803 | 1 | 5 | 14 | modulation of growth of symbiont involved in interaction with host |
GO:0044146 | 0.003 | 6.803 | 1 | 5 | 14 | negative regulation of growth of symbiont involved in interaction with host |
GO:0051569 | 0.003 | 6.803 | 1 | 5 | 14 | regulation of histone H3-K4 methylation |
GO:0061323 | 0.003 | 6.803 | 1 | 5 | 14 | cell proliferation involved in heart morphogenesis |
GO:2000136 | 0.003 | 6.803 | 1 | 5 | 14 | regulation of cell proliferation involved in heart morphogenesis |
GO:2000273 | 0.003 | 6.803 | 1 | 5 | 14 | positive regulation of receptor activity |
GO:0035666 | 0.003 | 2.838 | 5 | 12 | 64 | TRIF-dependent toll-like receptor signaling pathway |
GO:0046782 | 0.003 | 2.838 | 5 | 12 | 64 | regulation of viral transcription |
GO:0071706 | 0.003 | 2.838 | 5 | 12 | 64 | tumor necrosis factor superfamily cytokine production |
GO:0042542 | 0.003 | 2.572 | 6 | 14 | 81 | response to hydrogen peroxide |
GO:0001706 | 0.003 | 5.252 | 2 | 6 | 20 | endoderm formation |
GO:0006949 | 0.003 | 5.252 | 2 | 6 | 20 | syncytium formation |
GO:0031060 | 0.003 | 5.252 | 2 | 6 | 20 | regulation of histone methylation |
GO:0032459 | 0.003 | 5.252 | 2 | 6 | 20 | regulation of protein oligomerization |
GO:0032965 | 0.003 | 5.252 | 2 | 6 | 20 | regulation of collagen biosynthetic process |
GO:0035904 | 0.003 | 5.252 | 2 | 6 | 20 | aorta development |
GO:0043536 | 0.003 | 5.252 | 2 | 6 | 20 | positive regulation of blood vessel endothelial cell migration |
GO:0048821 | 0.003 | 5.252 | 2 | 6 | 20 | erythrocyte development |
GO:0032318 | 0.003 | 2.191 | 10 | 19 | 126 | regulation of Ras GTPase activity |
GO:0042742 | 0.003 | 2.463 | 7 | 15 | 90 | defense response to bacterium |
GO:0003211 | 0.003 | 9.788 | 1 | 4 | 9 | cardiac ventricle formation |
GO:0006855 | 0.003 | 9.788 | 1 | 4 | 9 | drug transmembrane transport |
GO:0030213 | 0.003 | 9.788 | 1 | 4 | 9 | hyaluronan biosynthetic process |
GO:0030277 | 0.003 | 9.788 | 1 | 4 | 9 | maintenance of gastrointestinal epithelium |
GO:0031061 | 0.003 | 9.788 | 1 | 4 | 9 | negative regulation of histone methylation |
GO:0033160 | 0.003 | 9.788 | 1 | 4 | 9 | positive regulation of protein import into nucleus, translocation |
GO:0042090 | 0.003 | 9.788 | 1 | 4 | 9 | interleukin-12 biosynthetic process |
GO:0045019 | 0.003 | 9.788 | 1 | 4 | 9 | negative regulation of nitric oxide biosynthetic process |
GO:0045075 | 0.003 | 9.788 | 1 | 4 | 9 | regulation of interleukin-12 biosynthetic process |
GO:0046426 | 0.003 | 9.788 | 1 | 4 | 9 | negative regulation of JAK-STAT cascade |
GO:0048714 | 0.003 | 9.788 | 1 | 4 | 9 | positive regulation of oligodendrocyte differentiation |
GO:0050872 | 0.003 | 9.788 | 1 | 4 | 9 | white fat cell differentiation |
GO:0050919 | 0.003 | 9.788 | 1 | 4 | 9 | negative chemotaxis |
GO:0071157 | 0.003 | 9.788 | 1 | 4 | 9 | negative regulation of cell cycle arrest |
GO:0072189 | 0.003 | 9.788 | 1 | 4 | 9 | ureter development |
GO:0090136 | 0.003 | 9.788 | 1 | 4 | 9 | epithelial cell-cell adhesion |
GO:0050921 | 0.003 | 2.666 | 6 | 13 | 73 | positive regulation of chemotaxis |
GO:0048010 | 0.003 | 3.453 | 3 | 9 | 41 | vascular endothelial growth factor receptor signaling pathway |
GO:0051258 | 0.003 | 2.128 | 10 | 20 | 136 | protein polymerization |
GO:0045088 | 0.003 | 1.888 | 15 | 27 | 204 | regulation of innate immune response |
GO:0032387 | 0.003 | 2.784 | 5 | 12 | 65 | negative regulation of intracellular transport |
GO:0034142 | 0.003 | 2.534 | 6 | 14 | 82 | toll-like receptor 4 signaling pathway |
GO:0048593 | 0.003 | 2.534 | 6 | 14 | 82 | camera-type eye morphogenesis |
GO:0001707 | 0.003 | 3.150 | 4 | 10 | 49 | mesoderm formation |
GO:0002673 | 0.003 | 3.150 | 4 | 10 | 49 | regulation of acute inflammatory response |
GO:0003151 | 0.003 | 3.150 | 4 | 10 | 49 | outflow tract morphogenesis |
GO:0050715 | 0.003 | 3.150 | 4 | 10 | 49 | positive regulation of cytokine secretion |
GO:0021532 | 0.003 | 4.292 | 2 | 7 | 27 | neural tube patterning |
GO:0046626 | 0.003 | 4.292 | 2 | 7 | 27 | regulation of insulin receptor signaling pathway |
GO:0060428 | 0.003 | 4.292 | 2 | 7 | 27 | lung epithelium development |
GO:0090102 | 0.003 | 4.292 | 2 | 7 | 27 | cochlea development |
GO:2000514 | 0.003 | 4.292 | 2 | 7 | 27 | regulation of CD4-positive, alpha-beta T cell activation |
GO:0007098 | 0.003 | 3.775 | 3 | 8 | 34 | centrosome cycle |
GO:0035019 | 0.003 | 3.775 | 3 | 8 | 34 | somatic stem cell maintenance |
GO:0060324 | 0.003 | 3.775 | 3 | 8 | 34 | face development |
GO:0003208 | 0.003 | 2.939 | 4 | 11 | 57 | cardiac ventricle morphogenesis |
GO:0035148 | 0.003 | 2.431 | 7 | 15 | 91 | tube formation |
GO:0050866 | 0.003 | 2.347 | 8 | 16 | 100 | negative regulation of cell activation |
GO:0006873 | 0.003 | 1.518 | 41 | 58 | 535 | cellular ion homeostasis |
GO:0008610 | 0.003 | 1.562 | 35 | 51 | 458 | lipid biosynthetic process |
GO:0051017 | 0.003 | 2.622 | 6 | 13 | 74 | actin filament bundle assembly |
GO:0016044 | 0.003 | 1.637 | 27 | 42 | 361 | cellular membrane organization |
GO:0002819 | 0.004 | 2.497 | 6 | 14 | 83 | regulation of adaptive immune response |
GO:0035967 | 0.004 | 2.497 | 6 | 14 | 83 | cellular response to topologically incorrect protein |
GO:0000077 | 0.004 | 2.197 | 9 | 18 | 119 | DNA damage checkpoint |
GO:0046328 | 0.004 | 2.197 | 9 | 18 | 119 | regulation of JNK cascade |
GO:0006282 | 0.004 | 3.348 | 3 | 9 | 42 | regulation of DNA repair |
GO:0048041 | 0.004 | 3.348 | 3 | 9 | 42 | focal adhesion assembly |
GO:0002756 | 0.004 | 2.732 | 5 | 12 | 66 | MyD88-independent toll-like receptor signaling pathway |
GO:0050707 | 0.004 | 2.732 | 5 | 12 | 66 | regulation of cytokine secretion |
GO:0051607 | 0.004 | 2.012 | 12 | 22 | 157 | defense response to virus |
GO:0034622 | 0.004 | 1.561 | 34 | 50 | 449 | cellular macromolecular complex assembly |
GO:0010712 | 0.004 | 4.901 | 2 | 6 | 21 | regulation of collagen metabolic process |
GO:0030574 | 0.004 | 4.901 | 2 | 6 | 21 | collagen catabolic process |
GO:0035924 | 0.004 | 4.901 | 2 | 6 | 21 | cellular response to vascular endothelial growth factor stimulus |
GO:0046579 | 0.004 | 4.901 | 2 | 6 | 21 | positive regulation of Ras protein signal transduction |
GO:0046627 | 0.004 | 4.901 | 2 | 6 | 21 | negative regulation of insulin receptor signaling pathway |
GO:0048169 | 0.004 | 4.901 | 2 | 6 | 21 | regulation of long-term neuronal synaptic plasticity |
GO:0018210 | 0.004 | 3.071 | 4 | 10 | 50 | peptidyl-threonine modification |
GO:0006979 | 0.004 | 1.813 | 17 | 29 | 227 | response to oxidative stress |
GO:0002246 | 0.004 | 18.335 | 0 | 3 | 5 | wound healing involved in inflammatory response |
GO:0003310 | 0.004 | 18.335 | 0 | 3 | 5 | pancreatic A cell differentiation |
GO:0006927 | 0.004 | 18.335 | 0 | 3 | 5 | transformed cell apoptotic process |
GO:0007406 | 0.004 | 18.335 | 0 | 3 | 5 | negative regulation of neuroblast proliferation |
GO:0007418 | 0.004 | 18.335 | 0 | 3 | 5 | ventral midline development |
GO:0010523 | 0.004 | 18.335 | 0 | 3 | 5 | negative regulation of calcium ion transport into cytosol |
GO:0010839 | 0.004 | 18.335 | 0 | 3 | 5 | negative regulation of keratinocyte proliferation |
GO:0010891 | 0.004 | 18.335 | 0 | 3 | 5 | negative regulation of sequestering of triglyceride |
GO:0014854 | 0.004 | 18.335 | 0 | 3 | 5 | response to inactivity |
GO:0022028 | 0.004 | 18.335 | 0 | 3 | 5 | tangential migration from the subventricular zone to the olfactory bulb |
GO:0031282 | 0.004 | 18.335 | 0 | 3 | 5 | regulation of guanylate cyclase activity |
GO:0032736 | 0.004 | 18.335 | 0 | 3 | 5 | positive regulation of interleukin-13 production |
GO:0032762 | 0.004 | 18.335 | 0 | 3 | 5 | mast cell cytokine production |
GO:0034983 | 0.004 | 18.335 | 0 | 3 | 5 | peptidyl-lysine deacetylation |
GO:0036295 | 0.004 | 18.335 | 0 | 3 | 5 | cellular response to increased oxygen levels |
GO:0042532 | 0.004 | 18.335 | 0 | 3 | 5 | negative regulation of tyrosine phosphorylation of STAT protein |
GO:0051891 | 0.004 | 18.335 | 0 | 3 | 5 | positive regulation of cardioblast differentiation |
GO:0060374 | 0.004 | 18.335 | 0 | 3 | 5 | mast cell differentiation |
GO:0060751 | 0.004 | 18.335 | 0 | 3 | 5 | branch elongation involved in mammary gland duct branching |
GO:0060947 | 0.004 | 18.335 | 0 | 3 | 5 | cardiac vascular smooth muscle cell differentiation |
GO:0070266 | 0.004 | 18.335 | 0 | 3 | 5 | necroptosis |
GO:0070562 | 0.004 | 18.335 | 0 | 3 | 5 | regulation of vitamin D receptor signaling pathway |
GO:0071455 | 0.004 | 18.335 | 0 | 3 | 5 | cellular response to hyperoxia |
GO:0072223 | 0.004 | 18.335 | 0 | 3 | 5 | metanephric glomerular mesangium development |
GO:0072257 | 0.004 | 18.335 | 0 | 3 | 5 | metanephric nephron tubule epithelial cell differentiation |
GO:0072307 | 0.004 | 18.335 | 0 | 3 | 5 | regulation of metanephric nephron tubule epithelial cell differentiation |
GO:0097300 | 0.004 | 18.335 | 0 | 3 | 5 | programmed necrotic cell death |
GO:2000501 | 0.004 | 18.335 | 0 | 3 | 5 | regulation of natural killer cell chemotaxis |
GO:0002822 | 0.004 | 2.579 | 6 | 13 | 75 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0051899 | 0.004 | 2.579 | 6 | 13 | 75 | membrane depolarization |
GO:0003203 | 0.004 | 6.122 | 1 | 5 | 15 | endocardial cushion morphogenesis |
GO:0010507 | 0.004 | 6.122 | 1 | 5 | 15 | negative regulation of autophagy |
GO:0034243 | 0.004 | 6.122 | 1 | 5 | 15 | regulation of transcription elongation from RNA polymerase II promoter |
GO:0060037 | 0.004 | 6.122 | 1 | 5 | 15 | pharyngeal system development |
GO:0061318 | 0.004 | 6.122 | 1 | 5 | 15 | renal filtration cell differentiation |
GO:0072112 | 0.004 | 6.122 | 1 | 5 | 15 | glomerular visceral epithelial cell differentiation |
GO:0072170 | 0.004 | 6.122 | 1 | 5 | 15 | metanephric tubule development |
GO:0072224 | 0.004 | 6.122 | 1 | 5 | 15 | metanephric glomerulus development |
GO:0072234 | 0.004 | 6.122 | 1 | 5 | 15 | metanephric nephron tubule development |
GO:0072243 | 0.004 | 6.122 | 1 | 5 | 15 | metanephric nephron epithelium development |
GO:0044281 | 0.004 | 1.268 | 161 | 191 | 2122 | small molecule metabolic process |
GO:0043487 | 0.004 | 3.635 | 3 | 8 | 35 | regulation of RNA stability |
GO:0045931 | 0.004 | 3.635 | 3 | 8 | 35 | positive regulation of mitotic cell cycle |
GO:0048168 | 0.004 | 3.635 | 3 | 8 | 35 | regulation of neuronal synaptic plasticity |
GO:0044243 | 0.004 | 4.087 | 2 | 7 | 28 | multicellular organismal catabolic process |
GO:0007163 | 0.004 | 2.292 | 8 | 16 | 102 | establishment or maintenance of cell polarity |
GO:0002253 | 0.004 | 1.747 | 20 | 32 | 259 | activation of immune response |
GO:0032069 | 0.004 | 2.683 | 5 | 12 | 67 | regulation of nuclease activity |
GO:0009118 | 0.004 | 1.869 | 15 | 26 | 198 | regulation of nucleoside metabolic process |
GO:0002562 | 0.004 | 3.249 | 3 | 9 | 43 | somatic diversification of immune receptors via germline recombination within a single locus |
GO:0016444 | 0.004 | 3.249 | 3 | 9 | 43 | somatic cell DNA recombination |
GO:0032231 | 0.004 | 3.249 | 3 | 9 | 43 | regulation of actin filament bundle assembly |
GO:0035872 | 0.004 | 3.249 | 3 | 9 | 43 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO:0044070 | 0.004 | 3.249 | 3 | 9 | 43 | regulation of anion transport |
GO:0048678 | 0.004 | 3.249 | 3 | 9 | 43 | response to axon injury |
GO:0021782 | 0.004 | 2.816 | 4 | 11 | 59 | glial cell development |
GO:0021987 | 0.004 | 2.816 | 4 | 11 | 59 | cerebral cortex development |
GO:0050777 | 0.004 | 2.996 | 4 | 10 | 51 | negative regulation of immune response |
GO:0010639 | 0.005 | 2.009 | 11 | 21 | 150 | negative regulation of organelle organization |
GO:0035264 | 0.005 | 2.265 | 8 | 16 | 103 | multicellular organism growth |
GO:0032271 | 0.005 | 2.338 | 7 | 15 | 94 | regulation of protein polymerization |
GO:0032890 | 0.005 | 3.505 | 3 | 8 | 36 | regulation of organic acid transport |
GO:0048742 | 0.005 | 3.505 | 3 | 8 | 36 | regulation of skeletal muscle fiber development |
GO:0060711 | 0.005 | 3.505 | 3 | 8 | 36 | labyrinthine layer development |
GO:0003171 | 0.005 | 8.156 | 1 | 4 | 10 | atrioventricular valve development |
GO:0003207 | 0.005 | 8.156 | 1 | 4 | 10 | cardiac chamber formation |
GO:0010837 | 0.005 | 8.156 | 1 | 4 | 10 | regulation of keratinocyte proliferation |
GO:0032656 | 0.005 | 8.156 | 1 | 4 | 10 | regulation of interleukin-13 production |
GO:0042976 | 0.005 | 8.156 | 1 | 4 | 10 | activation of Janus kinase activity |
GO:0043368 | 0.005 | 8.156 | 1 | 4 | 10 | positive T cell selection |
GO:0048368 | 0.005 | 8.156 | 1 | 4 | 10 | lateral mesoderm development |
GO:0048617 | 0.005 | 8.156 | 1 | 4 | 10 | embryonic foregut morphogenesis |
GO:0048712 | 0.005 | 8.156 | 1 | 4 | 10 | negative regulation of astrocyte differentiation |
GO:0051571 | 0.005 | 8.156 | 1 | 4 | 10 | positive regulation of histone H3-K4 methylation |
GO:0060363 | 0.005 | 8.156 | 1 | 4 | 10 | cranial suture morphogenesis |
GO:0070935 | 0.005 | 8.156 | 1 | 4 | 10 | 3'-UTR-mediated mRNA stabilization |
GO:0071780 | 0.005 | 8.156 | 1 | 4 | 10 | mitotic cell cycle G2/M transition checkpoint |
GO:0072109 | 0.005 | 8.156 | 1 | 4 | 10 | glomerular mesangium development |
GO:0097067 | 0.005 | 8.156 | 1 | 4 | 10 | cellular response to thyroid hormone stimulus |
GO:2000060 | 0.005 | 8.156 | 1 | 4 | 10 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0043269 | 0.005 | 1.760 | 18 | 30 | 241 | regulation of ion transport |
GO:0030224 | 0.005 | 4.594 | 2 | 6 | 22 | monocyte differentiation |
GO:0031103 | 0.005 | 4.594 | 2 | 6 | 22 | axon regeneration |
GO:0034405 | 0.005 | 4.594 | 2 | 6 | 22 | response to fluid shear stress |
GO:0034698 | 0.005 | 4.594 | 2 | 6 | 22 | response to gonadotropin stimulus |
GO:0043616 | 0.005 | 4.594 | 2 | 6 | 22 | keratinocyte proliferation |
GO:0043903 | 0.005 | 4.594 | 2 | 6 | 22 | regulation of symbiosis, encompassing mutualism through parasitism |
GO:0070306 | 0.005 | 4.594 | 2 | 6 | 22 | lens fiber cell differentiation |
GO:0055002 | 0.005 | 2.182 | 9 | 17 | 113 | striated muscle cell development |
GO:0010565 | 0.005 | 1.993 | 11 | 21 | 151 | regulation of cellular ketone metabolic process |
GO:0031295 | 0.005 | 2.758 | 5 | 11 | 60 | T cell costimulation |
GO:0050954 | 0.005 | 2.239 | 8 | 16 | 104 | sensory perception of mechanical stimulus |
GO:0010742 | 0.005 | 3.901 | 2 | 7 | 29 | macrophage derived foam cell differentiation |
GO:0014896 | 0.005 | 3.901 | 2 | 7 | 29 | muscle hypertrophy |
GO:0051702 | 0.005 | 3.901 | 2 | 7 | 29 | interaction with symbiont |
GO:0060323 | 0.005 | 3.901 | 2 | 7 | 29 | head morphogenesis |
GO:0090077 | 0.005 | 3.901 | 2 | 7 | 29 | foam cell differentiation |
GO:0030041 | 0.005 | 2.393 | 7 | 14 | 86 | actin filament polymerization |
GO:0030509 | 0.005 | 2.393 | 7 | 14 | 86 | BMP signaling pathway |
GO:0048638 | 0.005 | 2.308 | 7 | 15 | 95 | regulation of developmental growth |
GO:0000288 | 0.005 | 3.156 | 3 | 9 | 44 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO:0042308 | 0.005 | 3.156 | 3 | 9 | 44 | negative regulation of protein import into nucleus |
GO:0042311 | 0.005 | 2.924 | 4 | 10 | 52 | vasodilation |
GO:0051235 | 0.005 | 1.978 | 12 | 21 | 152 | maintenance of location |
GO:0002706 | 0.005 | 2.588 | 5 | 12 | 69 | regulation of lymphocyte mediated immunity |
GO:0034138 | 0.005 | 2.588 | 5 | 12 | 69 | toll-like receptor 3 signaling pathway |
GO:0048588 | 0.005 | 2.588 | 5 | 12 | 69 | developmental cell growth |
GO:0002764 | 0.005 | 1.785 | 17 | 28 | 222 | immune response-regulating signaling pathway |
GO:0009110 | 0.005 | 5.565 | 1 | 5 | 16 | vitamin biosynthetic process |
GO:0009713 | 0.005 | 5.565 | 1 | 5 | 16 | catechol-containing compound biosynthetic process |
GO:0034312 | 0.005 | 5.565 | 1 | 5 | 16 | diol biosynthetic process |
GO:0035412 | 0.005 | 5.565 | 1 | 5 | 16 | regulation of catenin import into nucleus |
GO:0042423 | 0.005 | 5.565 | 1 | 5 | 16 | catecholamine biosynthetic process |
GO:0044110 | 0.005 | 5.565 | 1 | 5 | 16 | growth involved in symbiotic interaction |
GO:0044116 | 0.005 | 5.565 | 1 | 5 | 16 | growth of symbiont involved in interaction with host |
GO:0044117 | 0.005 | 5.565 | 1 | 5 | 16 | growth of symbiont in host |
GO:0045070 | 0.005 | 5.565 | 1 | 5 | 16 | positive regulation of viral genome replication |
GO:0046189 | 0.005 | 5.565 | 1 | 5 | 16 | phenol-containing compound biosynthetic process |
GO:0051412 | 0.005 | 5.565 | 1 | 5 | 16 | response to corticosterone stimulus |
GO:0060669 | 0.005 | 5.565 | 1 | 5 | 16 | embryonic placenta morphogenesis |
GO:0060749 | 0.005 | 5.565 | 1 | 5 | 16 | mammary gland alveolus development |
GO:0061377 | 0.005 | 5.565 | 1 | 5 | 16 | mammary gland lobule development |
GO:0072010 | 0.005 | 5.565 | 1 | 5 | 16 | glomerular epithelium development |
GO:0072311 | 0.005 | 5.565 | 1 | 5 | 16 | glomerular epithelial cell differentiation |
GO:0002757 | 0.005 | 1.805 | 16 | 27 | 212 | immune response-activating signal transduction |
GO:0016064 | 0.006 | 2.360 | 7 | 14 | 87 | immunoglobulin mediated immune response |
GO:0030010 | 0.006 | 2.703 | 5 | 11 | 61 | establishment of cell polarity |
GO:0031570 | 0.006 | 2.093 | 9 | 18 | 124 | DNA integrity checkpoint |
GO:0034968 | 0.006 | 3.384 | 3 | 8 | 37 | histone lysine methylation |
GO:0042116 | 0.006 | 3.384 | 3 | 8 | 37 | macrophage activation |
GO:0043535 | 0.006 | 3.384 | 3 | 8 | 37 | regulation of blood vessel endothelial cell migration |
GO:0031396 | 0.006 | 1.963 | 12 | 21 | 153 | regulation of protein ubiquitination |
GO:0000022 | 0.006 | Inf | 0 | 2 | 2 | mitotic spindle elongation |
GO:0000917 | 0.006 | Inf | 0 | 2 | 2 | barrier septum assembly |
GO:0002036 | 0.006 | Inf | 0 | 2 | 2 | regulation of L-glutamate transport |
GO:0002238 | 0.006 | Inf | 0 | 2 | 2 | response to molecule of fungal origin |
GO:0002296 | 0.006 | Inf | 0 | 2 | 2 | T-helper 1 cell lineage commitment |
GO:0002572 | 0.006 | Inf | 0 | 2 | 2 | pro-T cell differentiation |
GO:0002904 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of B cell apoptotic process |
GO:0003169 | 0.006 | Inf | 0 | 2 | 2 | coronary vein morphogenesis |
GO:0003218 | 0.006 | Inf | 0 | 2 | 2 | cardiac left ventricle formation |
GO:0003415 | 0.006 | Inf | 0 | 2 | 2 | chondrocyte hypertrophy |
GO:0007227 | 0.006 | Inf | 0 | 2 | 2 | signal transduction downstream of smoothened |
GO:0007228 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of hh target transcription factor activity |
GO:0007356 | 0.006 | Inf | 0 | 2 | 2 | thorax and anterior abdomen determination |
GO:0010260 | 0.006 | Inf | 0 | 2 | 2 | organ senescence |
GO:0010587 | 0.006 | Inf | 0 | 2 | 2 | miRNA catabolic process |
GO:0010826 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of centrosome duplication |
GO:0014040 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of Schwann cell differentiation |
GO:0030221 | 0.006 | Inf | 0 | 2 | 2 | basophil differentiation |
GO:0032601 | 0.006 | Inf | 0 | 2 | 2 | connective tissue growth factor production |
GO:0032707 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of interleukin-23 production |
GO:0032764 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of mast cell cytokine production |
GO:0033484 | 0.006 | Inf | 0 | 2 | 2 | nitric oxide homeostasis |
GO:0033601 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of mammary gland epithelial cell proliferation |
GO:0034625 | 0.006 | Inf | 0 | 2 | 2 | fatty acid elongation, monounsaturated fatty acid |
GO:0035726 | 0.006 | Inf | 0 | 2 | 2 | common myeloid progenitor cell proliferation |
GO:0035854 | 0.006 | Inf | 0 | 2 | 2 | eosinophil fate commitment |
GO:0038162 | 0.006 | Inf | 0 | 2 | 2 | erythropoietin-mediated signaling pathway |
GO:0042524 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of tyrosine phosphorylation of Stat5 protein |
GO:0043366 | 0.006 | Inf | 0 | 2 | 2 | beta selection |
GO:0043369 | 0.006 | Inf | 0 | 2 | 2 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
GO:0043932 | 0.006 | Inf | 0 | 2 | 2 | ossification involved in bone remodeling |
GO:0043970 | 0.006 | Inf | 0 | 2 | 2 | histone H3-K9 acetylation |
GO:0046136 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of vitamin metabolic process |
GO:0046898 | 0.006 | Inf | 0 | 2 | 2 | response to cycloheximide |
GO:0048388 | 0.006 | Inf | 0 | 2 | 2 | endosomal lumen acidification |
GO:0051231 | 0.006 | Inf | 0 | 2 | 2 | spindle elongation |
GO:0060057 | 0.006 | Inf | 0 | 2 | 2 | apoptotic process involved in mammary gland involution |
GO:0060058 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of apoptotic process involved in mammary gland involution |
GO:0060516 | 0.006 | Inf | 0 | 2 | 2 | primary prostatic bud elongation |
GO:0060557 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of vitamin D biosynthetic process |
GO:0060730 | 0.006 | Inf | 0 | 2 | 2 | regulation of intestinal epithelial structure maintenance |
GO:0060738 | 0.006 | Inf | 0 | 2 | 2 | epithelial-mesenchymal signaling involved in prostate gland development |
GO:0060979 | 0.006 | Inf | 0 | 2 | 2 | vasculogenesis involved in coronary vascular morphogenesis |
GO:0061032 | 0.006 | Inf | 0 | 2 | 2 | visceral serous pericardium development |
GO:0070417 | 0.006 | Inf | 0 | 2 | 2 | cellular response to cold |
GO:0070488 | 0.006 | Inf | 0 | 2 | 2 | neutrophil aggregation |
GO:0070734 | 0.006 | Inf | 0 | 2 | 2 | histone H3-K27 methylation |
GO:0071335 | 0.006 | Inf | 0 | 2 | 2 | hair follicle cell proliferation |
GO:0071930 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of transcription involved in G1/S phase of mitotic cell cycle |
GO:0072183 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of nephron tubule epithelial cell differentiation |
GO:0072301 | 0.006 | Inf | 0 | 2 | 2 | regulation of metanephric glomerular mesangial cell proliferation |
GO:0072308 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of metanephric nephron tubule epithelial cell differentiation |
GO:0090402 | 0.006 | Inf | 0 | 2 | 2 | oncogene-induced senescence |
GO:0090529 | 0.006 | Inf | 0 | 2 | 2 | cell septum assembly |
GO:1900221 | 0.006 | Inf | 0 | 2 | 2 | regulation of beta-amyloid clearance |
GO:1900222 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of beta-amyloid clearance |
GO:1901298 | 0.006 | Inf | 0 | 2 | 2 | regulation of hydrogen peroxide-mediated programmed cell death |
GO:1901299 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of hydrogen peroxide-mediated programmed cell death |
GO:1901420 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of response to alcohol |
GO:1901533 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of hematopoietic progenitor cell differentiation |
GO:2000615 | 0.006 | Inf | 0 | 2 | 2 | regulation of histone H3-K9 acetylation |
GO:2000683 | 0.006 | Inf | 0 | 2 | 2 | regulation of cellular response to X-ray |
GO:2000697 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of epithelial cell differentiation involved in kidney development |
GO:2000974 | 0.006 | Inf | 0 | 2 | 2 | negative regulation of pro-B cell differentiation |
GO:2001074 | 0.006 | Inf | 0 | 2 | 2 | regulation of metanephric ureteric bud development |
GO:2001076 | 0.006 | Inf | 0 | 2 | 2 | positive regulation of metanephric ureteric bud development |
GO:0032446 | 0.006 | 1.535 | 33 | 48 | 437 | protein modification by small protein conjugation |
GO:0032649 | 0.006 | 2.856 | 4 | 10 | 53 | regulation of interferon-gamma production |
GO:1901615 | 0.006 | 1.620 | 25 | 38 | 329 | organic hydroxy compound metabolic process |
GO:0002294 | 0.006 | 3.731 | 2 | 7 | 30 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0014909 | 0.006 | 3.731 | 2 | 7 | 30 | smooth muscle cell migration |
GO:0042093 | 0.006 | 3.731 | 2 | 7 | 30 | T-helper cell differentiation |
GO:0046068 | 0.006 | 3.731 | 2 | 7 | 30 | cGMP metabolic process |
GO:0001935 | 0.006 | 2.422 | 6 | 13 | 79 | endothelial cell proliferation |
GO:0007605 | 0.006 | 2.251 | 7 | 15 | 97 | sensory perception of sound |
GO:0043489 | 0.006 | 4.324 | 2 | 6 | 23 | RNA stabilization |
GO:0048255 | 0.006 | 4.324 | 2 | 6 | 23 | mRNA stabilization |
GO:0051568 | 0.006 | 4.324 | 2 | 6 | 23 | histone H3-K4 methylation |
GO:2001242 | 0.006 | 4.324 | 2 | 6 | 23 | regulation of intrinsic apoptotic signaling pathway |
GO:0060627 | 0.006 | 1.852 | 14 | 24 | 184 | regulation of vesicle-mediated transport |
GO:0006869 | 0.006 | 1.880 | 13 | 23 | 174 | lipid transport |
GO:0000226 | 0.006 | 1.757 | 17 | 28 | 225 | microtubule cytoskeleton organization |
GO:0033121 | 0.007 | 1.816 | 15 | 25 | 195 | regulation of purine nucleotide catabolic process |
GO:0002312 | 0.007 | 3.271 | 3 | 8 | 38 | B cell activation involved in immune response |
GO:0032612 | 0.007 | 3.271 | 3 | 8 | 38 | interleukin-1 production |
GO:0032655 | 0.007 | 3.271 | 3 | 8 | 38 | regulation of interleukin-12 production |
GO:0034103 | 0.007 | 3.271 | 3 | 8 | 38 | regulation of tissue remodeling |
GO:0051492 | 0.007 | 3.271 | 3 | 8 | 38 | regulation of stress fiber assembly |
GO:0006412 | 0.007 | 1.575 | 28 | 41 | 364 | translation |
GO:0030307 | 0.007 | 2.386 | 6 | 13 | 80 | positive regulation of cell growth |
GO:0034332 | 0.007 | 2.386 | 6 | 13 | 80 | adherens junction organization |
GO:0042552 | 0.007 | 2.386 | 6 | 13 | 80 | myelination |
GO:0007009 | 0.007 | 2.296 | 7 | 14 | 89 | plasma membrane organization |
GO:0043393 | 0.007 | 2.296 | 7 | 14 | 89 | regulation of protein binding |
GO:0006898 | 0.007 | 2.094 | 9 | 17 | 117 | receptor-mediated endocytosis |
GO:0000085 | 0.007 | 6.990 | 1 | 4 | 11 | G2 phase of mitotic cell cycle |
GO:0010893 | 0.007 | 6.990 | 1 | 4 | 11 | positive regulation of steroid biosynthetic process |
GO:0032616 | 0.007 | 6.990 | 1 | 4 | 11 | interleukin-13 production |
GO:0033233 | 0.007 | 6.990 | 1 | 4 | 11 | regulation of protein sumoylation |
GO:0034390 | 0.007 | 6.990 | 1 | 4 | 11 | smooth muscle cell apoptotic process |
GO:0034391 | 0.007 | 6.990 | 1 | 4 | 11 | regulation of smooth muscle cell apoptotic process |
GO:0042510 | 0.007 | 6.990 | 1 | 4 | 11 | regulation of tyrosine phosphorylation of Stat1 protein |
GO:0043383 | 0.007 | 6.990 | 1 | 4 | 11 | negative T cell selection |
GO:0045060 | 0.007 | 6.990 | 1 | 4 | 11 | negative thymic T cell selection |
GO:0045725 | 0.007 | 6.990 | 1 | 4 | 11 | positive regulation of glycogen biosynthetic process |
GO:0046321 | 0.007 | 6.990 | 1 | 4 | 11 | positive regulation of fatty acid oxidation |
GO:0051319 | 0.007 | 6.990 | 1 | 4 | 11 | G2 phase |
GO:0060065 | 0.007 | 6.990 | 1 | 4 | 11 | uterus development |
GO:0071542 | 0.007 | 6.990 | 1 | 4 | 11 | dopaminergic neuron differentiation |
GO:0072091 | 0.007 | 6.990 | 1 | 4 | 11 | regulation of stem cell proliferation |
GO:0090049 | 0.007 | 6.990 | 1 | 4 | 11 | regulation of cell migration involved in sprouting angiogenesis |
GO:0090201 | 0.007 | 6.990 | 1 | 4 | 11 | negative regulation of release of cytochrome c from mitochondria |
GO:0097094 | 0.007 | 6.990 | 1 | 4 | 11 | craniofacial suture morphogenesis |
GO:0030811 | 0.007 | 1.806 | 15 | 25 | 196 | regulation of nucleotide catabolic process |
GO:0001783 | 0.007 | 5.101 | 1 | 5 | 17 | B cell apoptotic process |
GO:0001964 | 0.007 | 5.101 | 1 | 5 | 17 | startle response |
GO:0007184 | 0.007 | 5.101 | 1 | 5 | 17 | SMAD protein import into nucleus |
GO:0010714 | 0.007 | 5.101 | 1 | 5 | 17 | positive regulation of collagen metabolic process |
GO:0010823 | 0.007 | 5.101 | 1 | 5 | 17 | negative regulation of mitochondrion organization |
GO:0031641 | 0.007 | 5.101 | 1 | 5 | 17 | regulation of myelination |
GO:0032967 | 0.007 | 5.101 | 1 | 5 | 17 | positive regulation of collagen biosynthetic process |
GO:0050996 | 0.007 | 5.101 | 1 | 5 | 17 | positive regulation of lipid catabolic process |
GO:0060706 | 0.007 | 5.101 | 1 | 5 | 17 | cell differentiation involved in embryonic placenta development |
GO:0070265 | 0.007 | 5.101 | 1 | 5 | 17 | necrotic cell death |
GO:0071599 | 0.007 | 5.101 | 1 | 5 | 17 | otic vesicle development |
GO:0072077 | 0.007 | 5.101 | 1 | 5 | 17 | renal vesicle morphogenesis |
GO:0072087 | 0.007 | 5.101 | 1 | 5 | 17 | renal vesicle development |
GO:0072330 | 0.007 | 1.919 | 12 | 21 | 156 | monocarboxylic acid biosynthetic process |
GO:0007224 | 0.007 | 2.598 | 5 | 11 | 63 | smoothened signaling pathway |
GO:0001780 | 0.007 | 12.222 | 0 | 3 | 6 | neutrophil homeostasis |
GO:0002067 | 0.007 | 12.222 | 0 | 3 | 6 | glandular epithelial cell differentiation |
GO:0003140 | 0.007 | 12.222 | 0 | 3 | 6 | determination of left/right asymmetry in lateral mesoderm |
GO:0006924 | 0.007 | 12.222 | 0 | 3 | 6 | activation-induced cell death of T cells |
GO:0007095 | 0.007 | 12.222 | 0 | 3 | 6 | mitotic cell cycle G2/M transition DNA damage checkpoint |
GO:0007182 | 0.007 | 12.222 | 0 | 3 | 6 | common-partner SMAD protein phosphorylation |
GO:0010692 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of alkaline phosphatase activity |
GO:0021937 | 0.007 | 12.222 | 0 | 3 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0031392 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of prostaglandin biosynthetic process |
GO:0031442 | 0.007 | 12.222 | 0 | 3 | 6 | positive regulation of mRNA 3'-end processing |
GO:0031642 | 0.007 | 12.222 | 0 | 3 | 6 | negative regulation of myelination |
GO:0033084 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of immature T cell proliferation in thymus |
GO:0043497 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of protein heterodimerization activity |
GO:0045722 | 0.007 | 12.222 | 0 | 3 | 6 | positive regulation of gluconeogenesis |
GO:0048293 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of isotype switching to IgE isotypes |
GO:0048304 | 0.007 | 12.222 | 0 | 3 | 6 | positive regulation of isotype switching to IgG isotypes |
GO:0048845 | 0.007 | 12.222 | 0 | 3 | 6 | venous blood vessel morphogenesis |
GO:0051532 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of NFAT protein import into nucleus |
GO:0051573 | 0.007 | 12.222 | 0 | 3 | 6 | negative regulation of histone H3-K9 methylation |
GO:0060215 | 0.007 | 12.222 | 0 | 3 | 6 | primitive hemopoiesis |
GO:0060664 | 0.007 | 12.222 | 0 | 3 | 6 | epithelial cell proliferation involved in salivary gland morphogenesis |
GO:0070141 | 0.007 | 12.222 | 0 | 3 | 6 | response to UV-A |
GO:0070431 | 0.007 | 12.222 | 0 | 3 | 6 | nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0071605 | 0.007 | 12.222 | 0 | 3 | 6 | monocyte chemotactic protein-1 production |
GO:0071637 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of monocyte chemotactic protein-1 production |
GO:0072110 | 0.007 | 12.222 | 0 | 3 | 6 | glomerular mesangial cell proliferation |
GO:0072298 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of metanephric glomerulus development |
GO:0072497 | 0.007 | 12.222 | 0 | 3 | 6 | mesenchymal stem cell differentiation |
GO:0090050 | 0.007 | 12.222 | 0 | 3 | 6 | positive regulation of cell migration involved in sprouting angiogenesis |
GO:0090400 | 0.007 | 12.222 | 0 | 3 | 6 | stress-induced premature senescence |
GO:2000020 | 0.007 | 12.222 | 0 | 3 | 6 | positive regulation of male gonad development |
GO:2000109 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of macrophage apoptotic process |
GO:2001015 | 0.007 | 12.222 | 0 | 3 | 6 | negative regulation of skeletal muscle cell differentiation |
GO:2001279 | 0.007 | 12.222 | 0 | 3 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0001709 | 0.007 | 3.575 | 2 | 7 | 31 | cell fate determination |
GO:0007595 | 0.007 | 3.575 | 2 | 7 | 31 | lactation |
GO:0030004 | 0.007 | 3.575 | 2 | 7 | 31 | cellular monovalent inorganic cation homeostasis |
GO:0032330 | 0.007 | 3.575 | 2 | 7 | 31 | regulation of chondrocyte differentiation |
GO:0048286 | 0.007 | 3.575 | 2 | 7 | 31 | lung alveolus development |
GO:1901068 | 0.007 | 1.654 | 21 | 33 | 280 | guanosine-containing compound metabolic process |
GO:0051320 | 0.007 | 1.984 | 10 | 19 | 137 | S phase |
GO:0009267 | 0.008 | 2.458 | 5 | 12 | 72 | cellular response to starvation |
GO:0009116 | 0.008 | 1.484 | 37 | 52 | 488 | nucleoside metabolic process |
GO:0043279 | 0.008 | 2.266 | 7 | 14 | 90 | response to alkaloid |
GO:0048520 | 0.008 | 2.350 | 6 | 13 | 81 | positive regulation of behavior |
GO:0007090 | 0.008 | 4.083 | 2 | 6 | 24 | regulation of S phase of mitotic cell cycle |
GO:0008038 | 0.008 | 4.083 | 2 | 6 | 24 | neuron recognition |
GO:0009620 | 0.008 | 4.083 | 2 | 6 | 24 | response to fungus |
GO:0010470 | 0.008 | 4.083 | 2 | 6 | 24 | regulation of gastrulation |
GO:0010657 | 0.008 | 4.083 | 2 | 6 | 24 | muscle cell apoptotic process |
GO:0032873 | 0.008 | 4.083 | 2 | 6 | 24 | negative regulation of stress-activated MAPK cascade |
GO:0043029 | 0.008 | 4.083 | 2 | 6 | 24 | T cell homeostasis |
GO:0043303 | 0.008 | 4.083 | 2 | 6 | 24 | mast cell degranulation |
GO:0045923 | 0.008 | 4.083 | 2 | 6 | 24 | positive regulation of fatty acid metabolic process |
GO:0050869 | 0.008 | 4.083 | 2 | 6 | 24 | negative regulation of B cell activation |
GO:0051453 | 0.008 | 4.083 | 2 | 6 | 24 | regulation of intracellular pH |
GO:0070303 | 0.008 | 4.083 | 2 | 6 | 24 | negative regulation of stress-activated protein kinase signaling cascade |
GO:1901566 | 0.008 | 1.455 | 41 | 57 | 545 | organonitrogen compound biosynthetic process |
GO:0016331 | 0.008 | 2.118 | 8 | 16 | 109 | morphogenesis of embryonic epithelium |
GO:0032615 | 0.008 | 3.165 | 3 | 8 | 39 | interleukin-12 production |
GO:0042490 | 0.008 | 3.165 | 3 | 8 | 39 | mechanoreceptor differentiation |
GO:0043367 | 0.008 | 3.165 | 3 | 8 | 39 | CD4-positive, alpha-beta T cell differentiation |
GO:0043500 | 0.008 | 3.165 | 3 | 8 | 39 | muscle adaptation |
GO:0050764 | 0.008 | 3.165 | 3 | 8 | 39 | regulation of phagocytosis |
GO:0071695 | 0.008 | 3.165 | 3 | 8 | 39 | anatomical structure maturation |
GO:0002200 | 0.008 | 2.906 | 4 | 9 | 47 | somatic diversification of immune receptors |
GO:0048645 | 0.008 | 2.906 | 4 | 9 | 47 | organ formation |
GO:0002221 | 0.008 | 2.052 | 9 | 17 | 119 | pattern recognition receptor signaling pathway |
GO:0002695 | 0.008 | 2.236 | 7 | 14 | 91 | negative regulation of leukocyte activation |
GO:0002831 | 0.008 | 2.417 | 6 | 12 | 73 | regulation of response to biotic stimulus |
GO:0007612 | 0.008 | 2.316 | 6 | 13 | 82 | learning |
GO:0032526 | 0.008 | 2.316 | 6 | 13 | 82 | response to retinoic acid |
GO:0015918 | 0.009 | 2.669 | 4 | 10 | 56 | sterol transport |
GO:0021510 | 0.009 | 2.669 | 4 | 10 | 56 | spinal cord development |
GO:0030301 | 0.009 | 2.669 | 4 | 10 | 56 | cholesterol transport |
GO:0046849 | 0.009 | 2.669 | 4 | 10 | 56 | bone remodeling |
GO:0021872 | 0.009 | 3.432 | 2 | 7 | 32 | forebrain generation of neurons |
GO:0031076 | 0.009 | 3.432 | 2 | 7 | 32 | embryonic camera-type eye development |
GO:0032091 | 0.009 | 3.432 | 2 | 7 | 32 | negative regulation of protein binding |
GO:0032104 | 0.009 | 3.432 | 2 | 7 | 32 | regulation of response to extracellular stimulus |
GO:0032107 | 0.009 | 3.432 | 2 | 7 | 32 | regulation of response to nutrient levels |
GO:0060420 | 0.009 | 3.432 | 2 | 7 | 32 | regulation of heart growth |
GO:0071897 | 0.009 | 3.432 | 2 | 7 | 32 | DNA biosynthetic process |
GO:0046039 | 0.009 | 1.643 | 21 | 32 | 273 | GTP metabolic process |
GO:0016571 | 0.009 | 2.831 | 4 | 9 | 48 | histone methylation |
GO:0070647 | 0.009 | 1.466 | 37 | 52 | 493 | protein modification by small protein conjugation or removal |
GO:0010595 | 0.009 | 3.066 | 3 | 8 | 40 | positive regulation of endothelial cell migration |
GO:0000768 | 0.009 | 4.708 | 1 | 5 | 18 | syncytium formation by plasma membrane fusion |
GO:0002262 | 0.009 | 4.708 | 1 | 5 | 18 | myeloid cell homeostasis |
GO:0010575 | 0.009 | 4.708 | 1 | 5 | 18 | positive regulation vascular endothelial growth factor production |
GO:0035411 | 0.009 | 4.708 | 1 | 5 | 18 | catenin import into nucleus |
GO:0051452 | 0.009 | 4.708 | 1 | 5 | 18 | intracellular pH reduction |
GO:0097028 | 0.009 | 4.708 | 1 | 5 | 18 | dendritic cell differentiation |
GO:0007272 | 0.009 | 2.283 | 6 | 13 | 83 | ensheathment of neurons |
GO:0008366 | 0.009 | 2.283 | 6 | 13 | 83 | axon ensheathment |
GO:0002279 | 0.010 | 3.868 | 2 | 6 | 25 | mast cell activation involved in immune response |
GO:0002448 | 0.010 | 3.868 | 2 | 6 | 25 | mast cell mediated immunity |
GO:0014037 | 0.010 | 3.868 | 2 | 6 | 25 | Schwann cell differentiation |
GO:0021955 | 0.010 | 3.868 | 2 | 6 | 25 | central nervous system neuron axonogenesis |
GO:0030641 | 0.010 | 3.868 | 2 | 6 | 25 | regulation of cellular pH |
GO:0046580 | 0.010 | 3.868 | 2 | 6 | 25 | negative regulation of Ras protein signal transduction |
GO:0048640 | 0.010 | 3.868 | 2 | 6 | 25 | negative regulation of developmental growth |
GO:0072088 | 0.010 | 3.868 | 2 | 6 | 25 | nephron epithelium morphogenesis |
GO:0035966 | 0.010 | 2.012 | 9 | 17 | 121 | response to topologically incorrect protein |
GO:0050801 | 0.010 | 1.418 | 45 | 61 | 597 | ion homeostasis |
GO:0043154 | 0.010 | 2.612 | 4 | 10 | 57 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0003417 | 0.010 | 6.116 | 1 | 4 | 12 | growth plate cartilage development |
GO:0010829 | 0.010 | 6.116 | 1 | 4 | 12 | negative regulation of glucose transport |
GO:0010922 | 0.010 | 6.116 | 1 | 4 | 12 | positive regulation of phosphatase activity |
GO:0021513 | 0.010 | 6.116 | 1 | 4 | 12 | spinal cord dorsal/ventral patterning |
GO:0021542 | 0.010 | 6.116 | 1 | 4 | 12 | dentate gyrus development |
GO:0031062 | 0.010 | 6.116 | 1 | 4 | 12 | positive regulation of histone methylation |
GO:0032331 | 0.010 | 6.116 | 1 | 4 | 12 | negative regulation of chondrocyte differentiation |
GO:0032462 | 0.010 | 6.116 | 1 | 4 | 12 | regulation of protein homooligomerization |
GO:0032878 | 0.010 | 6.116 | 1 | 4 | 12 | regulation of establishment or maintenance of cell polarity |
GO:0033632 | 0.010 | 6.116 | 1 | 4 | 12 | regulation of cell-cell adhesion mediated by integrin |
GO:0034616 | 0.010 | 6.116 | 1 | 4 | 12 | response to laminar fluid shear stress |
GO:0042634 | 0.010 | 6.116 | 1 | 4 | 12 | regulation of hair cycle |
GO:0045920 | 0.010 | 6.116 | 1 | 4 | 12 | negative regulation of exocytosis |
GO:0048853 | 0.010 | 6.116 | 1 | 4 | 12 | forebrain morphogenesis |
GO:0051044 | 0.010 | 6.116 | 1 | 4 | 12 | positive regulation of membrane protein ectodomain proteolysis |
GO:0071364 | 0.010 | 6.116 | 1 | 4 | 12 | cellular response to epidermal growth factor stimulus |
GO:0044262 | 0.010 | 1.796 | 14 | 23 | 181 | cellular carbohydrate metabolic process |
GO:0014074 | 0.010 | 2.179 | 7 | 14 | 93 | response to purine-containing compound |
GO:0042594 | 0.010 | 2.179 | 7 | 14 | 93 | response to starvation |
GO:0006163 | 0.010 | 1.424 | 44 | 59 | 575 | purine nucleotide metabolic process |
GO:0019058 | 0.010 | 1.743 | 15 | 25 | 202 | viral infectious cycle |
GO:0050770 | 0.010 | 2.250 | 6 | 13 | 84 | regulation of axonogenesis |
GO:0071346 | 0.010 | 2.250 | 6 | 13 | 84 | cellular response to interferon-gamma |
GO:0019693 | 0.010 | 1.430 | 42 | 57 | 553 | ribose phosphate metabolic process |
GO:0030833 | 0.010 | 2.340 | 6 | 12 | 75 | regulation of actin filament polymerization |
GO:0030003 | 0.010 | 1.575 | 24 | 36 | 319 | cellular cation homeostasis |
GO:0030510 | 0.010 | 2.760 | 4 | 9 | 49 | regulation of BMP signaling pathway |
GO:0016567 | 0.010 | 1.504 | 31 | 44 | 407 | protein ubiquitination |
GO:0000302 | 0.010 | 1.993 | 9 | 17 | 122 | response to reactive oxygen species |
GO:0002758 | 0.010 | 1.993 | 9 | 17 | 122 | innate immune response-activating signal transduction |
GO:0032652 | 0.011 | 3.299 | 3 | 7 | 33 | regulation of interleukin-1 production |
GO:0042059 | 0.011 | 3.299 | 3 | 7 | 33 | negative regulation of epidermal growth factor receptor signaling pathway |
GO:0045861 | 0.011 | 3.299 | 3 | 7 | 33 | negative regulation of proteolysis |
GO:0060389 | 0.011 | 3.299 | 3 | 7 | 33 | pathway-restricted SMAD protein phosphorylation |
GO:1901185 | 0.011 | 3.299 | 3 | 7 | 33 | negative regulation of ERBB signaling pathway |
GO:0002224 | 0.011 | 2.097 | 8 | 15 | 103 | toll-like receptor signaling pathway |
GO:0032623 | 0.011 | 2.972 | 3 | 8 | 41 | interleukin-2 production |
GO:0035710 | 0.011 | 2.972 | 3 | 8 | 41 | CD4-positive, alpha-beta T cell activation |
GO:0030072 | 0.011 | 1.836 | 12 | 21 | 162 | peptide hormone secretion |
GO:0006184 | 0.011 | 1.631 | 20 | 31 | 266 | GTP catabolic process |
GO:0055007 | 0.011 | 2.557 | 4 | 10 | 58 | cardiac muscle cell differentiation |
GO:0070167 | 0.011 | 2.557 | 4 | 10 | 58 | regulation of biomineral tissue development |
GO:0006023 | 0.011 | 2.219 | 6 | 13 | 85 | aminoglycan biosynthetic process |
GO:0006024 | 0.011 | 2.219 | 6 | 13 | 85 | glycosaminoglycan biosynthetic process |
GO:0072175 | 0.011 | 2.219 | 6 | 13 | 85 | epithelial tube formation |
GO:0007093 | 0.011 | 1.974 | 9 | 17 | 123 | mitotic cell cycle checkpoint |
GO:0051271 | 0.011 | 1.974 | 9 | 17 | 123 | negative regulation of cellular component movement |
GO:0007422 | 0.011 | 2.412 | 5 | 11 | 67 | peripheral nervous system development |
GO:0030282 | 0.011 | 2.303 | 6 | 12 | 76 | bone mineralization |
GO:0010389 | 0.012 | 3.674 | 2 | 6 | 26 | regulation of G2/M transition of mitotic cell cycle |
GO:0014910 | 0.012 | 3.674 | 2 | 6 | 26 | regulation of smooth muscle cell migration |
GO:0043124 | 0.012 | 3.674 | 2 | 6 | 26 | negative regulation of I-kappaB kinase/NF-kappaB cascade |
GO:0044246 | 0.012 | 3.674 | 2 | 6 | 26 | regulation of multicellular organismal metabolic process |
GO:0050873 | 0.012 | 3.674 | 2 | 6 | 26 | brown fat cell differentiation |
GO:0051058 | 0.012 | 3.674 | 2 | 6 | 26 | negative regulation of small GTPase mediated signal transduction |
GO:0051489 | 0.012 | 3.674 | 2 | 6 | 26 | regulation of filopodium assembly |
GO:0060674 | 0.012 | 3.674 | 2 | 6 | 26 | placenta blood vessel development |
GO:0006111 | 0.012 | 4.371 | 1 | 5 | 19 | regulation of gluconeogenesis |
GO:0006182 | 0.012 | 4.371 | 1 | 5 | 19 | cGMP biosynthetic process |
GO:0021772 | 0.012 | 4.371 | 1 | 5 | 19 | olfactory bulb development |
GO:0021952 | 0.012 | 4.371 | 1 | 5 | 19 | central nervous system projection neuron axonogenesis |
GO:0032800 | 0.012 | 4.371 | 1 | 5 | 19 | receptor biosynthetic process |
GO:0043300 | 0.012 | 4.371 | 1 | 5 | 19 | regulation of leukocyte degranulation |
GO:0048557 | 0.012 | 4.371 | 1 | 5 | 19 | embryonic digestive tract morphogenesis |
GO:0048873 | 0.012 | 4.371 | 1 | 5 | 19 | homeostasis of number of cells within a tissue |
GO:0060997 | 0.012 | 4.371 | 1 | 5 | 19 | dendritic spine morphogenesis |
GO:0070231 | 0.012 | 4.371 | 1 | 5 | 19 | T cell apoptotic process |
GO:0070373 | 0.012 | 4.371 | 1 | 5 | 19 | negative regulation of ERK1 and ERK2 cascade |
GO:0007283 | 0.012 | 1.633 | 19 | 30 | 257 | spermatogenesis |
GO:0048232 | 0.012 | 1.633 | 19 | 30 | 257 | male gamete generation |
GO:0000271 | 0.012 | 2.693 | 4 | 9 | 50 | polysaccharide biosynthetic process |
GO:0006635 | 0.012 | 2.693 | 4 | 9 | 50 | fatty acid beta-oxidation |
GO:0017148 | 0.012 | 2.693 | 4 | 9 | 50 | negative regulation of translation |
GO:0021954 | 0.012 | 2.693 | 4 | 9 | 50 | central nervous system neuron development |
GO:0042632 | 0.012 | 2.693 | 4 | 9 | 50 | cholesterol homeostasis |
GO:0051149 | 0.012 | 2.693 | 4 | 9 | 50 | positive regulation of muscle cell differentiation |
GO:0055092 | 0.012 | 2.693 | 4 | 9 | 50 | sterol homeostasis |
GO:0072521 | 0.012 | 1.401 | 46 | 61 | 603 | purine-containing compound metabolic process |
GO:0006986 | 0.012 | 2.009 | 9 | 16 | 114 | response to unfolded protein |
GO:1901069 | 0.012 | 1.617 | 20 | 31 | 268 | guanosine-containing compound catabolic process |
GO:0002295 | 0.012 | 9.166 | 1 | 3 | 7 | T-helper cell lineage commitment |
GO:0002551 | 0.012 | 9.166 | 1 | 3 | 7 | mast cell chemotaxis |
GO:0003188 | 0.012 | 9.166 | 1 | 3 | 7 | heart valve formation |
GO:0003263 | 0.012 | 9.166 | 1 | 3 | 7 | cardioblast proliferation |
GO:0003299 | 0.012 | 9.166 | 1 | 3 | 7 | muscle hypertrophy in response to stress |
GO:0003339 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010940 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of necrotic cell death |
GO:0014010 | 0.012 | 9.166 | 1 | 3 | 7 | Schwann cell proliferation |
GO:0014898 | 0.012 | 9.166 | 1 | 3 | 7 | cardiac muscle hypertrophy in response to stress |
GO:0021889 | 0.012 | 9.166 | 1 | 3 | 7 | olfactory bulb interneuron differentiation |
GO:0022601 | 0.012 | 9.166 | 1 | 3 | 7 | menstrual cycle phase |
GO:0031620 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of fever generation |
GO:0031622 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of fever generation |
GO:0031650 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of heat generation |
GO:0031652 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of heat generation |
GO:0032287 | 0.012 | 9.166 | 1 | 3 | 7 | peripheral nervous system myelin maintenance |
GO:0033080 | 0.012 | 9.166 | 1 | 3 | 7 | immature T cell proliferation in thymus |
GO:0033083 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of immature T cell proliferation |
GO:0033127 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of histone phosphorylation |
GO:0035747 | 0.012 | 9.166 | 1 | 3 | 7 | natural killer cell chemotaxis |
GO:0038034 | 0.012 | 9.166 | 1 | 3 | 7 | signal transduction in absence of ligand |
GO:0045084 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of interleukin-12 biosynthetic process |
GO:0045683 | 0.012 | 9.166 | 1 | 3 | 7 | negative regulation of epidermis development |
GO:0045793 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of cell size |
GO:0048289 | 0.012 | 9.166 | 1 | 3 | 7 | isotype switching to IgE isotypes |
GO:0051095 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of helicase activity |
GO:0051488 | 0.012 | 9.166 | 1 | 3 | 7 | activation of anaphase-promoting complex activity |
GO:0051531 | 0.012 | 9.166 | 1 | 3 | 7 | NFAT protein import into nucleus |
GO:0051890 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of cardioblast differentiation |
GO:0051895 | 0.012 | 9.166 | 1 | 3 | 7 | negative regulation of focal adhesion assembly |
GO:0060017 | 0.012 | 9.166 | 1 | 3 | 7 | parathyroid gland development |
GO:0060770 | 0.012 | 9.166 | 1 | 3 | 7 | negative regulation of epithelial cell proliferation involved in prostate gland development |
GO:0070166 | 0.012 | 9.166 | 1 | 3 | 7 | enamel mineralization |
GO:0070932 | 0.012 | 9.166 | 1 | 3 | 7 | histone H3 deacetylation |
GO:0071850 | 0.012 | 9.166 | 1 | 3 | 7 | mitotic cell cycle arrest |
GO:0072050 | 0.012 | 9.166 | 1 | 3 | 7 | S-shaped body morphogenesis |
GO:0097186 | 0.012 | 9.166 | 1 | 3 | 7 | amelogenesis |
GO:0097192 | 0.012 | 9.166 | 1 | 3 | 7 | extrinsic apoptotic signaling pathway in absence of ligand |
GO:1901889 | 0.012 | 9.166 | 1 | 3 | 7 | negative regulation of cell junction assembly |
GO:2000018 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of male gonad development |
GO:2000505 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of energy homeostasis |
GO:2000648 | 0.012 | 9.166 | 1 | 3 | 7 | positive regulation of stem cell proliferation |
GO:2001239 | 0.012 | 9.166 | 1 | 3 | 7 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:1901657 | 0.012 | 1.439 | 38 | 52 | 501 | glycosyl compound metabolic process |
GO:0002444 | 0.012 | 2.885 | 3 | 8 | 42 | myeloid leukocyte mediated immunity |
GO:0003229 | 0.012 | 2.885 | 3 | 8 | 42 | ventricular cardiac muscle tissue development |
GO:0060419 | 0.012 | 2.885 | 3 | 8 | 42 | heart growth |
GO:0008156 | 0.012 | 3.177 | 3 | 7 | 34 | negative regulation of DNA replication |
GO:0014855 | 0.012 | 3.177 | 3 | 7 | 34 | striated muscle cell proliferation |
GO:0032611 | 0.012 | 3.177 | 3 | 7 | 34 | interleukin-1 beta production |
GO:0048008 | 0.012 | 3.177 | 3 | 7 | 34 | platelet-derived growth factor receptor signaling pathway |
GO:0060079 | 0.012 | 3.177 | 3 | 7 | 34 | regulation of excitatory postsynaptic membrane potential |
GO:0034329 | 0.012 | 1.839 | 12 | 20 | 154 | cell junction assembly |
GO:0006096 | 0.013 | 2.504 | 4 | 10 | 59 | glycolysis |
GO:0090100 | 0.013 | 2.504 | 4 | 10 | 59 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0034655 | 0.013 | 1.388 | 48 | 63 | 628 | nucleobase-containing compound catabolic process |
GO:0001936 | 0.013 | 2.369 | 5 | 11 | 68 | regulation of endothelial cell proliferation |
GO:0019439 | 0.013 | 1.377 | 50 | 66 | 663 | aromatic compound catabolic process |
GO:0009259 | 0.013 | 1.415 | 42 | 56 | 548 | ribonucleotide metabolic process |
GO:0044708 | 0.013 | 1.569 | 23 | 34 | 302 | single-organism behavior |
GO:0009150 | 0.013 | 1.418 | 41 | 55 | 537 | purine ribonucleotide metabolic process |
GO:0046883 | 0.013 | 1.797 | 13 | 21 | 165 | regulation of hormone secretion |
GO:0003015 | 0.013 | 1.894 | 10 | 18 | 135 | heart process |
GO:0060047 | 0.013 | 1.894 | 10 | 18 | 135 | heart contraction |
GO:0016051 | 0.013 | 1.857 | 11 | 19 | 145 | carbohydrate biosynthetic process |
GO:0046823 | 0.014 | 2.628 | 4 | 9 | 51 | negative regulation of nucleocytoplasmic transport |
GO:0003337 | 0.014 | 5.435 | 1 | 4 | 13 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0014911 | 0.014 | 5.435 | 1 | 4 | 13 | positive regulation of smooth muscle cell migration |
GO:0032303 | 0.014 | 5.435 | 1 | 4 | 13 | regulation of icosanoid secretion |
GO:0032461 | 0.014 | 5.435 | 1 | 4 | 13 | positive regulation of protein oligomerization |
GO:0032733 | 0.014 | 5.435 | 1 | 4 | 13 | positive regulation of interleukin-10 production |
GO:0033032 | 0.014 | 5.435 | 1 | 4 | 13 | regulation of myeloid cell apoptotic process |
GO:0034110 | 0.014 | 5.435 | 1 | 4 | 13 | regulation of homotypic cell-cell adhesion |
GO:0034505 | 0.014 | 5.435 | 1 | 4 | 13 | tooth mineralization |
GO:0042149 | 0.014 | 5.435 | 1 | 4 | 13 | cellular response to glucose starvation |
GO:0048103 | 0.014 | 5.435 | 1 | 4 | 13 | somatic stem cell division |
GO:0051000 | 0.014 | 5.435 | 1 | 4 | 13 | positive regulation of nitric-oxide synthase activity |
GO:0051154 | 0.014 | 5.435 | 1 | 4 | 13 | negative regulation of striated muscle cell differentiation |
GO:0060055 | 0.014 | 5.435 | 1 | 4 | 13 | angiogenesis involved in wound healing |
GO:0060742 | 0.014 | 5.435 | 1 | 4 | 13 | epithelial cell differentiation involved in prostate gland development |
GO:2000058 | 0.014 | 5.435 | 1 | 4 | 13 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0001659 | 0.014 | 3.499 | 2 | 6 | 27 | temperature homeostasis |
GO:0003300 | 0.014 | 3.499 | 2 | 6 | 27 | cardiac muscle hypertrophy |
GO:0010822 | 0.014 | 3.499 | 2 | 6 | 27 | positive regulation of mitochondrion organization |
GO:0014897 | 0.014 | 3.499 | 2 | 6 | 27 | striated muscle hypertrophy |
GO:0042304 | 0.014 | 3.499 | 2 | 6 | 27 | regulation of fatty acid biosynthetic process |
GO:0051250 | 0.014 | 2.233 | 6 | 12 | 78 | negative regulation of lymphocyte activation |
GO:0006987 | 0.014 | 2.454 | 5 | 10 | 60 | activation of signaling protein activity involved in unfolded protein response |
GO:0048644 | 0.014 | 2.454 | 5 | 10 | 60 | muscle organ morphogenesis |
GO:2000117 | 0.014 | 2.454 | 5 | 10 | 60 | negative regulation of cysteine-type endopeptidase activity |
GO:0002790 | 0.014 | 1.784 | 13 | 21 | 166 | peptide secretion |
GO:0030031 | 0.014 | 1.784 | 13 | 21 | 166 | cell projection assembly |
GO:0045995 | 0.014 | 2.328 | 5 | 11 | 69 | regulation of embryonic development |
GO:0002218 | 0.014 | 1.919 | 10 | 17 | 126 | activation of innate immune response |
GO:0006446 | 0.014 | 2.802 | 3 | 8 | 43 | regulation of translational initiation |
GO:0044255 | 0.015 | 1.368 | 51 | 66 | 667 | cellular lipid metabolic process |
GO:0003281 | 0.015 | 3.063 | 3 | 7 | 35 | ventricular septum development |
GO:0043299 | 0.015 | 3.063 | 3 | 7 | 35 | leukocyte degranulation |
GO:0009119 | 0.015 | 1.450 | 34 | 47 | 449 | ribonucleoside metabolic process |
GO:0010660 | 0.015 | 4.079 | 2 | 5 | 20 | regulation of muscle cell apoptotic process |
GO:0014009 | 0.015 | 4.079 | 2 | 5 | 20 | glial cell proliferation |
GO:0021846 | 0.015 | 4.079 | 2 | 5 | 20 | cell proliferation in forebrain |
GO:0021988 | 0.015 | 4.079 | 2 | 5 | 20 | olfactory lobe development |
GO:0032094 | 0.015 | 4.079 | 2 | 5 | 20 | response to food |
GO:0042491 | 0.015 | 4.079 | 2 | 5 | 20 | auditory receptor cell differentiation |
GO:0045622 | 0.015 | 4.079 | 2 | 5 | 20 | regulation of T-helper cell differentiation |
GO:0045851 | 0.015 | 4.079 | 2 | 5 | 20 | pH reduction |
GO:0045940 | 0.015 | 4.079 | 2 | 5 | 20 | positive regulation of steroid metabolic process |
GO:0061098 | 0.015 | 4.079 | 2 | 5 | 20 | positive regulation of protein tyrosine kinase activity |
GO:0090311 | 0.015 | 4.079 | 2 | 5 | 20 | regulation of protein deacetylation |
GO:0097061 | 0.015 | 4.079 | 2 | 5 | 20 | dendritic spine organization |
GO:0003012 | 0.015 | 1.597 | 20 | 30 | 262 | muscle system process |
GO:0030500 | 0.015 | 2.567 | 4 | 9 | 52 | regulation of bone mineralization |
GO:0002687 | 0.016 | 2.406 | 5 | 10 | 61 | positive regulation of leukocyte migration |
GO:0032609 | 0.016 | 2.406 | 5 | 10 | 61 | interferon-gamma production |
GO:1901361 | 0.016 | 1.353 | 53 | 68 | 694 | organic cyclic compound catabolic process |
GO:0071300 | 0.016 | 2.724 | 3 | 8 | 44 | cellular response to retinoic acid |
GO:0043123 | 0.016 | 1.929 | 9 | 16 | 118 | positive regulation of I-kappaB kinase/NF-kappaB cascade |
GO:2000146 | 0.016 | 1.929 | 9 | 16 | 118 | negative regulation of cell motility |
GO:0001781 | 0.016 | 24.419 | 0 | 2 | 3 | neutrophil apoptotic process |
GO:0002874 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of chronic inflammatory response to antigenic stimulus |
GO:0003273 | 0.016 | 24.419 | 0 | 2 | 3 | cell migration involved in endocardial cushion formation |
GO:0003340 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0006344 | 0.016 | 24.419 | 0 | 2 | 3 | maintenance of chromatin silencing |
GO:0006808 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of nitrogen utilization |
GO:0006933 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of cell adhesion involved in substrate-bound cell migration |
GO:0007161 | 0.016 | 24.419 | 0 | 2 | 3 | calcium-independent cell-matrix adhesion |
GO:0010421 | 0.016 | 24.419 | 0 | 2 | 3 | hydrogen peroxide-mediated programmed cell death |
GO:0010693 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of alkaline phosphatase activity |
GO:0010956 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
GO:0010979 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of vitamin D 24-hydroxylase activity |
GO:0010980 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of vitamin D 24-hydroxylase activity |
GO:0014038 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of Schwann cell differentiation |
GO:0014870 | 0.016 | 24.419 | 0 | 2 | 3 | response to muscle inactivity |
GO:0014877 | 0.016 | 24.419 | 0 | 2 | 3 | response to muscle inactivity involved in regulation of muscle adaptation |
GO:0014894 | 0.016 | 24.419 | 0 | 2 | 3 | response to denervation involved in regulation of muscle adaptation |
GO:0019049 | 0.016 | 24.419 | 0 | 2 | 3 | evasion or tolerance of host defenses by virus |
GO:0019368 | 0.016 | 24.419 | 0 | 2 | 3 | fatty acid elongation, unsaturated fatty acid |
GO:0019740 | 0.016 | 24.419 | 0 | 2 | 3 | nitrogen utilization |
GO:0021960 | 0.016 | 24.419 | 0 | 2 | 3 | anterior commissure morphogenesis |
GO:0030422 | 0.016 | 24.419 | 0 | 2 | 3 | production of siRNA involved in RNA interference |
GO:0030423 | 0.016 | 24.419 | 0 | 2 | 3 | targeting of mRNA for destruction involved in RNA interference |
GO:0032071 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of endodeoxyribonuclease activity |
GO:0032286 | 0.016 | 24.419 | 0 | 2 | 3 | central nervous system myelin maintenance |
GO:0032431 | 0.016 | 24.419 | 0 | 2 | 3 | activation of phospholipase A2 activity |
GO:0032632 | 0.016 | 24.419 | 0 | 2 | 3 | interleukin-3 production |
GO:0033139 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0033141 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0033561 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of water loss via skin |
GO:0034465 | 0.016 | 24.419 | 0 | 2 | 3 | response to carbon monoxide |
GO:0035022 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of Rac protein signal transduction |
GO:0035793 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
GO:0043313 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of neutrophil degranulation |
GO:0043615 | 0.016 | 24.419 | 0 | 2 | 3 | astrocyte cell migration |
GO:0044413 | 0.016 | 24.419 | 0 | 2 | 3 | avoidance of host defenses |
GO:0044415 | 0.016 | 24.419 | 0 | 2 | 3 | evasion or tolerance of host defenses |
GO:0045636 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of melanocyte differentiation |
GO:0045899 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly |
GO:0046532 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of photoreceptor cell differentiation |
GO:0046533 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of photoreceptor cell differentiation |
GO:0048295 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of isotype switching to IgE isotypes |
GO:0050942 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of pigment cell differentiation |
GO:0051097 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of helicase activity |
GO:0051832 | 0.016 | 24.419 | 0 | 2 | 3 | avoidance of defenses of other organism involved in symbiotic interaction |
GO:0051834 | 0.016 | 24.419 | 0 | 2 | 3 | evasion or tolerance of defenses of other organism involved in symbiotic interaction |
GO:0052251 | 0.016 | 24.419 | 0 | 2 | 3 | induction by organism of defense response of other organism involved in symbiotic interaction |
GO:0060018 | 0.016 | 24.419 | 0 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.016 | 24.419 | 0 | 2 | 3 | transdifferentiation |
GO:0060398 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of growth hormone receptor signaling pathway |
GO:0060459 | 0.016 | 24.419 | 0 | 2 | 3 | left lung development |
GO:0060523 | 0.016 | 24.419 | 0 | 2 | 3 | prostate epithelial cord elongation |
GO:0060545 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of necroptosis |
GO:0060553 | 0.016 | 24.419 | 0 | 2 | 3 | activation of necroptosis |
GO:0060555 | 0.016 | 24.419 | 0 | 2 | 3 | activation of necroptosis by extracellular signals |
GO:0060741 | 0.016 | 24.419 | 0 | 2 | 3 | prostate gland stromal morphogenesis |
GO:0060948 | 0.016 | 24.419 | 0 | 2 | 3 | cardiac vascular smooth muscle cell development |
GO:0061419 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
GO:0070314 | 0.016 | 24.419 | 0 | 2 | 3 | G1 to G0 transition |
GO:0070316 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of G0 to G1 transition |
GO:0070318 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of G0 to G1 transition |
GO:0071639 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of monocyte chemotactic protein-1 production |
GO:0072135 | 0.016 | 24.419 | 0 | 2 | 3 | kidney mesenchymal cell proliferation |
GO:0072136 | 0.016 | 24.419 | 0 | 2 | 3 | metanephric mesenchymal cell proliferation involved in metanephros development |
GO:0072275 | 0.016 | 24.419 | 0 | 2 | 3 | metanephric glomerulus morphogenesis |
GO:0072276 | 0.016 | 24.419 | 0 | 2 | 3 | metanephric glomerulus vasculature morphogenesis |
GO:0072277 | 0.016 | 24.419 | 0 | 2 | 3 | metanephric glomerular capillary formation |
GO:0072603 | 0.016 | 24.419 | 0 | 2 | 3 | interleukin-5 secretion |
GO:0072611 | 0.016 | 24.419 | 0 | 2 | 3 | interleukin-13 secretion |
GO:0090185 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of kidney development |
GO:0090240 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of histone H4 acetylation |
GO:0090370 | 0.016 | 24.419 | 0 | 2 | 3 | negative regulation of cholesterol efflux |
GO:0097242 | 0.016 | 24.419 | 0 | 2 | 3 | beta-amyloid clearance |
GO:0097468 | 0.016 | 24.419 | 0 | 2 | 3 | programmed cell death in response to reactive oxygen species |
GO:1900107 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of nodal signaling pathway |
GO:1900127 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of hyaluronan biosynthetic process |
GO:1900145 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of nodal signaling pathway involved in determination of left/right asymmetry |
GO:1900175 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:1900238 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
GO:1901532 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of hematopoietic progenitor cell differentiation |
GO:1901724 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of cell proliferation involved in kidney development |
GO:1901725 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of histone deacetylase activity |
GO:1901727 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of histone deacetylase activity |
GO:2000111 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of macrophage apoptotic process |
GO:2000288 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of myoblast proliferation |
GO:2000343 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO:2000591 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of metanephric mesenchymal cell migration |
GO:2000662 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of interleukin-5 secretion |
GO:2000665 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of interleukin-13 secretion |
GO:2000973 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of pro-B cell differentiation |
GO:2001038 | 0.016 | 24.419 | 0 | 2 | 3 | regulation of cellular response to drug |
GO:2001241 | 0.016 | 24.419 | 0 | 2 | 3 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0006305 | 0.017 | 3.339 | 2 | 6 | 28 | DNA alkylation |
GO:0006306 | 0.017 | 3.339 | 2 | 6 | 28 | DNA methylation |
GO:0030279 | 0.017 | 3.339 | 2 | 6 | 28 | negative regulation of ossification |
GO:0032760 | 0.017 | 3.339 | 2 | 6 | 28 | positive regulation of tumor necrosis factor production |
GO:0070423 | 0.017 | 3.339 | 2 | 6 | 28 | nucleotide-binding oligomerization domain containing signaling pathway |
GO:0071277 | 0.017 | 3.339 | 2 | 6 | 28 | cellular response to calcium ion |
GO:0046128 | 0.017 | 1.449 | 33 | 45 | 430 | purine ribonucleoside metabolic process |
GO:0046700 | 0.017 | 1.360 | 50 | 65 | 660 | heterocycle catabolic process |
GO:0002753 | 0.017 | 2.957 | 3 | 7 | 36 | cytoplasmic pattern recognition receptor signaling pathway |
GO:0021545 | 0.017 | 2.957 | 3 | 7 | 36 | cranial nerve development |
GO:0031929 | 0.017 | 2.957 | 3 | 7 | 36 | TOR signaling cascade |
GO:0009117 | 0.017 | 1.352 | 52 | 67 | 684 | nucleotide metabolic process |
GO:0006007 | 0.017 | 2.250 | 5 | 11 | 71 | glucose catabolic process |
GO:0009062 | 0.017 | 2.359 | 5 | 10 | 62 | fatty acid catabolic process |
GO:0032075 | 0.017 | 2.359 | 5 | 10 | 62 | positive regulation of nuclease activity |
GO:0043547 | 0.018 | 1.910 | 9 | 16 | 119 | positive regulation of GTPase activity |
GO:0090276 | 0.018 | 1.830 | 11 | 18 | 139 | regulation of peptide hormone secretion |
GO:0008625 | 0.018 | 4.891 | 1 | 4 | 14 | extrinsic apoptotic signaling pathway via death domain receptors |
GO:0010155 | 0.018 | 4.891 | 1 | 4 | 14 | regulation of proton transport |
GO:0010830 | 0.018 | 4.891 | 1 | 4 | 14 | regulation of myotube differentiation |
GO:0032105 | 0.018 | 4.891 | 1 | 4 | 14 | negative regulation of response to extracellular stimulus |
GO:0032108 | 0.018 | 4.891 | 1 | 4 | 14 | negative regulation of response to nutrient levels |
GO:0035987 | 0.018 | 4.891 | 1 | 4 | 14 | endodermal cell differentiation |
GO:0042347 | 0.018 | 4.891 | 1 | 4 | 14 | negative regulation of NF-kappaB import into nucleus |
GO:0043586 | 0.018 | 4.891 | 1 | 4 | 14 | tongue development |
GO:0045737 | 0.018 | 4.891 | 1 | 4 | 14 | positive regulation of cyclin-dependent protein kinase activity |
GO:0045922 | 0.018 | 4.891 | 1 | 4 | 14 | negative regulation of fatty acid metabolic process |
GO:0046641 | 0.018 | 4.891 | 1 | 4 | 14 | positive regulation of alpha-beta T cell proliferation |
GO:0046685 | 0.018 | 4.891 | 1 | 4 | 14 | response to arsenic-containing substance |
GO:0048820 | 0.018 | 4.891 | 1 | 4 | 14 | hair follicle maturation |
GO:0060260 | 0.018 | 4.891 | 1 | 4 | 14 | regulation of transcription initiation from RNA polymerase II promoter |
GO:0060442 | 0.018 | 4.891 | 1 | 4 | 14 | branching involved in prostate gland morphogenesis |
GO:0060713 | 0.018 | 4.891 | 1 | 4 | 14 | labyrinthine layer morphogenesis |
GO:0070875 | 0.018 | 4.891 | 1 | 4 | 14 | positive regulation of glycogen metabolic process |
GO:1901655 | 0.018 | 4.891 | 1 | 4 | 14 | cellular response to ketone |
GO:0051224 | 0.018 | 2.074 | 7 | 13 | 90 | negative regulation of protein transport |
GO:0072503 | 0.018 | 1.617 | 18 | 27 | 233 | cellular divalent inorganic cation homeostasis |
GO:0042278 | 0.018 | 1.441 | 33 | 45 | 432 | purine nucleoside metabolic process |
GO:0043087 | 0.018 | 1.736 | 13 | 21 | 170 | regulation of GTPase activity |
GO:0002886 | 0.018 | 3.824 | 2 | 5 | 21 | regulation of myeloid leukocyte mediated immunity |
GO:0006110 | 0.018 | 3.824 | 2 | 5 | 21 | regulation of glycolysis |
GO:0007530 | 0.018 | 3.824 | 2 | 5 | 21 | sex determination |
GO:0017145 | 0.018 | 3.824 | 2 | 5 | 21 | stem cell division |
GO:0031057 | 0.018 | 3.824 | 2 | 5 | 21 | negative regulation of histone modification |
GO:0035020 | 0.018 | 3.824 | 2 | 5 | 21 | regulation of Rac protein signal transduction |
GO:0046633 | 0.018 | 3.824 | 2 | 5 | 21 | alpha-beta T cell proliferation |
GO:0048147 | 0.018 | 3.824 | 2 | 5 | 21 | negative regulation of fibroblast proliferation |
GO:0090003 | 0.018 | 3.824 | 2 | 5 | 21 | regulation of establishment of protein localization to plasma membrane |
GO:0001660 | 0.018 | 7.332 | 1 | 3 | 8 | fever generation |
GO:0002328 | 0.018 | 7.332 | 1 | 3 | 8 | pro-B cell differentiation |
GO:0003181 | 0.018 | 7.332 | 1 | 3 | 8 | atrioventricular valve morphogenesis |
GO:0003198 | 0.018 | 7.332 | 1 | 3 | 8 | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0006356 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of transcription from RNA polymerase I promoter |
GO:0010889 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of sequestering of triglyceride |
GO:0014887 | 0.018 | 7.332 | 1 | 3 | 8 | cardiac muscle adaptation |
GO:0023014 | 0.018 | 7.332 | 1 | 3 | 8 | signal transduction by phosphorylation |
GO:0031440 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of mRNA 3'-end processing |
GO:0031657 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of cyclin-dependent protein kinase activity involved in G1/S |
GO:0032000 | 0.018 | 7.332 | 1 | 3 | 8 | positive regulation of fatty acid beta-oxidation |
GO:0032308 | 0.018 | 7.332 | 1 | 3 | 8 | positive regulation of prostaglandin secretion |
GO:0032372 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of sterol transport |
GO:0032375 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of cholesterol transport |
GO:0032604 | 0.018 | 7.332 | 1 | 3 | 8 | granulocyte macrophage colony-stimulating factor production |
GO:0032645 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:0032700 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of interleukin-17 production |
GO:0032928 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of superoxide anion generation |
GO:0033033 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of myeloid cell apoptotic process |
GO:0033079 | 0.018 | 7.332 | 1 | 3 | 8 | immature T cell proliferation |
GO:0033235 | 0.018 | 7.332 | 1 | 3 | 8 | positive regulation of protein sumoylation |
GO:0033689 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of osteoblast proliferation |
GO:0034661 | 0.018 | 7.332 | 1 | 3 | 8 | ncRNA catabolic process |
GO:0036003 | 0.018 | 7.332 | 1 | 3 | 8 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
GO:0038092 | 0.018 | 7.332 | 1 | 3 | 8 | nodal signaling pathway |
GO:0042473 | 0.018 | 7.332 | 1 | 3 | 8 | outer ear morphogenesis |
GO:0043353 | 0.018 | 7.332 | 1 | 3 | 8 | enucleate erythrocyte differentiation |
GO:0045059 | 0.018 | 7.332 | 1 | 3 | 8 | positive thymic T cell selection |
GO:0045662 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of myoblast differentiation |
GO:0045792 | 0.018 | 7.332 | 1 | 3 | 8 | negative regulation of cell size |
GO:0046599 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of centriole replication |
GO:0048505 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of timing of cell differentiation |
GO:0048703 | 0.018 | 7.332 | 1 | 3 | 8 | embryonic viscerocranium morphogenesis |
GO:0051570 | 0.018 | 7.332 | 1 | 3 | 8 | regulation of histone H3-K9 methylation |
GO:0060056 | 0.018 | 7.332 | 1 | 3 | 8 | mammary gland involution |
GO:0060536 | 0.018 | 7.332 | 1 | 3 | 8 | cartilage morphogenesis |
GO:0060638 | 0.018 | 7.332 | 1 | 3 | 8 | mesenchymal-epithelial cell signaling |
GO:0071372 | 0.018 | 7.332 | 1 | 3 | 8 | cellular response to follicle-stimulating hormone stimulus |
GO:0071888 | 0.018 | 7.332 | 1 | 3 | 8 | macrophage apoptotic process |
GO:0097009 | 0.018 | 7.332 | 1 | 3 | 8 | energy homeostasis |
GO:2000573 | 0.018 | 7.332 | 1 | 3 | 8 | positive regulation of DNA biosynthetic process |
GO:0002456 | 0.019 | 2.650 | 3 | 8 | 45 | T cell mediated immunity |
GO:0006383 | 0.019 | 2.650 | 3 | 8 | 45 | transcription from RNA polymerase III promoter |
GO:0060322 | 0.019 | 2.650 | 3 | 8 | 45 | head development |
GO:0045089 | 0.019 | 1.785 | 11 | 19 | 150 | positive regulation of innate immune response |
GO:0016053 | 0.019 | 1.592 | 19 | 28 | 245 | organic acid biosynthetic process |
GO:0046394 | 0.019 | 1.592 | 19 | 28 | 245 | carboxylic acid biosynthetic process |
GO:0055088 | 0.019 | 2.213 | 5 | 11 | 72 | lipid homeostasis |
GO:0060193 | 0.019 | 2.213 | 5 | 11 | 72 | positive regulation of lipase activity |
GO:0042058 | 0.019 | 2.452 | 4 | 9 | 54 | regulation of epidermal growth factor receptor signaling pathway |
GO:0050688 | 0.019 | 2.452 | 4 | 9 | 54 | regulation of defense response to virus |
GO:0090317 | 0.019 | 2.452 | 4 | 9 | 54 | negative regulation of intracellular protein transport |
GO:0010171 | 0.020 | 2.858 | 3 | 7 | 37 | body morphogenesis |
GO:0031645 | 0.020 | 2.858 | 3 | 7 | 37 | negative regulation of neurological system process |
GO:0044728 | 0.020 | 2.858 | 3 | 7 | 37 | DNA methylation or demethylation |
GO:0050918 | 0.020 | 2.858 | 3 | 7 | 37 | positive chemotaxis |
GO:0055086 | 0.020 | 1.332 | 55 | 70 | 724 | nucleobase-containing small molecule metabolic process |
GO:0009205 | 0.020 | 1.464 | 29 | 40 | 378 | purine ribonucleoside triphosphate metabolic process |
GO:0042246 | 0.020 | 3.194 | 2 | 6 | 29 | tissue regeneration |
GO:0072507 | 0.020 | 1.585 | 19 | 28 | 246 | divalent inorganic cation homeostasis |
GO:0002791 | 0.020 | 1.800 | 11 | 18 | 141 | regulation of peptide secretion |
GO:0090087 | 0.020 | 1.800 | 11 | 18 | 141 | regulation of peptide transport |
GO:0033124 | 0.020 | 1.712 | 13 | 21 | 172 | regulation of GTP catabolic process |
GO:0000084 | 0.020 | 1.834 | 10 | 17 | 131 | S phase of mitotic cell cycle |
GO:0006753 | 0.021 | 1.336 | 52 | 67 | 691 | nucleoside phosphate metabolic process |
GO:0010517 | 0.021 | 2.177 | 6 | 11 | 73 | regulation of phospholipase activity |
GO:2000045 | 0.021 | 2.021 | 7 | 13 | 92 | regulation of G1/S transition of mitotic cell cycle |
GO:0042180 | 0.021 | 1.657 | 15 | 23 | 194 | cellular ketone metabolic process |
GO:0021675 | 0.022 | 2.399 | 4 | 9 | 55 | nerve development |
GO:1901184 | 0.022 | 2.399 | 4 | 9 | 55 | regulation of ERBB signaling pathway |
GO:0002828 | 0.022 | 3.599 | 2 | 5 | 22 | regulation of type 2 immune response |
GO:0003401 | 0.022 | 3.599 | 2 | 5 | 22 | axis elongation |
GO:0005979 | 0.022 | 3.599 | 2 | 5 | 22 | regulation of glycogen biosynthetic process |
GO:0010962 | 0.022 | 3.599 | 2 | 5 | 22 | regulation of glucan biosynthetic process |
GO:0030104 | 0.022 | 3.599 | 2 | 5 | 22 | water homeostasis |
GO:0032732 | 0.022 | 3.599 | 2 | 5 | 22 | positive regulation of interleukin-1 production |
GO:0044253 | 0.022 | 3.599 | 2 | 5 | 22 | positive regulation of multicellular organismal metabolic process |
GO:0035690 | 0.022 | 2.766 | 3 | 7 | 38 | cellular response to drug |
GO:0045445 | 0.022 | 2.766 | 3 | 7 | 38 | myoblast differentiation |
GO:0048483 | 0.022 | 2.766 | 3 | 7 | 38 | autonomic nervous system development |
GO:0006310 | 0.023 | 1.690 | 13 | 21 | 174 | DNA recombination |
GO:0015833 | 0.023 | 1.690 | 13 | 21 | 174 | peptide transport |
GO:0001829 | 0.023 | 4.446 | 1 | 4 | 15 | trophectodermal cell differentiation |
GO:0007263 | 0.023 | 4.446 | 1 | 4 | 15 | nitric oxide mediated signal transduction |
GO:0010874 | 0.023 | 4.446 | 1 | 4 | 15 | regulation of cholesterol efflux |
GO:0010894 | 0.023 | 4.446 | 1 | 4 | 15 | negative regulation of steroid biosynthetic process |
GO:0021904 | 0.023 | 4.446 | 1 | 4 | 15 | dorsal/ventral neural tube patterning |
GO:0022011 | 0.023 | 4.446 | 1 | 4 | 15 | myelination in peripheral nervous system |
GO:0031063 | 0.023 | 4.446 | 1 | 4 | 15 | regulation of histone deacetylation |
GO:0032292 | 0.023 | 4.446 | 1 | 4 | 15 | peripheral nervous system axon ensheathment |
GO:0043304 | 0.023 | 4.446 | 1 | 4 | 15 | regulation of mast cell degranulation |
GO:0043403 | 0.023 | 4.446 | 1 | 4 | 15 | skeletal muscle tissue regeneration |
GO:0046622 | 0.023 | 4.446 | 1 | 4 | 15 | positive regulation of organ growth |
GO:0050995 | 0.023 | 4.446 | 1 | 4 | 15 | negative regulation of lipid catabolic process |
GO:0060644 | 0.023 | 4.446 | 1 | 4 | 15 | mammary gland epithelial cell differentiation |
GO:0071371 | 0.023 | 4.446 | 1 | 4 | 15 | cellular response to gonadotropin stimulus |
GO:0072283 | 0.023 | 4.446 | 1 | 4 | 15 | metanephric renal vesicle morphogenesis |
GO:2000278 | 0.023 | 4.446 | 1 | 4 | 15 | regulation of DNA biosynthetic process |
GO:2001244 | 0.023 | 4.446 | 1 | 4 | 15 | positive regulation of intrinsic apoptotic signaling pathway |
GO:0060041 | 0.023 | 1.995 | 7 | 13 | 93 | retina development in camera-type eye |
GO:0009144 | 0.023 | 1.447 | 29 | 40 | 382 | purine nucleoside triphosphate metabolic process |
GO:0009199 | 0.023 | 1.447 | 29 | 40 | 382 | ribonucleoside triphosphate metabolic process |
GO:0042445 | 0.023 | 1.771 | 11 | 18 | 143 | hormone metabolic process |
GO:0006897 | 0.023 | 1.495 | 24 | 34 | 315 | endocytosis |
GO:0031123 | 0.023 | 2.142 | 6 | 11 | 74 | RNA 3'-end processing |
GO:0006775 | 0.023 | 3.060 | 2 | 6 | 30 | fat-soluble vitamin metabolic process |
GO:0032651 | 0.023 | 3.060 | 2 | 6 | 30 | regulation of interleukin-1 beta production |
GO:0035094 | 0.023 | 3.060 | 2 | 6 | 30 | response to nicotine |
GO:0000086 | 0.023 | 1.802 | 10 | 17 | 133 | G2/M transition of mitotic cell cycle |
GO:0016358 | 0.023 | 1.932 | 8 | 14 | 103 | dendrite development |
GO:0044270 | 0.024 | 1.334 | 50 | 64 | 660 | cellular nitrogen compound catabolic process |
GO:0009880 | 0.024 | 2.514 | 4 | 8 | 47 | embryonic pattern specification |
GO:0032434 | 0.024 | 2.514 | 4 | 8 | 47 | regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0001838 | 0.024 | 2.046 | 6 | 12 | 84 | embryonic epithelial tube formation |
GO:0008064 | 0.024 | 2.046 | 6 | 12 | 84 | regulation of actin polymerization or depolymerization |
GO:0019320 | 0.024 | 2.046 | 6 | 12 | 84 | hexose catabolic process |
GO:0030073 | 0.024 | 1.757 | 11 | 18 | 144 | insulin secretion |
GO:2000021 | 0.025 | 1.786 | 10 | 17 | 134 | regulation of ion homeostasis |
GO:0046165 | 0.025 | 1.861 | 9 | 15 | 114 | alcohol biosynthetic process |
GO:0048741 | 0.025 | 2.109 | 6 | 11 | 75 | skeletal muscle fiber development |
GO:0007006 | 0.026 | 2.679 | 3 | 7 | 39 | mitochondrial membrane organization |
GO:0042733 | 0.026 | 2.679 | 3 | 7 | 39 | embryonic digit morphogenesis |
GO:0060078 | 0.026 | 2.679 | 3 | 7 | 39 | regulation of postsynaptic membrane potential |
GO:0000731 | 0.026 | 6.109 | 1 | 3 | 9 | DNA synthesis involved in DNA repair |
GO:0003161 | 0.026 | 6.109 | 1 | 3 | 9 | cardiac conduction system development |
GO:0007183 | 0.026 | 6.109 | 1 | 3 | 9 | SMAD protein complex assembly |
GO:0010944 | 0.026 | 6.109 | 1 | 3 | 9 | negative regulation of transcription by competitive promoter binding |
GO:0015732 | 0.026 | 6.109 | 1 | 3 | 9 | prostaglandin transport |
GO:0018023 | 0.026 | 6.109 | 1 | 3 | 9 | peptidyl-lysine trimethylation |
GO:0022038 | 0.026 | 6.109 | 1 | 3 | 9 | corpus callosum development |
GO:0032306 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of prostaglandin secretion |
GO:0032310 | 0.026 | 6.109 | 1 | 3 | 9 | prostaglandin secretion |
GO:0032494 | 0.026 | 6.109 | 1 | 3 | 9 | response to peptidoglycan |
GO:0033008 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of mast cell activation involved in immune response |
GO:0033327 | 0.026 | 6.109 | 1 | 3 | 9 | Leydig cell differentiation |
GO:0040034 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of development, heterochronic |
GO:0042511 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of tyrosine phosphorylation of Stat1 protein |
GO:0042789 | 0.026 | 6.109 | 1 | 3 | 9 | mRNA transcription from RNA polymerase II promoter |
GO:0043306 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of mast cell degranulation |
GO:0045628 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of T-helper 2 cell differentiation |
GO:0045655 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of monocyte differentiation |
GO:0046325 | 0.026 | 6.109 | 1 | 3 | 9 | negative regulation of glucose import |
GO:0048302 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of isotype switching to IgG isotypes |
GO:0048679 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of axon regeneration |
GO:0048711 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of astrocyte differentiation |
GO:0052173 | 0.026 | 6.109 | 1 | 3 | 9 | response to defenses of other organism involved in symbiotic interaction |
GO:0052200 | 0.026 | 6.109 | 1 | 3 | 9 | response to host defenses |
GO:0060174 | 0.026 | 6.109 | 1 | 3 | 9 | limb bud formation |
GO:0060253 | 0.026 | 6.109 | 1 | 3 | 9 | negative regulation of glial cell proliferation |
GO:0060379 | 0.026 | 6.109 | 1 | 3 | 9 | cardiac muscle cell myoblast differentiation |
GO:0060391 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of SMAD protein import into nucleus |
GO:0060872 | 0.026 | 6.109 | 1 | 3 | 9 | semicircular canal development |
GO:0061029 | 0.026 | 6.109 | 1 | 3 | 9 | eyelid development in camera-type eye |
GO:0061081 | 0.026 | 6.109 | 1 | 3 | 9 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
GO:0070102 | 0.026 | 6.109 | 1 | 3 | 9 | interleukin-6-mediated signaling pathway |
GO:0070570 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of neuron projection regeneration |
GO:0075136 | 0.026 | 6.109 | 1 | 3 | 9 | response to host |
GO:0090192 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of glomerulus development |
GO:2000008 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of protein localization to cell surface |
GO:2000036 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of stem cell maintenance |
GO:2000114 | 0.026 | 6.109 | 1 | 3 | 9 | regulation of establishment of cell polarity |
GO:0007292 | 0.026 | 2.190 | 5 | 10 | 66 | female gamete generation |
GO:0010518 | 0.026 | 2.190 | 5 | 10 | 66 | positive regulation of phospholipase activity |
GO:0022618 | 0.026 | 2.017 | 6 | 12 | 85 | ribonucleoprotein complex assembly |
GO:0030832 | 0.026 | 2.017 | 6 | 12 | 85 | regulation of actin filament length |
GO:0009164 | 0.026 | 1.451 | 27 | 37 | 352 | nucleoside catabolic process |
GO:0003230 | 0.027 | 3.398 | 2 | 5 | 23 | cardiac atrium development |
GO:0006904 | 0.027 | 3.398 | 2 | 5 | 23 | vesicle docking involved in exocytosis |
GO:0032309 | 0.027 | 3.398 | 2 | 5 | 23 | icosanoid secretion |
GO:0032856 | 0.027 | 3.398 | 2 | 5 | 23 | activation of Ras GTPase activity |
GO:0035329 | 0.027 | 3.398 | 2 | 5 | 23 | hippo signaling cascade |
GO:0042481 | 0.027 | 3.398 | 2 | 5 | 23 | regulation of odontogenesis |
GO:0045124 | 0.027 | 3.398 | 2 | 5 | 23 | regulation of bone resorption |
GO:0045739 | 0.027 | 3.398 | 2 | 5 | 23 | positive regulation of DNA repair |
GO:0071715 | 0.027 | 3.398 | 2 | 5 | 23 | icosanoid transport |
GO:1901571 | 0.027 | 3.398 | 2 | 5 | 23 | fatty acid derivative transport |
GO:0001938 | 0.027 | 2.450 | 4 | 8 | 48 | positive regulation of endothelial cell proliferation |
GO:0010863 | 0.027 | 2.298 | 4 | 9 | 57 | positive regulation of phospholipase C activity |
GO:0031279 | 0.027 | 2.298 | 4 | 9 | 57 | regulation of cyclase activity |
GO:0060048 | 0.027 | 2.298 | 4 | 9 | 57 | cardiac muscle contraction |
GO:0009409 | 0.027 | 2.938 | 2 | 6 | 31 | response to cold |
GO:0042992 | 0.027 | 2.938 | 2 | 6 | 31 | negative regulation of transcription factor import into nucleus |
GO:0072676 | 0.027 | 2.938 | 2 | 6 | 31 | lymphocyte migration |
GO:0030336 | 0.027 | 1.843 | 9 | 15 | 115 | negative regulation of cell migration |
GO:0006875 | 0.028 | 1.500 | 22 | 31 | 286 | cellular metal ion homeostasis |
GO:0019752 | 0.028 | 1.305 | 55 | 69 | 726 | carboxylic acid metabolic process |
GO:0003416 | 0.029 | 4.075 | 1 | 4 | 16 | endochondral bone growth |
GO:0007520 | 0.029 | 4.075 | 1 | 4 | 16 | myoblast fusion |
GO:0030823 | 0.029 | 4.075 | 1 | 4 | 16 | regulation of cGMP metabolic process |
GO:0033006 | 0.029 | 4.075 | 1 | 4 | 16 | regulation of mast cell activation involved in immune response |
GO:0033688 | 0.029 | 4.075 | 1 | 4 | 16 | regulation of osteoblast proliferation |
GO:0042119 | 0.029 | 4.075 | 1 | 4 | 16 | neutrophil activation |
GO:0045939 | 0.029 | 4.075 | 1 | 4 | 16 | negative regulation of steroid metabolic process |
GO:0060251 | 0.029 | 4.075 | 1 | 4 | 16 | regulation of glial cell proliferation |
GO:0070059 | 0.029 | 4.075 | 1 | 4 | 16 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO:0071514 | 0.029 | 4.075 | 1 | 4 | 16 | genetic imprinting |
GO:0090190 | 0.029 | 4.075 | 1 | 4 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:2000142 | 0.029 | 4.075 | 1 | 4 | 16 | regulation of DNA-dependent transcription, initiation |
GO:0010594 | 0.029 | 2.151 | 5 | 10 | 67 | regulation of endothelial cell migration |
GO:0043414 | 0.029 | 1.923 | 7 | 13 | 96 | macromolecule methylation |
GO:0060191 | 0.029 | 1.923 | 7 | 13 | 96 | regulation of lipase activity |
GO:0006633 | 0.029 | 1.869 | 8 | 14 | 106 | fatty acid biosynthetic process |
GO:0002260 | 0.029 | 2.598 | 3 | 7 | 40 | lymphocyte homeostasis |
GO:0061387 | 0.029 | 2.598 | 3 | 7 | 40 | regulation of extent of cell growth |
GO:0051346 | 0.029 | 1.600 | 15 | 23 | 200 | negative regulation of hydrolase activity |
GO:0051339 | 0.030 | 2.251 | 4 | 9 | 58 | regulation of lyase activity |
GO:0051591 | 0.030 | 2.251 | 4 | 9 | 58 | response to cAMP |
GO:1900274 | 0.030 | 2.251 | 4 | 9 | 58 | regulation of phospholipase C activity |
GO:0002690 | 0.030 | 2.390 | 4 | 8 | 49 | positive regulation of leukocyte chemotaxis |
GO:0009165 | 0.030 | 1.533 | 19 | 27 | 244 | nucleotide biosynthetic process |
GO:1901658 | 0.031 | 1.433 | 27 | 37 | 356 | glycosyl compound catabolic process |
GO:0046365 | 0.031 | 1.963 | 7 | 12 | 87 | monosaccharide catabolic process |
GO:0071826 | 0.031 | 1.963 | 7 | 12 | 87 | ribonucleoprotein complex subunit organization |
GO:0022406 | 0.031 | 2.824 | 2 | 6 | 32 | membrane docking |
GO:0032481 | 0.031 | 2.824 | 2 | 6 | 32 | positive regulation of type I interferon production |
GO:0033344 | 0.031 | 2.824 | 2 | 6 | 32 | cholesterol efflux |
GO:0048009 | 0.031 | 2.824 | 2 | 6 | 32 | insulin-like growth factor receptor signaling pathway |
GO:0060038 | 0.031 | 2.824 | 2 | 6 | 32 | cardiac muscle cell proliferation |
GO:0070830 | 0.031 | 2.824 | 2 | 6 | 32 | tight junction assembly |
GO:0003001 | 0.031 | 1.473 | 23 | 32 | 300 | generation of a signal involved in cell-cell signaling |
GO:0023061 | 0.031 | 1.473 | 23 | 32 | 300 | signal release |
GO:0000710 | 0.031 | 12.208 | 0 | 2 | 4 | meiotic mismatch repair |
GO:0001547 | 0.031 | 12.208 | 0 | 2 | 4 | antral ovarian follicle growth |
GO:0002227 | 0.031 | 12.208 | 0 | 2 | 4 | innate immune response in mucosa |
GO:0002309 | 0.031 | 12.208 | 0 | 2 | 4 | T cell proliferation involved in immune response |
GO:0002318 | 0.031 | 12.208 | 0 | 2 | 4 | myeloid progenitor cell differentiation |
GO:0002439 | 0.031 | 12.208 | 0 | 2 | 4 | chronic inflammatory response to antigenic stimulus |
GO:0002513 | 0.031 | 12.208 | 0 | 2 | 4 | tolerance induction to self antigen |
GO:0002677 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of chronic inflammatory response |
GO:0002678 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of chronic inflammatory response |
GO:0003032 | 0.031 | 12.208 | 0 | 2 | 4 | detection of oxygen |
GO:0003413 | 0.031 | 12.208 | 0 | 2 | 4 | chondrocyte differentiation involved in endochondral bone morphogenesis |
GO:0007354 | 0.031 | 12.208 | 0 | 2 | 4 | zygotic determination of anterior/posterior axis, embryo |
GO:0009730 | 0.031 | 12.208 | 0 | 2 | 4 | detection of carbohydrate stimulus |
GO:0009732 | 0.031 | 12.208 | 0 | 2 | 4 | detection of hexose stimulus |
GO:0009912 | 0.031 | 12.208 | 0 | 2 | 4 | auditory receptor cell fate commitment |
GO:0010216 | 0.031 | 12.208 | 0 | 2 | 4 | maintenance of DNA methylation |
GO:0010748 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of plasma membrane long-chain fatty acid transport |
GO:0010957 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of vitamin D biosynthetic process |
GO:0014805 | 0.031 | 12.208 | 0 | 2 | 4 | smooth muscle adaptation |
GO:0016199 | 0.031 | 12.208 | 0 | 2 | 4 | axon midline choice point recognition |
GO:0016242 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of macroautophagy |
GO:0021800 | 0.031 | 12.208 | 0 | 2 | 4 | cerebral cortex tangential migration |
GO:0021891 | 0.031 | 12.208 | 0 | 2 | 4 | olfactory bulb interneuron development |
GO:0030222 | 0.031 | 12.208 | 0 | 2 | 4 | eosinophil differentiation |
GO:0032070 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of deoxyribonuclease activity |
GO:0032430 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of phospholipase A2 activity |
GO:0032754 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of interleukin-5 production |
GO:0032763 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of mast cell cytokine production |
GO:0033087 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of immature T cell proliferation |
GO:0033088 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of immature T cell proliferation in thymus |
GO:0034287 | 0.031 | 12.208 | 0 | 2 | 4 | detection of monosaccharide stimulus |
GO:0035278 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of translation involved in gene silencing by miRNA |
GO:0035728 | 0.031 | 12.208 | 0 | 2 | 4 | response to hepatocyte growth factor stimulus |
GO:0035729 | 0.031 | 12.208 | 0 | 2 | 4 | cellular response to hepatocyte growth factor stimulus |
GO:0035787 | 0.031 | 12.208 | 0 | 2 | 4 | cell migration involved in kidney development |
GO:0035788 | 0.031 | 12.208 | 0 | 2 | 4 | cell migration involved in metanephros development |
GO:0035789 | 0.031 | 12.208 | 0 | 2 | 4 | metanephric mesenchymal cell migration |
GO:0035799 | 0.031 | 12.208 | 0 | 2 | 4 | ureter maturation |
GO:0036017 | 0.031 | 12.208 | 0 | 2 | 4 | response to erythropoietin |
GO:0036018 | 0.031 | 12.208 | 0 | 2 | 4 | cellular response to erythropoietin |
GO:0038033 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway |
GO:0038083 | 0.031 | 12.208 | 0 | 2 | 4 | peptidyl-tyrosine autophosphorylation |
GO:0040033 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of translation, ncRNA-mediated |
GO:0042518 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of tyrosine phosphorylation of Stat3 protein |
GO:0045113 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of integrin biosynthetic process |
GO:0045974 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of translation, ncRNA-mediated |
GO:0046668 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of retinal cell programmed cell death |
GO:0048170 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of long-term neuronal synaptic plasticity |
GO:0048681 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of axon regeneration |
GO:0048702 | 0.031 | 12.208 | 0 | 2 | 4 | embryonic neurocranium morphogenesis |
GO:0048799 | 0.031 | 12.208 | 0 | 2 | 4 | organ maturation |
GO:0051045 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of membrane protein ectodomain proteolysis |
GO:0051534 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of NFAT protein import into nucleus |
GO:0051547 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of keratinocyte migration |
GO:0051549 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of keratinocyte migration |
GO:0051594 | 0.031 | 12.208 | 0 | 2 | 4 | detection of glucose |
GO:0051712 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of killing of cells of other organism |
GO:0060011 | 0.031 | 12.208 | 0 | 2 | 4 | Sertoli cell proliferation |
GO:0060120 | 0.031 | 12.208 | 0 | 2 | 4 | inner ear receptor cell fate commitment |
GO:0060164 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of timing of neuron differentiation |
GO:0060364 | 0.031 | 12.208 | 0 | 2 | 4 | frontal suture morphogenesis |
GO:0060421 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of heart growth |
GO:0060528 | 0.031 | 12.208 | 0 | 2 | 4 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development |
GO:0060708 | 0.031 | 12.208 | 0 | 2 | 4 | spongiotrophoblast differentiation |
GO:0060743 | 0.031 | 12.208 | 0 | 2 | 4 | epithelial cell maturation involved in prostate gland development |
GO:0060750 | 0.031 | 12.208 | 0 | 2 | 4 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:0061325 | 0.031 | 12.208 | 0 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070100 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of chemokine-mediated signaling pathway |
GO:0070427 | 0.031 | 12.208 | 0 | 2 | 4 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
GO:0070487 | 0.031 | 12.208 | 0 | 2 | 4 | monocyte aggregation |
GO:0070571 | 0.031 | 12.208 | 0 | 2 | 4 | negative regulation of neuron projection regeneration |
GO:0070662 | 0.031 | 12.208 | 0 | 2 | 4 | mast cell proliferation |
GO:0071481 | 0.031 | 12.208 | 0 | 2 | 4 | cellular response to X-ray |
GO:0071679 | 0.031 | 12.208 | 0 | 2 | 4 | commissural neuron axon guidance |
GO:0072584 | 0.031 | 12.208 | 0 | 2 | 4 | caveolin-mediated endocytosis |
GO:0072602 | 0.031 | 12.208 | 0 | 2 | 4 | interleukin-4 secretion |
GO:0090170 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of Golgi inheritance |
GO:0090237 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of arachidonic acid secretion |
GO:2000049 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:2000291 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of myoblast proliferation |
GO:2000319 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of T-helper 17 cell differentiation |
GO:2000345 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of hepatocyte proliferation |
GO:2000503 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of natural killer cell chemotaxis |
GO:2000589 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of metanephric mesenchymal cell migration |
GO:2001023 | 0.031 | 12.208 | 0 | 2 | 4 | regulation of response to drug |
GO:2001028 | 0.031 | 12.208 | 0 | 2 | 4 | positive regulation of endothelial cell chemotaxis |
GO:0042454 | 0.031 | 1.439 | 26 | 36 | 345 | ribonucleoside catabolic process |
GO:0008154 | 0.031 | 1.848 | 8 | 14 | 107 | actin polymerization or depolymerization |
GO:0001954 | 0.031 | 3.219 | 2 | 5 | 24 | positive regulation of cell-matrix adhesion |
GO:0001960 | 0.031 | 3.219 | 2 | 5 | 24 | negative regulation of cytokine-mediated signaling pathway |
GO:0030325 | 0.031 | 3.219 | 2 | 5 | 24 | adrenal gland development |
GO:0042596 | 0.031 | 3.219 | 2 | 5 | 24 | fear response |
GO:0045600 | 0.031 | 3.219 | 2 | 5 | 24 | positive regulation of fat cell differentiation |
GO:0045933 | 0.031 | 3.219 | 2 | 5 | 24 | positive regulation of muscle contraction |
GO:0048384 | 0.031 | 3.219 | 2 | 5 | 24 | retinoic acid receptor signaling pathway |
GO:0050650 | 0.031 | 3.219 | 2 | 5 | 24 | chondroitin sulfate proteoglycan biosynthetic process |
GO:0050690 | 0.031 | 3.219 | 2 | 5 | 24 | regulation of defense response to virus by virus |
GO:0060043 | 0.031 | 3.219 | 2 | 5 | 24 | regulation of cardiac muscle cell proliferation |
GO:0050796 | 0.033 | 1.755 | 10 | 16 | 128 | regulation of insulin secretion |
GO:0006611 | 0.033 | 2.521 | 3 | 7 | 41 | protein export from nucleus |
GO:0006940 | 0.033 | 2.521 | 3 | 7 | 41 | regulation of smooth muscle contraction |
GO:0045055 | 0.033 | 2.521 | 3 | 7 | 41 | regulated secretory pathway |
GO:0050807 | 0.033 | 2.521 | 3 | 7 | 41 | regulation of synapse organization |
GO:0090257 | 0.033 | 1.788 | 9 | 15 | 118 | regulation of muscle system process |
GO:1901293 | 0.033 | 1.519 | 19 | 27 | 246 | nucleoside phosphate biosynthetic process |
GO:0006304 | 0.033 | 2.333 | 4 | 8 | 50 | DNA modification |
GO:0010506 | 0.033 | 2.333 | 4 | 8 | 50 | regulation of autophagy |
GO:0015908 | 0.033 | 2.333 | 4 | 8 | 50 | fatty acid transport |
GO:0051297 | 0.033 | 2.333 | 4 | 8 | 50 | centrosome organization |
GO:0072657 | 0.033 | 1.937 | 7 | 12 | 88 | protein localization to membrane |
GO:0042886 | 0.033 | 1.615 | 14 | 21 | 181 | amide transport |
GO:0072523 | 0.033 | 1.409 | 29 | 39 | 381 | purine-containing compound catabolic process |
GO:0044723 | 0.034 | 1.368 | 35 | 46 | 462 | single-organism carbohydrate metabolic process |
GO:0009798 | 0.034 | 2.078 | 5 | 10 | 69 | axis specification |
GO:0060333 | 0.034 | 2.078 | 5 | 10 | 69 | interferon-gamma-mediated signaling pathway |
GO:0001542 | 0.035 | 5.236 | 1 | 3 | 10 | ovulation from ovarian follicle |
GO:0003272 | 0.035 | 5.236 | 1 | 3 | 10 | endocardial cushion formation |
GO:0006349 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of gene expression by genetic imprinting |
GO:0009404 | 0.035 | 5.236 | 1 | 3 | 10 | toxin metabolic process |
GO:0030205 | 0.035 | 5.236 | 1 | 3 | 10 | dermatan sulfate metabolic process |
GO:0030208 | 0.035 | 5.236 | 1 | 3 | 10 | dermatan sulfate biosynthetic process |
GO:0032695 | 0.035 | 5.236 | 1 | 3 | 10 | negative regulation of interleukin-12 production |
GO:0032740 | 0.035 | 5.236 | 1 | 3 | 10 | positive regulation of interleukin-17 production |
GO:0034114 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of heterotypic cell-cell adhesion |
GO:0035024 | 0.035 | 5.236 | 1 | 3 | 10 | negative regulation of Rho protein signal transduction |
GO:0035357 | 0.035 | 5.236 | 1 | 3 | 10 | peroxisome proliferator activated receptor signaling pathway |
GO:0043302 | 0.035 | 5.236 | 1 | 3 | 10 | positive regulation of leukocyte degranulation |
GO:0045717 | 0.035 | 5.236 | 1 | 3 | 10 | negative regulation of fatty acid biosynthetic process |
GO:0045749 | 0.035 | 5.236 | 1 | 3 | 10 | negative regulation of S phase of mitotic cell cycle |
GO:0045780 | 0.035 | 5.236 | 1 | 3 | 10 | positive regulation of bone resorption |
GO:0046852 | 0.035 | 5.236 | 1 | 3 | 10 | positive regulation of bone remodeling |
GO:0048291 | 0.035 | 5.236 | 1 | 3 | 10 | isotype switching to IgG isotypes |
GO:0051567 | 0.035 | 5.236 | 1 | 3 | 10 | histone H3-K9 methylation |
GO:0051797 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of hair follicle development |
GO:0060033 | 0.035 | 5.236 | 1 | 3 | 10 | anatomical structure regression |
GO:0060123 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of growth hormone secretion |
GO:0060707 | 0.035 | 5.236 | 1 | 3 | 10 | trophoblast giant cell differentiation |
GO:0070587 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of cell-cell adhesion involved in gastrulation |
GO:0071675 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of mononuclear cell migration |
GO:0090184 | 0.035 | 5.236 | 1 | 3 | 10 | positive regulation of kidney development |
GO:0090399 | 0.035 | 5.236 | 1 | 3 | 10 | replicative senescence |
GO:2000380 | 0.035 | 5.236 | 1 | 3 | 10 | regulation of mesoderm development |
GO:2000757 | 0.035 | 5.236 | 1 | 3 | 10 | negative regulation of peptidyl-lysine acetylation |
GO:0006152 | 0.035 | 1.430 | 26 | 35 | 337 | purine nucleoside catabolic process |
GO:0046130 | 0.035 | 1.430 | 26 | 35 | 337 | purine ribonucleoside catabolic process |
GO:0006298 | 0.035 | 3.761 | 1 | 4 | 17 | mismatch repair |
GO:0014044 | 0.035 | 3.761 | 1 | 4 | 17 | Schwann cell development |
GO:0032757 | 0.035 | 3.761 | 1 | 4 | 17 | positive regulation of interleukin-8 production |
GO:0043277 | 0.035 | 3.761 | 1 | 4 | 17 | apoptotic cell clearance |
GO:0060395 | 0.035 | 3.761 | 1 | 4 | 17 | SMAD protein signal transduction |
GO:0090103 | 0.035 | 3.761 | 1 | 4 | 17 | cochlea morphogenesis |
GO:2000779 | 0.035 | 3.761 | 1 | 4 | 17 | regulation of double-strand break repair |
GO:2001234 | 0.035 | 3.761 | 1 | 4 | 17 | negative regulation of apoptotic signaling pathway |
GO:1901135 | 0.035 | 1.238 | 82 | 98 | 1085 | carbohydrate derivative metabolic process |
GO:0071779 | 0.035 | 1.984 | 6 | 11 | 79 | G1/S transition checkpoint |
GO:0045670 | 0.036 | 2.720 | 3 | 6 | 33 | regulation of osteoclast differentiation |
GO:0000910 | 0.036 | 1.912 | 7 | 12 | 89 | cytokinesis |
GO:0048747 | 0.036 | 1.912 | 7 | 12 | 89 | muscle fiber development |
GO:0019228 | 0.036 | 1.855 | 8 | 13 | 99 | regulation of action potential in neuron |
GO:0042391 | 0.036 | 1.505 | 19 | 27 | 248 | regulation of membrane potential |
GO:0009141 | 0.036 | 1.392 | 30 | 40 | 395 | nucleoside triphosphate metabolic process |
GO:0042787 | 0.037 | 2.279 | 4 | 8 | 51 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0090263 | 0.037 | 2.449 | 3 | 7 | 42 | positive regulation of canonical Wnt receptor signaling pathway |
GO:0010631 | 0.037 | 3.058 | 2 | 5 | 25 | epithelial cell migration |
GO:0021879 | 0.037 | 3.058 | 2 | 5 | 25 | forebrain neuron differentiation |
GO:0030514 | 0.037 | 3.058 | 2 | 5 | 25 | negative regulation of BMP signaling pathway |
GO:0032924 | 0.037 | 3.058 | 2 | 5 | 25 | activin receptor signaling pathway |
GO:0040018 | 0.037 | 3.058 | 2 | 5 | 25 | positive regulation of multicellular organism growth |
GO:0045620 | 0.037 | 3.058 | 2 | 5 | 25 | negative regulation of lymphocyte differentiation |
GO:0048278 | 0.037 | 3.058 | 2 | 5 | 25 | vesicle docking |
GO:0070873 | 0.037 | 3.058 | 2 | 5 | 25 | regulation of glycogen metabolic process |
GO:0090132 | 0.037 | 3.058 | 2 | 5 | 25 | epithelium migration |
GO:0007005 | 0.037 | 1.574 | 15 | 22 | 194 | mitochondrion organization |
GO:0006921 | 0.038 | 2.043 | 5 | 10 | 70 | cellular component disassembly involved in execution phase of apoptosis |
GO:0046683 | 0.038 | 1.955 | 6 | 11 | 80 | response to organophosphorus |
GO:0009203 | 0.038 | 1.427 | 25 | 34 | 328 | ribonucleoside triphosphate catabolic process |
GO:0009207 | 0.038 | 1.427 | 25 | 34 | 328 | purine ribonucleoside triphosphate catabolic process |
GO:0006066 | 0.039 | 1.480 | 20 | 28 | 261 | alcohol metabolic process |
GO:0048813 | 0.039 | 2.121 | 5 | 9 | 61 | dendrite morphogenesis |
GO:0009146 | 0.040 | 1.422 | 25 | 34 | 329 | purine nucleoside triphosphate catabolic process |
GO:0005978 | 0.040 | 2.622 | 3 | 6 | 34 | glycogen biosynthetic process |
GO:0007052 | 0.040 | 2.622 | 3 | 6 | 34 | mitotic spindle organization |
GO:0009250 | 0.040 | 2.622 | 3 | 6 | 34 | glucan biosynthetic process |
GO:0045168 | 0.040 | 2.622 | 3 | 6 | 34 | cell-cell signaling involved in cell fate commitment |
GO:0055013 | 0.040 | 2.622 | 3 | 6 | 34 | cardiac muscle cell development |
GO:0060113 | 0.040 | 2.622 | 3 | 6 | 34 | inner ear receptor cell differentiation |
GO:0050434 | 0.041 | 2.227 | 4 | 8 | 52 | positive regulation of viral transcription |
GO:0006091 | 0.041 | 1.384 | 29 | 39 | 387 | generation of precursor metabolites and energy |
GO:0009260 | 0.041 | 1.555 | 15 | 22 | 196 | ribonucleotide biosynthetic process |
GO:0002275 | 0.041 | 2.380 | 3 | 7 | 43 | myeloid cell activation involved in immune response |
GO:0031032 | 0.041 | 2.380 | 3 | 7 | 43 | actomyosin structure organization |
GO:0002685 | 0.042 | 1.927 | 6 | 11 | 81 | regulation of leukocyte migration |
GO:0051259 | 0.042 | 1.458 | 21 | 29 | 274 | protein oligomerization |
GO:0001516 | 0.043 | 3.492 | 1 | 4 | 18 | prostaglandin biosynthetic process |
GO:0002076 | 0.043 | 3.492 | 1 | 4 | 18 | osteoblast development |
GO:0002407 | 0.043 | 3.492 | 1 | 4 | 18 | dendritic cell chemotaxis |
GO:0010799 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of peptidyl-threonine phosphorylation |
GO:0021871 | 0.043 | 3.492 | 1 | 4 | 18 | forebrain regionalization |
GO:0030449 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of complement activation |
GO:0032925 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of activin receptor signaling pathway |
GO:0033687 | 0.043 | 3.492 | 1 | 4 | 18 | osteoblast proliferation |
GO:0036336 | 0.043 | 3.492 | 1 | 4 | 18 | dendritic cell migration |
GO:0043330 | 0.043 | 3.492 | 1 | 4 | 18 | response to exogenous dsRNA |
GO:0045581 | 0.043 | 3.492 | 1 | 4 | 18 | negative regulation of T cell differentiation |
GO:0046457 | 0.043 | 3.492 | 1 | 4 | 18 | prostanoid biosynthetic process |
GO:0046640 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of alpha-beta T cell proliferation |
GO:0051491 | 0.043 | 3.492 | 1 | 4 | 18 | positive regulation of filopodium assembly |
GO:0051926 | 0.043 | 3.492 | 1 | 4 | 18 | negative regulation of calcium ion transport |
GO:0060045 | 0.043 | 3.492 | 1 | 4 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:0070527 | 0.043 | 3.492 | 1 | 4 | 18 | platelet aggregation |
GO:0070741 | 0.043 | 3.492 | 1 | 4 | 18 | response to interleukin-6 |
GO:0071604 | 0.043 | 3.492 | 1 | 4 | 18 | transforming growth factor beta production |
GO:0071634 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of transforming growth factor beta production |
GO:2000257 | 0.043 | 3.492 | 1 | 4 | 18 | regulation of protein activation cascade |
GO:0009152 | 0.043 | 1.565 | 14 | 21 | 186 | purine ribonucleotide biosynthetic process |
GO:0015849 | 0.043 | 1.565 | 14 | 21 | 186 | organic acid transport |
GO:0046942 | 0.043 | 1.565 | 14 | 21 | 186 | carboxylic acid transport |
GO:0002762 | 0.043 | 2.912 | 2 | 5 | 26 | negative regulation of myeloid leukocyte differentiation |
GO:0010743 | 0.043 | 2.912 | 2 | 5 | 26 | regulation of macrophage derived foam cell differentiation |
GO:0015682 | 0.043 | 2.912 | 2 | 5 | 26 | ferric iron transport |
GO:0030212 | 0.043 | 2.912 | 2 | 5 | 26 | hyaluronan metabolic process |
GO:0030318 | 0.043 | 2.912 | 2 | 5 | 26 | melanocyte differentiation |
GO:0030501 | 0.043 | 2.912 | 2 | 5 | 26 | positive regulation of bone mineralization |
GO:0033572 | 0.043 | 2.912 | 2 | 5 | 26 | transferrin transport |
GO:0046850 | 0.043 | 2.912 | 2 | 5 | 26 | regulation of bone remodeling |
GO:0050931 | 0.043 | 2.912 | 2 | 5 | 26 | pigment cell differentiation |
GO:0072512 | 0.043 | 2.912 | 2 | 5 | 26 | trivalent inorganic cation transport |
GO:0007229 | 0.043 | 2.080 | 5 | 9 | 62 | integrin-mediated signaling pathway |
GO:0007613 | 0.043 | 2.080 | 5 | 9 | 62 | memory |
GO:0006368 | 0.044 | 1.977 | 5 | 10 | 72 | transcription elongation from RNA polymerase II promoter |
GO:0006941 | 0.045 | 1.899 | 6 | 11 | 82 | striated muscle contraction |
GO:0010469 | 0.045 | 2.177 | 4 | 8 | 53 | regulation of receptor activity |
GO:0002768 | 0.045 | 1.705 | 9 | 15 | 123 | immune response-regulating cell surface receptor signaling pathway |
GO:0003214 | 0.045 | 4.581 | 1 | 3 | 11 | cardiac left ventricle morphogenesis |
GO:0007099 | 0.045 | 4.581 | 1 | 3 | 11 | centriole replication |
GO:0010591 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of lamellipodium assembly |
GO:0021783 | 0.045 | 4.581 | 1 | 3 | 11 | preganglionic parasympathetic nervous system development |
GO:0021903 | 0.045 | 4.581 | 1 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0031649 | 0.045 | 4.581 | 1 | 3 | 11 | heat generation |
GO:0031664 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of lipopolysaccharide-mediated signaling pathway |
GO:0032305 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of icosanoid secretion |
GO:0032354 | 0.045 | 4.581 | 1 | 3 | 11 | response to follicle-stimulating hormone stimulus |
GO:0032769 | 0.045 | 4.581 | 1 | 3 | 11 | negative regulation of monooxygenase activity |
GO:0032793 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of CREB transcription factor activity |
GO:0032968 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of transcription elongation from RNA polymerase II promoter |
GO:0033005 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of mast cell activation |
GO:0036315 | 0.045 | 4.581 | 1 | 3 | 11 | cellular response to sterol |
GO:0042640 | 0.045 | 4.581 | 1 | 3 | 11 | anagen |
GO:0043923 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation by host of viral transcription |
GO:0045408 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of interleukin-6 biosynthetic process |
GO:0046621 | 0.045 | 4.581 | 1 | 3 | 11 | negative regulation of organ growth |
GO:0046639 | 0.045 | 4.581 | 1 | 3 | 11 | negative regulation of alpha-beta T cell differentiation |
GO:0051894 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of focal adhesion assembly |
GO:0060390 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of SMAD protein import into nucleus |
GO:0060438 | 0.045 | 4.581 | 1 | 3 | 11 | trachea development |
GO:0070586 | 0.045 | 4.581 | 1 | 3 | 11 | cell-cell adhesion involved in gastrulation |
GO:0071397 | 0.045 | 4.581 | 1 | 3 | 11 | cellular response to cholesterol |
GO:0071674 | 0.045 | 4.581 | 1 | 3 | 11 | mononuclear cell migration |
GO:0090030 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of steroid hormone biosynthetic process |
GO:0097178 | 0.045 | 4.581 | 1 | 3 | 11 | ruffle assembly |
GO:1900115 | 0.045 | 4.581 | 1 | 3 | 11 | extracellular regulation of signal transduction |
GO:1900116 | 0.045 | 4.581 | 1 | 3 | 11 | extracellular negative regulation of signal transduction |
GO:1901890 | 0.045 | 4.581 | 1 | 3 | 11 | positive regulation of cell junction assembly |
GO:2000310 | 0.045 | 4.581 | 1 | 3 | 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0043623 | 0.046 | 1.446 | 21 | 29 | 276 | cellular protein complex assembly |
GO:0006508 | 0.046 | 1.266 | 57 | 69 | 745 | proteolysis |
GO:0006284 | 0.046 | 2.531 | 3 | 6 | 35 | base-excision repair |
GO:0031281 | 0.046 | 2.531 | 3 | 6 | 35 | positive regulation of cyclase activity |
GO:0045778 | 0.046 | 2.531 | 3 | 6 | 35 | positive regulation of ossification |
GO:2001251 | 0.046 | 2.531 | 3 | 6 | 35 | negative regulation of chromosome organization |
GO:0007017 | 0.046 | 1.402 | 25 | 34 | 333 | microtubule-based process |
GO:0050803 | 0.046 | 2.316 | 3 | 7 | 44 | regulation of synapse structure and activity |
GO:0006195 | 0.046 | 1.375 | 29 | 38 | 379 | purine nucleotide catabolic process |
GO:0035023 | 0.047 | 1.665 | 10 | 16 | 134 | regulation of Rho protein signal transduction |
GO:0006937 | 0.047 | 1.772 | 8 | 13 | 103 | regulation of muscle contraction |
GO:0009143 | 0.048 | 1.397 | 25 | 34 | 334 | nucleoside triphosphate catabolic process |
GO:0072329 | 0.048 | 1.945 | 6 | 10 | 73 | monocarboxylic acid catabolic process |
GO:0035303 | 0.048 | 1.873 | 6 | 11 | 83 | regulation of dephosphorylation |
GO:0009166 | 0.048 | 1.363 | 30 | 39 | 392 | nucleotide catabolic process |
GO:0055065 | 0.049 | 1.408 | 24 | 32 | 312 | metal ion homeostasis |
GO:0001866 | 0.049 | 8.138 | 0 | 2 | 5 | NK T cell proliferation |
GO:0001880 | 0.049 | 8.138 | 0 | 2 | 5 | Mullerian duct regression |
GO:0001957 | 0.049 | 8.138 | 0 | 2 | 5 | intramembranous ossification |
GO:0002326 | 0.049 | 8.138 | 0 | 2 | 5 | B cell lineage commitment |
GO:0002740 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of cytokine secretion involved in immune response |
GO:0002829 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of type 2 immune response |
GO:0003183 | 0.049 | 8.138 | 0 | 2 | 5 | mitral valve morphogenesis |
GO:0005984 | 0.049 | 8.138 | 0 | 2 | 5 | disaccharide metabolic process |
GO:0007035 | 0.049 | 8.138 | 0 | 2 | 5 | vacuolar acidification |
GO:0010042 | 0.049 | 8.138 | 0 | 2 | 5 | response to manganese ion |
GO:0010534 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of activation of JAK2 kinase activity |
GO:0010535 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of activation of JAK2 kinase activity |
GO:0010592 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of lamellipodium assembly |
GO:0010624 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of Schwann cell proliferation |
GO:0010746 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of plasma membrane long-chain fatty acid transport |
GO:0010832 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of myotube differentiation |
GO:0010871 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of receptor biosynthetic process |
GO:0014874 | 0.049 | 8.138 | 0 | 2 | 5 | response to stimulus involved in regulation of muscle adaptation |
GO:0021779 | 0.049 | 8.138 | 0 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021924 | 0.049 | 8.138 | 0 | 2 | 5 | cell proliferation in external granule layer |
GO:0021930 | 0.049 | 8.138 | 0 | 2 | 5 | cerebellar granule cell precursor proliferation |
GO:0030011 | 0.049 | 8.138 | 0 | 2 | 5 | maintenance of cell polarity |
GO:0031394 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of prostaglandin biosynthetic process |
GO:0031953 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of protein autophosphorylation |
GO:0032119 | 0.049 | 8.138 | 0 | 2 | 5 | sequestering of zinc ion |
GO:0032516 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of phosphoprotein phosphatase activity |
GO:0032725 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0032747 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of interleukin-23 production |
GO:0033129 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of histone phosphorylation |
GO:0034112 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
GO:0034244 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of transcription elongation from RNA polymerase II promoter |
GO:0034393 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of smooth muscle cell apoptotic process |
GO:0035791 | 0.049 | 8.138 | 0 | 2 | 5 | platelet-derived growth factor receptor-beta signaling pathway |
GO:0035988 | 0.049 | 8.138 | 0 | 2 | 5 | chondrocyte proliferation |
GO:0036072 | 0.049 | 8.138 | 0 | 2 | 5 | direct ossification |
GO:0038089 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway |
GO:0038107 | 0.049 | 8.138 | 0 | 2 | 5 | nodal signaling pathway involved in determination of left/right asymmetry |
GO:0042421 | 0.049 | 8.138 | 0 | 2 | 5 | norepinephrine biosynthetic process |
GO:0042761 | 0.049 | 8.138 | 0 | 2 | 5 | very long-chain fatty acid biosynthetic process |
GO:0043301 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of leukocyte degranulation |
GO:0043379 | 0.049 | 8.138 | 0 | 2 | 5 | memory T cell differentiation |
GO:0043380 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of memory T cell differentiation |
GO:0044030 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of DNA methylation |
GO:0045112 | 0.049 | 8.138 | 0 | 2 | 5 | integrin biosynthetic process |
GO:0045605 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of epidermal cell differentiation |
GO:0045634 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of melanocyte differentiation |
GO:0045657 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of monocyte differentiation |
GO:0045820 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of glycolysis |
GO:0045955 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of calcium ion-dependent exocytosis |
GO:0046137 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of vitamin metabolic process |
GO:0048102 | 0.049 | 8.138 | 0 | 2 | 5 | autophagic cell death |
GO:0048552 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of metalloenzyme activity |
GO:0048554 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of metalloenzyme activity |
GO:0050932 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of pigment cell differentiation |
GO:0051709 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of killing of cells of other organism |
GO:0052031 | 0.049 | 8.138 | 0 | 2 | 5 | modulation by symbiont of host defense response |
GO:0052255 | 0.049 | 8.138 | 0 | 2 | 5 | modulation by organism of defense response of other organism involved in symbiotic interaction |
GO:0052509 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation by symbiont of host defense response |
GO:0052510 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation by organism of defense response of other organism involved in symbiotic interaction |
GO:0060019 | 0.049 | 8.138 | 0 | 2 | 5 | radial glial cell differentiation |
GO:0060044 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of cardiac muscle cell proliferation |
GO:0060126 | 0.049 | 8.138 | 0 | 2 | 5 | somatotropin secreting cell differentiation |
GO:0060452 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of cardiac muscle contraction |
GO:0060510 | 0.049 | 8.138 | 0 | 2 | 5 | Type II pneumocyte differentiation |
GO:0060605 | 0.049 | 8.138 | 0 | 2 | 5 | tube lumen cavitation |
GO:0060662 | 0.049 | 8.138 | 0 | 2 | 5 | salivary gland cavitation |
GO:0060745 | 0.049 | 8.138 | 0 | 2 | 5 | mammary gland branching involved in pregnancy |
GO:0060789 | 0.049 | 8.138 | 0 | 2 | 5 | hair follicle placode formation |
GO:0061003 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of dendritic spine morphogenesis |
GO:0070234 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of T cell apoptotic process |
GO:0070424 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0070857 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of bile acid biosynthetic process |
GO:0070986 | 0.049 | 8.138 | 0 | 2 | 5 | left/right axis specification |
GO:0071361 | 0.049 | 8.138 | 0 | 2 | 5 | cellular response to ethanol |
GO:0071503 | 0.049 | 8.138 | 0 | 2 | 5 | response to heparin |
GO:0071504 | 0.049 | 8.138 | 0 | 2 | 5 | cellular response to heparin |
GO:0071680 | 0.049 | 8.138 | 0 | 2 | 5 | response to indole-3-methanol |
GO:0071681 | 0.049 | 8.138 | 0 | 2 | 5 | cellular response to indole-3-methanol |
GO:0072049 | 0.049 | 8.138 | 0 | 2 | 5 | comma-shaped body morphogenesis |
GO:0072103 | 0.049 | 8.138 | 0 | 2 | 5 | glomerulus vasculature morphogenesis |
GO:0072104 | 0.049 | 8.138 | 0 | 2 | 5 | glomerular capillary formation |
GO:0072124 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of glomerular mesangial cell proliferation |
GO:0072574 | 0.049 | 8.138 | 0 | 2 | 5 | hepatocyte proliferation |
GO:0072575 | 0.049 | 8.138 | 0 | 2 | 5 | epithelial cell proliferation involved in liver morphogenesis |
GO:0072576 | 0.049 | 8.138 | 0 | 2 | 5 | liver morphogenesis |
GO:0080182 | 0.049 | 8.138 | 0 | 2 | 5 | histone H3-K4 trimethylation |
GO:0090239 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of histone H4 acetylation |
GO:1900094 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry |
GO:1900164 | 0.049 | 8.138 | 0 | 2 | 5 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:1901723 | 0.049 | 8.138 | 0 | 2 | 5 | negative regulation of cell proliferation involved in kidney development |
GO:2000316 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of T-helper 17 type immune response |
GO:2000341 | 0.049 | 8.138 | 0 | 2 | 5 | regulation of chemokine (C-X-C motif) ligand 2 production |
GO:2001280 | 0.049 | 8.138 | 0 | 2 | 5 | positive regulation of unsaturated fatty acid biosynthetic process |
GO:0006874 | 0.049 | 1.491 | 17 | 24 | 222 | cellular calcium ion homeostasis |
GO:0002429 | 0.049 | 1.718 | 9 | 14 | 114 | immune response-activating cell surface receptor signaling pathway |
GO:0010976 | 0.049 | 2.130 | 4 | 8 | 54 | positive regulation of neuron projection development |
GO:0031023 | 0.049 | 2.130 | 4 | 8 | 54 | microtubule organizing center organization |
GO:0032941 | 0.049 | 2.130 | 4 | 8 | 54 | secretion by tissue |
GO:0002920 | 0.050 | 2.779 | 2 | 5 | 27 | regulation of humoral immune response |
GO:0003407 | 0.050 | 2.779 | 2 | 5 | 27 | neural retina development |
GO:0032729 | 0.050 | 2.779 | 2 | 5 | 27 | positive regulation of interferon-gamma production |
GO:0055021 | 0.050 | 2.779 | 2 | 5 | 27 | regulation of cardiac muscle tissue growth |
GO:0060996 | 0.050 | 2.779 | 2 | 5 | 27 | dendritic spine development |
GO:0046390 | 0.050 | 1.520 | 15 | 22 | 200 | ribose phosphate biosynthetic process |